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ABSTRACT
Biphenyl nfôtabolism has been extensively studied in isolated 
viable adult rat hepatocytes in suspension with regard to both 
phase I and phase II reactions. A wide range of primary and secondary 
metabolites are produced by these cells, which closely reflects the 
situation appertaining vivo. Using biphenyl, and the three primary 
metabolites, 2-, 3- and 4-hydroxybiphenyl, assessment of toxicity due 
to the substrate, primary or secondary metabolites, examination of the 
relationship between phase I and phase II metabolism, and the effect of 
inducers and inhibitors on the total metabolic profile has been made. 
Possible rate limiting phenomena operating in the intact cell that 
affect the rate of xenobiotic metabolism have also been studied.
With this insight into the isolated hepatocytes metabolic 
capabilities, particularly with respect to xenobiotic metabolism, 
isolated adult rat hepatocytes in suspension and primary maintenance 
culture were then used as ^  vitro model systems for the assessment 
of xenobiotic-induced toxicity.
Using a mixed liver cell approach, the fibroblast cytotoxicity 
(as measLured by inhibition of cell growth) of a number of xenobiotics 
is shown to be fully expressed only when metabolised to their 'active' 
species by the hepatocytes vitro, closely reflecting the situation 
known to occur vivo. The versatility and general applicability 
of such a mixed-cell approach to in vitro toxicity and carcinogenicity 
assessment of xenobiotics is discussed.
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In order to decide whether hepatocytes model systems could be 
used to assess a xenobiotics hepatotoxic potential, the changes in 
viability and functional capabilities of cultured hepatocytes were 
monitored after exposure to known m  vivo hepatotoxic agents. Results 
presented here indicate that xenobiotics that are hepatotoxic vivo 
are also hepatotoxic vitro, though whether by a similar mechanism 
is as yet unclear.
The advantages and limitations to the use of such in vitro 
hepatocyte model systems for the assessment of xenobiotic-induced 
toxicity in the light of the wide range and variety of other in vitro 
models that are currently being used are discussed.
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CHAPTER 1
1.1. General Introduction
Man has, in recent years, became increasingly aware of the possible 
deleterious effects the vast numbers of s^mthetic drugs, food additives, 
pesticides and other chemicals (collectively termed xenobiotics) can have 
on his environment. This concern is not confined to those chemicals of 
relatively recent introduction into the environment but also includes 
those naturally occurring. The effective and economical safety evaluation 
of such xenobiotics is vital. This assessment of potential hazard has 
in the past almost entirely been carried out ir vivo in experimental 
animals particularly rats, mice and dogs, assessment of toxicity being 
based largely on pathological considerations. The need for animal studies 
derives directly from the fact that many studies would be unethical and/or 
impractical if directly carried out on human subjects. There is wide 
agreement that no-one is entitled to administer a new xenobiotic to another 
human being unless they have full knowledge of its composition and of the 
impurities it may contain and information about the likely effects it may 
have on the recipient.
In the last few years, biochemists, pharmacologists and physiologists 
have begun to contribute to these studies and the understanding of basic 
principles governing toxicity has improved considerably.
\Vhen the xenobiotic is administered it may undergo modifications in 
the course of digestion, absorption or transport through various organs 
and tissues. Since the body's excretory mechanisms are tailored to
handling water-soluble compounds, not lipid soluble ones, lipophilic 
chemicals must be converted to more hydrophilic ones in order to be 
excreted. These metabolites may have the same biological properties 
as the parent compound, or they may differ quantitatively and/or 
qualitatively from them.
The biological changes that occur, due either to the xenobiotic 
and/or its metabolites which determine the overall effects of a xenobiotic 
on the body may vary from species to species or from strain to strain.
In using animals for predicting effects in man, it is important to know 
what modifications are brought about in the different species and strains 
of animals used and the relationship of these changes to those that occur 
in man (Conney ^  1974). Better prediction may be expected if animals
are used that handle the xenobiotic under test in a manner similar to human 
subjects. This important aspect in a toxicological study is all too 
frequently emitted. Ideally, the choice of animals for acute and toxicological 
studies should be based on adequate biochemical and metabolic information. 
However there are not sufficient suitable different species availaole for 
such studies due to a paucity of information on animal husbandry and patho­
logical considerations in all but a few species. \Vhat xenobiotic metabolite 
comparisons between animal and man have been made usually refer to the stable 
inactive metabolites, i.e. those found in urine and bile and not the less 
stable, but potentially more inportant, active metabolites. Although 
animal experiments have contributed very significantly in the; past to 
identifying the toxic potential and the effects of new xenobiotics, there 
have also been failures despite the intensive efforts that have been made 
to improve the predictability of animal experiments for man, chlorpromazine 
causing drug-induced jaundice, and sulphonamides producing skin allergy 
are two notable examples.
By their nature, the development of gross anatomical changes must 
be studied in the intact animal. However, for investigating toxicity 
at the cellular or biochemical levels, it is often more convenient to 
use ^  vitro model systems (Walton and Buckley, 1975). With the need 
for rapid and reproducible screening of vast numbers of drugs, synthetic 
and natural compounds already in the environment^becoming more pressing, 
the development of appropriate short-term readily manageable preliminary 
assessment systems to evaluate the potential hazard is vital (Bridges, 1976). 
Before these tests can be used routinely, validation is essential.
These methods, if reliable, would not only be invaluable to industry for 
testing purposes but should enhance our understanding of the nature of the 
lesion and early mechanisms of toxic damage engendered by xenobiotics.
1.2. Advantages of in vitro model systems for Toxicity Assessment
In vivo tests are, despite their value, cumbersome, lengthy and 
expensive, requiring highly specialised personnel and suitable facilities 
to house the animals under study. (N.B. Cumbersome due to the large 
numbers of animals required, lengthy because of the time taken to generate 
the effects, up to 2 years in rats and mice or 7 years in the dog. The 
cost of such studies is very high due mainly to their complexity, which 
is dependent to a large extent on the skill of the operators in measuring 
the changes in vivo). Primary lesions are often obscured by subsequent 
severe secondary effects, rendering it difficult to follow the sequential 
development of metabolic and structural lesions in whole animals. Obfuscating 
factors such as hormones, intertissue effects, stress and other environmental 
variables are operative and there is poor control of dose/time parameters 
with in vivo studies. The availability of the large amounts of conpound 
required for such tests can also present a-problan.
These and other disadvantages of in vivo experiments can be largely 
overcome by the use of suitable in vitro systens. They are generally 
by their very nature far more economical to set up and maintain than 
in vivo systems, being far less wasteful of animals, chemicals and man­
power and capable of handling a large throughput.
In preparing an in vitro system, the cells or tissues can be isolated 
from the animal body and placed in a physiological medium, which is both 
quantitatively and qualitatively defined, and in which the CO^ level, 
pH and temperature can be controlled. That the isolation procedure 
has not damaged or otherwise altered the cells or tissues must be checked.
To the medium can be added known concentrations of toxic agents which 
remain in contact with the cells for known periods of time. Such a 
defined experimental medium permits the changes which are produced directly 
in the cells to be distinguished from those, such as hormone-mediated 
changes, which are produced indirectly. Also, because in vitro conditions 
allow control of the concentration of the xenobiotic^  studies can be 
readily carried out to determine dose-response, time-concentration 
relationships and reversibility (or otherwise) of the toxic damage 
produced in the cells. Under the simplified conditions used with cultures, 
the lesions are often more clearly and rapidly defined than when they are 
produced ^  vivo and the results tend to be more reproducible. Care should 
be taken in the selection of in vitro system, particularly in relation to 
the type of problem to be solved. It is important to devise a model system 
which is related to the mode of toxicity of the xenobiotic under test.
Wliile some drugs such as cyanide which, being a general metabolic toxin, 
affects all cell types, can be studied with any type of cultured cells, others, 
like cyclophosphamide, influence only certain types of cells. With this 
approach, it becanes possible to enconpass a variety of tissues and species.
and a range of doses and time intervals which would be impossible in vivo 
together with the unique possibility of being able to observe the reaction 
of tissues from man under the same conditions as those of experimental 
animals using the many monitoring devices that can be brought to bear.
Although many advantages are apparent in the use of ^  vitro systems, 
great caution must be exercised with the interpretation of results and 
their application to the whole animal situation. It is important to 
realise some of the inherent limitations of in vitro model systems.
These will be discussed later (section 1.5) with particular reference to 
intact cell systems.
1.3. jn vitro approaches to Toxicological Assessment
In vitro systems which have been used for toxicological studies vary 
considerably in their complexity. On one hand there are isolated organs 
or organ slices, while at the other extreme, cell hcmogenates, isolated 
cell components and individual mcromolecules have all been used in 
toxicological studies. Preparations such as freshly isolated and cultured 
cells and isolated kidney tubules represent an intermediate level of 
complexity for experimental studies of toxic agents and their biological 
substrates. Cell homogenates, isolated cell components and macromolecules 
usually have a very limited experimental life-span (less than 1 hr) and 
so can be only used in a very short-term study. Organs and organ slices 
however can be maintained in vitro under (IwGioWg&W conditions for longer 
periods, up to 8 hours, while cultured cells have a considerably extended 
viable life in vitro, usually several days or even months (Paul, 197 3). 
Such models therefore lend themselves to much longer term toxicological 
investigations. Seme of the in vitro systems which have been used are 
summarised in Table 1.1.
Table 1.1. In vitro Systems used in Toxicological Studies
System Tissue/Cell/FractionUsed Particular Aspect Studied Reference
Isolated perfused Rat liver Phalloidin Jahn (1972)organs poisoning
Rat liver Bromobenzene and 
Carbon tetra­chloride toxicity
Davis et al (1973)
Rat liver Chlordiazepoxide HCl toxicity Abernathy et al (1975a
Rat liver 6-Aminochrysenekinetics Russo et al (1976)
Rabbit lung Uptalce and metabolism of Nicotine McCovern et al (1976)
Organ slices Rat liver and Binding of Phenyl- Massey andkidney mercuric and Mercuric acetate Fang (1968)
Rat kidney Metabolism of lactate after Mercurial 
intoxication
Ellis and Fang (1973)
Rat liver Paracetamol toxicity McLean and 
Nuttall(1976
Organ subunits Flounder kidney tubules Cyanide toxicity Trump and Bulger (1968
Organ cultures Table 1.2.
Explant cultures Table 1.3.
Cell lines and Table 1.4.established celllines
Primary cultures Table 1.5.
Protozoa Amoeba proteus N-methyl-N-nitroso- urethane $|3(dichloro- diethyl )methylamine and Methylmercury chloride toxicity
Qrd (1976)
Tissue hcmogenates Rat and Human liver Metabolism of Methyl- Strotherhomogenates carbamate insecticides (1972)
Rat kidney mito­ Transformation by Evan (1973)chondria Lithium carbonate
Rat liver microsomes Carbon tetrachloride- induced damage Archakov and Karuzina (1973)
Pure macromolecules Acetylcholinesterase Inhibition of enzyme Aldridgepreparation action by organo- phosphorus compounds (1974)
1.4. Tissue Culture and Toxicology
There have been a number of reviews of the use of tissue culture 
methods in toxicology (Rofe, 1971; Dawson, 1972; Worden, 1974; Styles, 1977). 
For a survey of the most recent tissue culture methods used, not covered 
by these reviews see Chapter 4.
1.4.1. Definition of Terms
The term 'tissue culture' is most v.ldely accepted as meaning the 
maintenance of cells in a viable and functional state for a time period 
greater than 24 hours, and this definition will be the one applied in the 
following discussion. There are basically three tissue-culture systems, 
namely organ culture, explant culture and cell culture.
1.4.1.1. Organ Culture
This involves the maintenance of an organ or organ fragment such that 
its cellular architecture is unaltered and peripheral outgrowth from the 
cultured tissue is discouraged. This is usually achieved by placing the 
tissue at the culture medium-gas interface either by flotation or on a 
grid (Mosccna et al, 1965). Organ culture has been successfully applied 
to foetal tissues of most types as well as some adult mamnalian tissues.
A major problen with the use of organ culmure is one of necrosis in the 
centre of the cultured tissue, which is related to the problem of adequate 
gas exchange between the gas overlay and the centre of the fragment, a 
factor 'Which has almost certainly contributed to the relatively few 
toxicological studies that have used this model (for examples see Table 1.2.)
1.4.1.2. Explant Culture
Tills system is very similar to organ culture in that small fragments 
of tissue are used but differs from it in that peripheral outgrowth is 
encouraged and the outgrov/ing cells, not the expiant, are examined. This
10
Table 1.2. Organ Culture Systems used in Toxicological Studies
Organ Particular Aspect Studied Reference
Rat Lymph Nodes Nitrogen mustard cytotoxicity Trowell (1961)
Rat Prostrate Actinomycin effects on RNA synthesis Lasnitzki (1968)
Human Pleura Asbestos toxicity Rajan et al (1972)
Human Bronchi Polycyclic aromatic hydrocarbon binding
Harris et al (1974)
Rat and Efeumster Trachea, Benzo(a)pyrene metabolism Bronchi and Lung Cohen and Moore (1976)
Human, Hamster and Rat Lung Benzo (a )pyrene metabolism Cohen et al (1976) .
Rat Trachea Benzo(a)pyrene metabolism and binding Cohen et al (1977)
Table 1.3. Explant Culture Systems used in Toxicological Studies
Tissue Particular Aspect Studied
Reference
Chick Embryo Penicillin toxicity Abraham e+ al (1941)
Chick Embryo Heart Polymixin B sulphate toxicity Metzger et al (1952)
Newborn Rat and Chick Embryo Ganglia Guanthidine and 6-Hydroxy- dopamine toxicity
Hill et al (1973)
Newborn Rat Cerebella Phthalate ester toxicity Kasuya (1974)
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is accarplished by attaching the explant to a solid surface and flooding 
with medium. As with organ culture there are only a few examples of 
this model system employed in toxicological studies (see Table 1.3.).
1.4.1.3. Cell Culture
In this system, the organ or tissue is dissociated by suitable 
means (mechanical, chemical or enzymic) to produce a monodisperse cell 
suspension which can either be used immediately or can be cultured either 
by a-ttachment to a solid support (usually glass or plastic) or in 
suspension. The cultures which are obtained directly after dissociation 
of the tissue are termed 'primary cultures' ; once these cultures are 
passaged, the resulting culture becomes a 'cell line'. Many of these 
cell lines have a finite life span but occasionally they beconfô transformed 
either spontaneously or by deliberate manipulation, and so became capable 
of unlimited cell growth ; such cultures are termed ' established cell lines ', 
Cell suspensions, primary cultures, cell lines and established cell 
lines can and have all been used in toxicity studies.
The use of cells maintained in culture for the evaluation of toxicity 
of various drugs and other xenobiotics is widespread. Cell culture 
systems not only may be used for the examination of a particular aspect 
of the toxicity of a compound in relation to its toxicity in vivo, but 
also for the comparison of toxicity of a series of related compounds 
(Palmer et al, 1972).
1.5. Limitations to the use of Cell Culture Systems in Toxicological Studies
As with every in vitro system the use of dissociated intact cells 
does pose problems peculiar to the system, particularly in the areas of 
cell function and specialisation. They include dedifferentiation.
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cell-type identification, cell viability and sample handling and analysis.
1.5.1. Dedifferentiation ~
Tils is a major problem and difficult to define. Dedifferentiation 
involves the loss of certain functional characteristics as the cells 
are cultured for a number of generations such that after a certain 
time the structure and function bear little resemblance to the freshly 
isolated cells from which they were derived. The difficulty of inter­
pretation of findings arises when one considers the reversion of cultured 
adult cells to the foetal state. For although foetal cells in vivo 
exhibit foetal-specific functional and structural characteristics not 
found in adult cells, they must have the potential for these functions.
In the foetal state, adult-specific chai^ acteristics are not lost, only 
suppressed.
Dedifferentiation is of particular significance in toxicology 
studies since many toxic reactions arise through interference with 
specialised cellular Dnctioiis which may be lost in the dedifferentiation/ 
reversion process. The ability of cells to convert a xenobiotic to 
toxic entity may be regarded as such a specialised function particularly 
susceptible to loss during dedifferentiation (Quzelian et 1977) and 
will be dicussed in detail elsewhere (Chapter 2). As a rule, cell lines 
and established cell lines retain very few specialised functions.
1.5.2. Cell-type Identification
Isolation of cells from organs or tissues must lead to problems of 
cell-type identification due to the heterogenicity of their cellular 
make-up. Mammalian lung, for example, is said to possess at least 40 
different cell-types. A detailed assessment of the cell-types present
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must therefore be included with any toxicological study involving 
isolated cells.
1.5.3. Cell Viability
To assess how much the isolation and handling procedures have 
altered the functional ccmpetence of the cell can be difficult. A 
satisfactory standard for comparison may not be available, viability 
can be assessed using a wide range of structural and functional criteria 
differing considerably in their sensitivity to assess cellular damage.
These methods will be defined and commented upon in Chapter 2.
1.5.4. Sample handling and Analysis
As most cell systems involve the use of small numbeis of cells, 
this can pose problems of handling and analysis. Techniques such as 
histochemistry, autoradiography, electron microscopy and more recently 
fluorimetry using a laser as the light source have been utilised to over­
came such problems.
In spite of the inherent limitations discussed above, the most 
widely used cell systems are cell lines and established cell lines, 
primarily because they are easy to maintain and are reproducible (for 
examples see Table 1.4.). However, the use of freshly isolated primary 
cultures for toxicity assessment (see Table 1.5.) may in many instances 
be more relevant since the cells are obviously closer in their biochemical 
and physiological responses to cells of the same origin in the intact 
organism, and the findings obtained with the latter may be regarded as more 
reliable for predicting the anticipated effects under in vivo conditions. 
Problems of alteration in cellular characteristics associated with pro-
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Table 1.4. Cell Culture Systems used in Toxicological Studies
(a) CellLimes and Established Cell Lines
Cell Type Xenobiotic(s) Studied Reference
Chang liver DSS Dujcvne and Shoeman (1972)
EB cancer CPA Dolfini et ^  (1973)
Rat embryo liver E3 and Bl, Rat embryo fibroblasts
CPA Grayzel and Beck (1974^
Human melanoma Papaverine Kelson et al (1974)
HeLa 6-Mercaptopurine Horakova et al (1974)
HeLa Chlorphenamidine Muralcani and Fukami (1974)
HeLa, HEp—2 Actinomycin D and Methotrexate Pacsa (1974)
Walker tumour CPA Phillips (1974)
Rat embryo liver E3 7,12D]\1BA and Aflatoxin B^ Schwartz (1974)
Chang liver, 3T6 fibroblasts Alcohol Walker et ^  (1974)
HeLa TCDD Beatty et ^  (1975)
HeLa Carbaryl and Dieldrin Blevins and Dunn (1975]
Chang Liver Erythromycin Derivatives Dujovne (1975)
Human Wl-38 Phthalate Esters Jones et ^  (1975)
Mouse Leukemic L5178Y Mercuric compounds Nakazawa et ^  (1975)
Ascites sarcoma BP8 Tobacco and Tobacco Smoke 
Constituents Pilotti et al (1975)
Human skin fibroblasts A^ -THC and Aflatoxin B^ Cooper and Goldstein 
(1976a)
Human skin fibroblasts CPA Cooper and Goldstein (1976b)
Chang liver General Anaesthetics Goto ' et al (1976a)
Rat hepatcma CC1144 General Anaesthetics Goto et ^  (1976b)
Mouse liver Benzo(a)pyrene Landolph ^  al (1976)
P388D1 Macrophages Asbestos Wade et ^  (1976)
Monkey kidney Pesticides Desi et al (1977)
Abbreviations used: CPA - Cyclophosphamide
DSS - Dioctyl sodium sulphosuccinate
7,12D1VIBA - 7,12-Dime thy Ibenz (a )anthracene
TCDD - 2,3,7,8-Tetrachlorodibenzo-p-Dioxin
A^-THC-A^ -Tetrahydrocannabinol
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Table 1.5. Cell Culture Systems used in Toxicological Studies 
(b) Primary Cultures
Cell Type Xenobiotic(s) Studied Reference
Human tumour Range of Cytostatics Dawson and Dendy 
(1971)
Monkey kidney BHT Metcalfe (1971)
Guinea-pig kidney fibroblasts Hydroxyurea, Sodium lauryl sulphate and Rose Bengal Ferguson and Prottey (1974)
Rat alveolar and peri­toneal macrophages Paraquat and Diquat Styles (1974)
Rat foetal liver Dieldrin Sheinman and Yannai (1974)
Rat heart endothium Various Reed and Wenzel 
(1975)
Rat heart muscle and 
endothelium Caffeine
Acosta and Anufuro 
(1976)
Guinea-pig kidney 
fibroblasts
Surfactants Ferguson and Prottey 
(1976)
Mouse spleen Alcohol Freund and Forbes (1976)
Rat kidney Mercuric chloride Inamoto et al (1976)
Abbreviations used:- BHT - Butylated hydroxy toluene
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longed culture (Eagle, 1965) are therefore minimized by the use of 
primary cultures. The correct selection of those cells to be studied 
is vital and since the liver is highly susceptible to adverse effects 
of many xenobiotics, hepatic cells would appear an obvious vehicle 
for many toxicity studies.
Toxicologically the liver is important for two main reasons.
Firstly, because of its position as a presystemic site for the attention 
of ingested xenobiotics, the liver often exhibits signs of xenobiotic- 
induced toxicity. Secondly, because of its primary role in xenobiotic 
metabolism, both in forming inactive metabolites and highly toxic 
metabolites which manifest their adverse effects either in the liver 
cells themselves or to cells in other oigans distant fran the liver 
(Mitchell and Jollow^  1975).
Tie development, in recent years of techniques for the isolation 
of large numbers of viable adult hepatic cells, has made possible the 
use of hepatocytes vitro for the evaluation of toxic potential 
in vivo. Tvo approaches are available, isolated liver cell suspensions 
and short-term maintenance liver cell cultures, both of which were employed 
in the present study. These systems possess a well developed metabolic 
capability, particularly with respect to xenobiotics for it is well 
known that cultured hepatocytes, particularly a dividing population, tend 
to lose their xenobiotic-metabolising capability and extent of inducibility 
whilst retaining other liver-specific functions (Bissell and Guzelian, 1975) 
Short-term maintenance adult hepatocyte cultures and cell suspensions then 
potentially allow the study of both phase I and phase II metabolism of 
xenobiotics and the assessment of active metabolite contribution to cell 
toxicity.
17
ŒAPim 2
Drug Metabolism vitro - Cell Suspensions 
and Cell Cultures
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CHAPTER 2
2.1. Xenobiotic Metabolism - General Characteristics
Tlie mammalian liver is the organ responsible for the vast majority 
of transformations of xenobiotics in vivo, although various other 
organs (e.g. lungs, small intestine and skin) also possess this 
capability, to a lesser extent. Williams (1959) has classified 
xenobiotic metabolism into two separate phases, namely phase I (bio- 
transformation or preconjugation) and phase II(conjugation). Although 
direct conjugation can occur, most xenobiotics are metabolised by both 
phases of the proctAs.
The phase I hepatic metabolism of xenobiotics is localised in a 
number of subcellular fractions including mitochrondria, cytosol and 
most importantly the endoplasmic reticulum and involves oxidation, 
reduction and hydrolysis reactions. One type of reaction mediated by 
the mixed function oxidases QXK)) (Mason, 1957) is believed to be 
responsible for most of these oxidation reactions, imny of which can be 
regarded as involving an initial hydroxylation step (Brodie et al, 1958) 
At the heart of the major MEG system is the terminal oxidase cytochrone 
P~450, so called because it gives a wavelength mæcimum at 450 nra in 
the reduced state in the presence of carbon monoxide (Qnura and Sato, 
1964). After binding to the substrate and reduction, cytochrome P-450 
is capable of accepting molecular oxygen and converting it to an active 
oxygen species which can bring about the oxidation of the substrate 
(see figure 2.1. for a diagram of the essential components of tliis 
system and their interrelationships). This oxidation process also has 
an absolute requirement for NADPH \^ hich is supplied from the cytosol. 
Sever Ell excellent reviews on the hepatic MEO system have been written 
(Estabrook et al, 1971; Gillette, 1971; Ivîannering,1971; Lu and Levin,
20
(product)BOH
( substrate )REï3+P-450. Fe’
uncoupling 3+2+ (form giving binding spectra)
P-450. Fe'
RH
NADP NADPH
2+2+ P-450.Fe‘P-450.Fe t c reductase 
(P-450 reductase) RH
2+P-450.Fe'h IË 0-0 H
Figure 2.1. Schematic diagram of cytochrome P-450 mediated
hydroxylation of xenobiotics (from Fry and Bridges, 1977a)
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1974; Estabrook et al, 1975; and Lu, 1976) which deal with this 
subject in far greater detail than is appropriate here. Tiie initial 
step in P-450-iædiated oxidation, substrate binding to oxidised 
P-450, can be observed spectrophotometrically, using microsomal 
fractions or cell suspensions . These spectral changes are characterised 
by their wavelength maxima and minima (type I: Xmax at 385-390 nm,
Amin 418-427 nm; reverse type I: Amax at 418-423 nm, Amin 385-390 nm 
and type II: Amax at 425-435 nra, Amin at 390-405 nm) (figure 2.2.).
Dehner et^  ^  (1968); Uehleke et ^  (1970)and Ziegler and Mtchell
(1972) however have shown that cytochrome P-450 is not a conponent of the 
hepatic ÎÆPO system that catalyses the N-oxidation of secondary and 
tertiary amines.
A wide range of chemicals, including drugs, insecticides and 
polycyclic hydrocarbons readily induce the P-450 &@0 systen (Rammer,
1972) a process only demonstrated so far in intact cells as it 
necessitates de novo protein synthesis. Phenobarbitone (PB) and the 
polycyclic hydrocarbon 3-methylcholanthrene (3-M3) are the most widely 
studied inducers. They have been shown by many workers (Gillette,
1971; Renner, 1972; Conney et al, 1973) to exert their inducing effects 
by different imchanisns. Induction by PB enhances almost all the 
reactions catalysed by P-450 whereas 3-IC induces relatively few 
pathways. The appearance of a different form of P-450 (from that of the 
control or PB-induced state) termed P-448 (P^ -450) acccanpanies this 
selective induction by 3-MC. Enzyme inducers nay therefore modify 
the rate of metabolism and hence the toxicological effects, both 
short-term and long-term, produced by xenobiotics (Hunter and Chasseaud, 
1976). As far as the effects on man are concerned, the evidence is 
generally indirect, being ^  from animal experiments.
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Figure 2.2. Binding of Type I and Type II compounds to liver 
raicrosomes (from Fry and Bridges, 1977a)
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Parke (1968) has pointed to the important role that non-niicroscmal 
systems play in the metabolism of certain xenobiotics such as mescaline, 
disulfiram, procaine, phenytoin and isoniazid. Present in the mito­
chondria are amine oxidases and enzymes which aromatise saturated 
alicyclic compounds. In the soluble fraction are found the enzymes 
alcohol dehydrogenase, aldehyde oxidase and xanthine oxidase. These 
non-microsomal systems therefore must not be ignored.
Conjugation reactions that occur in the cell most often use the 
donor molecule glucuronic acid in the form of uridinediphosphoglucuronic 
acid (UDKIâ). Glucuronidation is associated with the endoplasmic 
reticulum of the liver cells though UDPGA is produced by the cytosol. 
Other conjugation reactions such as sulphation, méthylation, acétylation, 
glutathione conjugation and peptide-bond formation occur in the liver 
cells but are non-inicrosoml in distribution.
2.2, In vitro Systems for studying Metabolism of Xenobiotics
Liver tissue homogenates and subcellular fractions of liver have 
been the most widely used systems for ^  vitro drug metabolisn studies. 
The reasons being (i) simplicity of isolation of the fragments 
(however irrpure) of endoplasmic reticulum, i.e. microsones, (ii) 
optimal assay conditions easily established and (iii) ready adapta­
bility of methods from one species to another.
There are however serious drawbacks to this system which have 
been discussed in detail by Fry and Bridges (1977a ) and so only a 
summary will be given here. Tissue homogenisation is a harsh 
treatment presenting shear and stress problems, \iiich can lead to 
art if actual changes in the homogenate due to destruction of membrane 
ccmponents and cofactors through dénaturation due to shear^  localised
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heat or the release of lysosomal and other enzymes. This procedure 
may also lead to activation or inhibition of the enzymes by the 
choice of homogenising medium (Bachmann et 1970) or the release 
of compartmentalised endogenous inhibitors (Liehman and Anaclerio,
1961).
The optimal levels of cofactors used in the incubations will 
almost certainly not correspond with the levels existing within the 
cell. Mtochondrial control of cofactor levels operative in vivo 
(Cinti and Schehkman, 1972; Cinti et al, 1972 a,b; Moldeus et al,
1973 a) is not operative in homogenates or microsomal fractions 
and so misleading results may be obtained from such studies. It may 
give an undue emphasis to the foimation of certain metabolites which 
are of minor significance ^  vivo  ^ an aspect very crucial in studies 
where the relative importance of the toxic metabolite produced in 
relation to the total metabolic profile is being assessed. The total 
cellular metabolism of a drug will not be shown if it is carried through 
the cooperation of a number of different organelles. Finally the 
dependence of xenobiotic metabolisn on rate of entry of the conpound 
into the cell and rate of excretion/secretion from the cell cannot 
be assessed in isolated microsoml fractions or tissue honogenates.
Fry and Bridges (1977a) conclude therefore that metabolism studies 
using subcellular fraction incubation systems may misrepresent both 
quantitatively and qualitatively the in vivo situation. The authors 
suggest that for liver, the pertinent alternatives to cell homogenates 
and fractions are those of the perfused organ,justices, isolated cells 
and tissue cultures. Tliese in vitro systems are, in their opinion, 
potentially a much closer approximation to the in vivo state than is 
the use of isolated liver fractions, largely because their individual
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cell architecture is unchanged. Hov/ever due mainly to technical
danands few drug n-etabolism studies have been made of’ these intact
cell preparations compared with those on tissue homogenates and cell
fractions. Dutton (1959) and Cinti et ^  (1972a) have used liver 
eKiLSQ.slices buty^ suffer the disadvantages of mechanical damage to the cells as 
a result of the slicing procedure and lack of reproducibility due to 
necrosis In the centre of the slice, which severely limits its 
viability. Isolated perfused liver preparations have been more widely 
used in xenobiotic metabolism studies (Juchau et 1965; Cordelli 
et al, 1969; Bickel and Minder, 1970; von Bahr et 1970; Minck 
et al, 1973; Bock, 1974). Although this approach does have its merits, 
problems of technique do exist which are of a serious nature especially 
when considering general applicability (Fry and Bridges, 1977a). These 
drawbacks include possible interference of hormones, adequate gas 
exhange, limited viable time (less than 6 hours) choice of suitable 
viability criteria during the perfusion and lack of reproducibility. ' 
Species comparisons are difficult and it also is a very time consuming 
and costly method coipared to other procedures.
2.2.1. Advantages to the use of Cell Suspensions and Cultures in 
Xenobiotic Metabolism Studies
V/hen using freshly isolated cells or cells in culture, many of the 
problems associated with the whole-cell systems described above (i.e. 
slices and perfusion) do not arise and consequently these systems may 
be particularly relevant in vitro models with which to study the 
metabolism of xenobiotics (Bridges and Fry, 1976; Fry and Bridges^  
1977a). The particular advantages to the use of studies in cells have 
been reviewed by these authors. Briefly the value of cell suspensions
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or cell cultures lies, in the fact that the full canplement of drug 
metabolising enzymes is present and possible rate-limiting phenomena 
such as cofactor levels, control mechanisms and cellular transport 
mechanisms are probably preserved intact. Furthermore, the concentration 
of drug to which each cell is exposed is similar and obfuscating factors 
such as fluctuating hormonal influence are avoided. The relationship 
between xenobiotic metabolism and changes that occur within the cells, 
including toxicity, can be more readily studied using such iu vitro 
models,. For further discussion and specific examples see Chapters 4 and 
5.
2.2.2. Problems with the use of Cell Suspensions and Cultures in 
Xenobiotic Metabolic Studies
Although cell suspensions and cell cultures possess great advantages, 
there are problems associated with their use. These are related to 
handling, analysis and expression of results. Bridges and Fry (1976) 
and Fry and Bridges (1977a) have again reviewed this aspect in some 
detail, so only a brief assesanent will be made here.
Sensitive assay systems are required to separate and distinguish 
the large numbers of metabolites produced by the relatively small numbers 
of cells which are used. To date radioisotopic,fluornmetric and more 
recently histochenical techniques have been most widely employed. The 
choice of an appropriate solvent in which to dissolve the drug substrate 
or test compound prior to addition to the culture medium is another 
problem. Water-soluble compounds present no serious difficulties as they 
are readily dissolved in a suitable salt solution. However it is with 
lipid-soluble compounds that problems arise. Small amounts of organic 
solvents such as acetone, dimethylformamide or dhmethylsuXphoxide may
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be used. The effects of these solvents on the system under must 
however be thoroughly checked. Sonication of lipid soluble compounds 
can also be used to aid dispersion, prior to adding to the cells.
Cell viability checks at the end of an experiment are advisable, since 
cytotoxicity may be produced by the drug substrate. A new solvent or 
increased solvent volume make such checks essential. Correct expression 
of results is yet another problem. Whether cell number, cell protein or 
cell D M  are used depends on the nature of the study. Specific examples 
of both advantages and problems to the use of intact cell systems will 
be highlighted in the present studies,
2,3. Development of Techniques. for the Preparation of Hepatic Parenchymal 
Cell Suspensions - A History and Rationale
As mentioned previously the liver has a major responsibility for 
the metabolism of xenobiotics, and for this reason rat liver parenchymal 
cells in suspension have been used in most of the few reports of 
xenobiotic metabolism that have appeared in the literature. First, 
however, it is appropriate to include a brief review of the history and 
rationjile of the development of cell separation techniques that are 
pertinent to the isolation of hepatic cells in a viable and functional 
state. Current methodologies for cell separation owe a great deal to 
studies stretching back over 75 years. The development of sound 
techniques for the separation of cells of solid organs required not only 
seme Imowledge about how cells are joined together, but also the 
commercial availability of the tools to take than apart.
2.3.1. Development of knowledge concerning Cell Adhesion
Ringer (1890) was the first to draw attention to the possible 
role calcium ions might possess for cell adhesion with observations
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made chiefly on tadpoles and a green alga, Laminaria. Tliis finding was 
confirmed by Herbst (IKD) and Lillie (1906). Such early observations 
prompted workers in the field of organ culture to omit calcium ions 
from the incubation medium when cell separation was desired.
It was as early as the mid 19th century that light microscopists 
first described junctions between two opposed cells which were regarded 
by them as adhesive plates to which both cells contributed. Schaffer 
(1927) identified areas of thickening and adhesiveness at cell boundaries 
which he called "terminal bars". However it was not until the introduction 
of the electron microscope that the fine structure of cell junctions was 
elucidated. The elegant work of Farquhar and Palade (1963) clarified 
the confusion that had existed till then. These workers clearly 
distinguished the tight juction (zonula occludens) wiiere the cell 
membranes of two contiguous cells actually fuse and the gap junction 
(zonula adlaerens) which is characterised by a true intercellular space.
The desraosone (macula adherens) was also identified (see figure 2.3.).
2.3.2. Use of Enzymes in Cell Separation
The use of trypsin to loosen cells from tissues also has a long 
history dating as far back as Rous (1916). Trypsin remained the enzyme 
of choice for workers in the field of tissue culture (Moscona, 1952) 
until 1953 when Mandl and co-workers isolated and characterised collagenase 
from Cl histolyticum. Lasfargues (1957) utilised the enzyme for the 
isolation of cells from normal mammary epithelium. In 1964, Rodbell 
used the now commercially available preparation for the isolation of 
intact fat cells from adipose tissue with considerable success.
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Figure 2.3. Diagram to show the fine structure of cell junctions 
in the manmalian hepatocyte (taken from Evans, 1977),
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2.3.3. The Histology and Cell Types of Marrmalian Liver
The parenchymal cells of the mammalian liver are arranged in a 
series of branching and anastomosing perforated plates to form a 
labyrinth between which run the sinusoids. The plates are usually 
one cell thick, although any single cell is bordered by several others.
Thus each cell will be firmly attached to a number of its neighbours 
by means of the functional conplexes described above. The entire 
organ is peimeated by a fibroconnective tissue skeleton composed 
of collagenous fibres. Within each hepatic lobule there is a fine 
meshwork of reticular and collagenous fibres around the sinusoids and 
within the perisinusoidal spaces. The non-parenchymal cells present 
in the mammalian liver of which there are a large number of different 
types (Table 2.1.), constitute quite significant proportions of the total 
cell population of the liver; approximately 16% in man (Gates et al,
1961) and nearly 40% in rats (Daoust, 1958). One might be forced 
to deduce from these facts that the likelihood of success in preparing 
intact hepatocytes from the mammalian liver would be very low. Fortunately, 
the early workers in the field of liver cell preparation were either 
unaware or undaunted by the difficulties they faced.
2.3.4. Mechanical/Chemical Methods for Liver Parenchymal Cell Isolation
One of the earliest attempts found in the literature concerning 
the preparation of hepatic cell suspensions was in 1943, when Schneider 
and Potter forced liver tissue through cheese cloth and then through 
bolting silk. The isolated cells were separated from the tissue debris 
by repeated low-speed centrifugation and resuspension in hypotonic 
phosphate buffer at pH 7.4. St. Aubin and Bucher (1952) obtained isolated 
cells by suspending rat liver slices in an aqueous medium and shalcing 
them with glass beads in a mechanical shaker. Anderson (1953)
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Table 2.1. The Cell Types of Mammalian Liver
Tissue Cell Classes Site
Parenchyma Hepatocjdes Intralobular
Reticulo-Endothelial Littoral (Kupffer and undifferentiated lining cells)
Intralobular
Bile Duct Bile Duct Epithelium Interlobular
Connective Tissue Fibroblasts
Macrophages
Interlobular
Blood Vessel Walls Fibroblasts 
Pavement Epithelium
Inter- and Intrai 
lobular |
Blood Erythroc^ rtes 
Leucocytes 
Lymphocytes 
Monocytes 
Plasma Cells
Inter- and Intrai lobular
(taken from Fry, 1974)
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described the first method for the preparation of isolated cells from 
rat liver in high yield. A liver from an adult rat was perfused ir situ 
with an approximately isotonic calcium-free solution containing a 
calcium chelating agent such a pyrophosphate, ethylenediaminetetraacetate 
(EDTA) or citrate prior to gentle homogenisation. This method was 
modified by several workers (Branster and Morton, 1957; Jacob and 
Bhargava, 1962; McLimans, 1969). The one example of chenical dissociation 
of rat liver, using tetraphenylboron (TPB) as a potassium-chelator was 
described by Rapaport and Howze in 1966. However it soon became 
apparent that cells isolated by these physical or chemical methods 
were completely non-viable as judged by dye-exclusion tests and 
also showed poor respiratory and other functional activities Qiurthy 
and Petering, 1969; Suzanger and Dickson, 1970; Gallai-Hatchard and 
Gray, 1971; Rutzky ^  1971; Lipson et al, 1972; Muller et al, 1972).
2.3.5. Enzymic Techniques for Liver Cell Isolation
It was not until collagenase became available that Howard et ^
(1967) reported the preparation of intact parenchymal cells from adult 
rat liver. The authors injected a calcium-free buffer containing 0.05% 
collagenase plus 0.1% hyaluronidase into the vessels of the liver under 
sufficient pressure to blanche the organ. They then cut slices and 
incubated them in the enzyme-containing medium. The incubation vessel 
contents were then filtered and the freed cells separated by centrifugation, 
followed by several washes in enzyme-free medium. Yields of intact cells 
representing 3-5% (^  6 x 10 ^  cells / g) of the original liver were 
obtained. In the following year, 1968, Howard and Pesch reported a 
modification of this technique which resulted in the production of cells 
of much better quality, as judged by dye exclusion and respiratory rates.
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but again the cell yield was low. This stimulated attempts to find
an enzymic procedure that gave high cell yields. It seened desirable
to try and obtain better exposure of the connective tissues of the
liver to enzyme and better survival of rhe cells during incubation.
This was achieved by Berry and Friend (1969), adding collagenase
and hyaluronidase, in the concentrations which had been found optimal
by Howard et ^  (1967), to a calcium-free medium which was oxygenated
and re-circulated through the liver for 20-30 minutes by means of a standard
rat liver perfusion technique. The soirened liver was then removed
fron the rat and broken up with a blunt spatula. Additional enzyme-
containing medium was added and the resultant suspension incubated in a
shaking water bath for 10-15 minutes. After filtration through nylon
mesh, cells were separated from tissue debris by differential centrifugation.
Yields representing a conversion of 30-50% (a. 80 x 10  ^cells/g) of the
liver to isolated cells were obtained in this way. ^hen a second short
perfusion with a medium containing EDTA was used, yields as high as 60%
6{'h 120 X 10 cells/g"» were obtained.
2.3.6. Current Methodologies
The majority of current methods are based on the procedure of 
Berry and Friend. A number of workers have omitted hyaluronidase*
(Christoffersen and Berg, 1974; Zahlten et 1973), while others 
have modified the perfusion medium (Cornell ek 1973) or perfusion 
teclinique (Capuzzi et 1971; Ingebretsen and Wagle, 1972).
Consistently good yields from 40-60%, even in the absence of EDTA, have 
been obtained with a simplified version of the method of Berry and 
Friend as described by Berry (1974). Seglen (1972, 1973a, 1973b) 
introduced an interesting variation by pre-perfusing the liver with 
a calcium-free medium for 5 to 10 minutes, the perfusion fluid is then
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exchanged for a medium containing collagenase and 5 mM calcium chloride 
and allowed to recirculate through the liver for 10 minutes. Of 
considerable interest was the finding that inclusion of calcium ions 
in the medium after pre-perfusion did not prevent the attainment of 
a reasonable yield of isolated cells. On the other hand if calcium ions 
were also present during the pre-perfusion no intact isolated cells 
were obtained.
Knowledge about the factors governing cellular adlresion has aided 
in developing separation techniques. Likewise the evolution of 
separation methods has thrown new light on factors governing cell 
adhesion (Berry, 1976). It appears that irreversible splitting of the 
desmosomal junctions of the cell membranes brought about by exposure 
of the whole liver or liver slices to calcium-free and/or chelator- 
containing media (Berry and Friend, 1969; Seglen, 1972, 1973 a and b;
Fry ot 1976) is the key elanent in liver cell isolation techniques. 
For a coiTprehensive review of liver cell isolation methods see Seglen
(1976),
2.4. Functional and Metabolic Canp-e bance of Isolated Hepatocytes
Liver cells prepared by either physical or chemical methods, as
mentioned previously, are conpletely non-viable. However liver cell
bysuspensions prepared^collagenase/hyaluronidase digestion have shown very 
good viability, respiratory activity and a retention of a number of 
hepatocyte-specific functions QÆirthy and Petering, 1969; Suzanger 
and Dickson, 1970; Gallai-Hatchard and Gray, 1971; Rutzl^ et al, 1971; 
Lipson et al, 1972; Muller et al, 1972; ïhy 'et 1976). These cells 
have been used in a number of different biochemical studies (Table 2,2).
Table 2.2.
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Sane biochenical studies that have utilised viable
hepatocyte suspensions
Biochemical function Particular Aspect Studied Reference
Lipogenesis
Glycogenolysis/ gluconeogenesis
Protein synthesis and secretion
Tryptophan oxygenase 
Active transport of
Induction of iS-AIA
Regulation by cyclic nucleotides Capuzzi et ^  (1974) 
Inhibition by clofibrate 
Inhibition by halothane
Capuzzi 'et al (1975)
Control by glucagon, epinephrine, insulin and cyclic nucleotides.
Effect of lysine on gluconeogenesis
Gluconeogenesis from D-tagatose
Control of pyruvate kinase flux during gluconeogenesis
Inhibition of glycogenolysis 
by D-galactosamine
Plasm protein synthesis
Thyroxin-binding globulin 
synthesis
VLDL synthesis
Hemopexin synthesis
Angiotensingogen synthesis
Inhibition of protein synthesis 
by ethanol
Inhibition of protein secretion by ammonia
Induction by glucocorticoids
Hormonal control
Requironent of cyclic
nucleotides for induction by allylisopropylacetamide
Mapes (1977)
( Garrison and Haynes(1973)( Wagle and Ingebret­sen (1973)( Zahlten ot ^  (1973) ( Tolbert and Fain(1974)( Wagle (1974)( Byus et ^  (1976)( Claus and Pilkis(1976)( Arinze (1977)
Cornell et al (1974)
Rognstad (1975)
Rognstad (1976)
Wagle et ^  (1976)
Weigand et al (1971) East et ^  (1973) 
Jeejeebhoy et al (1975a)Crane and Miller 
(1977)
Glinoer et ^  (1976)
Jeejeebhoy et al (1975b)
Jeejeebhoy et al(1976)
Weigand ot al (1977)
Morland and Besseson(1977)
Seglen and Reith(1977)
Berg et ^  (1972)
Barnabe! et ^(1974)
Edwards and Elliot(1974)
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Several reports are to be found in the literature of liver 
dissociation using species other than rat, by the collagenase/hyal- 
uronidase technique (Table 2.3.). Miilst perfusion techniques are 
perfectly adequate for use with relatively small animals (i.e. guinea- 
pig, hamster, chick and monkey) they do pose problems when using large 
animals, (sheep, pig, dog, human), very small animals (mice) or 
isolated samples of liver material. Perfusion of wedge biopses of 
pig and human liver (Belfrage et 1975) and excised lobes of
lamb liver (Clark et 1976) have been reported. Systems which 
obviate the requirement for a perfusion stage have also been reported for 
the isolation of liver cells by the collagenase/hyaluronidase digestion 
of liver slices (Fry ^  ad, 1976; Ash and Pogson, 1977). The method 
of Fry et ^  (1976) has been successfully applied to a number of 
species including rat, hamster, guinea pig, ferret, rabbit, dog, pig, 
sheep, and human (Jones, 1978). It is this method that has been used 
throughout the present studies.
2.4.1. Viability Criteria used for Isolated Hepatocytes
During the isolation procedure, liver cells can be damaged by the 
removal of calciuim-ions, the action of lytic enzymes and mechanical stress 
(Howard ^  1973). Thus suitable criteria for estimating their
viability are essential. The following cellular properties can and 
have been used in studies of cell vitality: morphological features
(Weigand et 1971; Berry, 1974), permeability of plasna membrane
(Howard and Pesch, 1968), functional state of the mitochondria (Ontko 
et al, 1975; Dubinslcy and Cockrell, 1975) and complex synthetic and 
metabolic functions (Wagle and Ingebretsen, 1973; Schreiber ^  al,
1974; Wagle, 1975; Claus et al.1975; Claus and Pilkis, 1976;
Grammeltvedt and Berg, 1976). Occasionally the cells are further
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Table 2.3. Sane methods used for the isolation of viable hepatocytes
from species other than rat.
Species Isolation Procedure Reference
Monkey Collagenase/hyaluronidase perfusion in situ
Collagenase/hyaluronidase perfusion in situ (+EDTA)
Collagenase/hyaluronidase perfusion in vitro (-MDTA)
Capuzzi et ^  (1975) 
Glinoer et ^  (1976) 
Poole and Urwin (1976)
Guinea Pig Collagenase perfusion in situ (+EDTA)
Collagenase digestion of perfused liver
Elliott and Pogson (1977 
Arinze and.-Rowley (1975)
Hamster Collagenase perfusion in situ (+EDTA) Rognstad (1975)
Chicken Collagenase digestion of perfused liver
Badeno ch-Jones and 
Buttery (1975)
Mice Collagenase/hyaluronidase perfusion in situ, also various mechanical techniques
Crisp and Pogson (1972)
Pig )Human ) Collagenase perfusion of wedge biopses Belfrage et ^  (1975)
Lamb Collagenase perfusion of excised caudate lobe Clark et ad (1976)
Sheep Collagenase/hyaluronidase digestion of liver slices Ash and Pogson (1977)
Hamster, Guinea Pig, Ferret, Rabbit, Dog, 
Pig, Sheep and Human
Collagenase/hyaluronidase digestion of liver slices 
(+EGTA)
Jones (1978)
38
characterised by electron microscopy (Berry and Friend, 1969; Ikiller 
et 1972; Howard et al, 1973), content of adenine nucleotides 
(Quistorff et 1973),- enzymes (Lentz and DiLuzio, 1971), their 
ability to synthesiæ and secrete various compounds (Crane and Miller,
1974; Jegeebhoy et 1975a) or modify xenobiotics (Cantrell and 
Bresnick, 1972; Fry et al, 1976). Most authors however, have confined 
thoDselves to the trypan blue exclusion test , \diich is based on the 
fact that only cells with damaged membranes permit entry of the 
stain. The meaning of the various criteria of viability and their 
sensitivity remain unclear. Bàur and co-\rorkers (1975) have surveyed 
a number of pararrfôters of the vitality of isolated liver cells in an 
attempt to clarify this situation. An ideal criterion of viability 
should, in the opinion of these authors, be very sensitive and yet 
simple to apply, but these properties are rarely coupled.
The trypan blue test is very easy to perform and reflects a 
change in the permeability of the plasma membrane. However a lesser 
degree of damage of the membrane which might be detected by a decrease 
in membrane potential or intracellular potassium ion concentration 
is not picked up by trypan blue. The trypan blue test allows a very 
fast survey of the cells but detects only fairly severe irreversible 
damage to the plasma membrane. The same is true of the measurement 
of the leakage of a cytoplasmic enzyræ, such as lactate dehydrogenase.
Membrane potential and intracellular potassium and sodium ion 
concentrations were found by Baur et ^  (1975) to be the most sensitive 
criteria of viability, but these determinations suffer from the fact they 
are time-consuming and experimental results can therefore only be 
subjected to retrospective judgement. Another sensitive measure of cell
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viability is the incorporation of labelled uridine into trichloroacetic 
acid-precipitable material. Although readily measurable, it is not easily 
standardised and judgement is again retrospective. The ATP/ADP ratio 
m s  another criterion of viability appraised by Baur and coworkers 
but was found to lack sensitivity, decreases in ATP concentration 
and adenine nucleotide content lagging behind the decrease of membrane 
potential.
The most suitable sensitive test of cell viability out of all those 
surveyed is in their opinion the stimulation of cellular respiration 
by 1 imM succinate. Only a damaged plasma membrane allows succinate 
permeation at a rate sufficient to stimulate endogenous respiration 
(Mapes and Harris, 1975),
Great divergencies, however, will persist in claims for length 
of viability until agreement on the most appropriate sensitive criteria 
of cellular vitality is reached. Viability criteria used should 
ideally be linlced to the type of study performed. Most workers claim 
good viability for rat hepatocytes for up to 3 hours in suspension 
but Crane and Miller (1977) and Jeejeebhoy ^  (1975a) claim that
their hepatocyte suspensions kept at 37°C retain a good cell viability 
as judged by dye exclusion for periods up to 30 and 48 hours respectively.
2.5. Cellular* Uptalæ and Excretion Studies in Isolated Hepatocytes
Numerous reports in the literature are to be found relating to 
the use of isolated liver cells in suspension in studies of the 
mechanisms and importance of cellular uptalæ and excretion of many different 
compounds, both endogenous and foreign.
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Uptake of bromosulphoplithalein, an anionic dye used to test 
liver function, has been studied by two groups (van Bezooijen et al,
1976; Schv/ehk et al, 1976a) in isolated rat hepatocytes. Thtat is 
however, a slight divergence of opinion as to the mechanism. Both 
groups agree that uptake is an energy requiring process, the former 
group suggesting an active carrier mechanism, whilst the latter 
though not eliminating this possiblity, propose a much less specific 
process. Decreased cell viability (as measured by membrane potential^  
respiration increase bj^ succinate and dye exclusion) has been shown to 
result in a concomitant reduction in bromosulphophthalein uptake 
(Schwehk et 1976 b ) demonstrating that membrane integrity is 
one of the essential requirements for cellular uptake or the 
prevention of releakage. The entry of cholic acid (Anwer et 1976) 
and cortisol (Rao et 1976) into isolated rat hepatocytes has been 
shown to occur by an energy dependent carrier process in addition 
to simple diffusion. The existence of active carrier mechanisms for 
butyrobetaine and carnitine uptalce (Christiansen and Brener, 1976), tauro- 
cholate uptake. (Schwarz et al, 1976) and excretion (Schwarz et 1976) 
in isolated rat liver cells has also been reported.
There are however, few reports of cellular release or excretion 
in isolated liver cells. The secretion of plasma proteins has been 
most mdely studied (Crane and Mller, 1974; Weigand and Otto,1974;
Seglen and Reith, 1977) although excretion of bile acids (Anwer et al, 
1975; Schwarz 1976), acetylcarnitine and carnitine (Christiar^ en
and Bremer, 1976) has also been reported.
The importance of cellular uptake as a determinant for the rate 
of metabolism of drugs is exemplified by the findings that, although
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formation of a type I binding spectrum on addition of hexobarbitone 
to isolated rat hepatocyte suspensions is conplete within 1-2 seconds, 
this is very much slower than for homogenates or microsomes (von Bahr 
et al ,1974). The delay is not due to the removal of bound endogenous 
substrate since it has been shown that the major part of cytochrome 
P-4K) in the isolated liver cell is present in an oxidised, non 
substrate-bound foim (Molcfeu.s et 1973b). There is a linear 
relationship between the rate of uptake (as measured by the formation 
of a type I spectrum) of a series of four barbiturates into isolated 
rat hepatocytes and their lipid solubility (von Bahr et 1974), 
suggesting that it is the rate of passage of substrates into the lipid 
phase of the cells that governs the rate of entry. Uptake of lipopliilic 
compounds, which would include most xenobiotics, appears to be by passive 
diffusion and so probably not rate-limiting on subsequent metabolism.
For weakly lipid-soluble compounds the rate of cellular uptal^ e may 
be much slower and hence significantly effect their rate of metabolism. 
The uptake of methotrexate into isolated hepatocytes by an active 
transport system has recently been proposed (Horne et 1976), raising 
the possibility of other xenobiotics also being actively transported 
into or out from the cells. This view is supported by the findings 
of Erickson and Holtzraan (1976) who interpreted a significant reduction 
of Kin for ethylmorphine in isolated hepatocytes (50 u M) when compared 
to microsones (250 u M) as due to the presence of an active transport 
system for ethylmorphine into the cells. Moldeus et al, (1974) found 
that the Km values for alprenolol^isolated hepatocytes and microsones 
were about the same (10 p M)„
This suggests ^ by the same reasoning, there may be no active 
transport system for this very lipophilic drug, entering the cell by
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passive diffusion. The validity of such reasoning is however open 
to severe questioning due mainly to the few xenobiotics that 
have been studied in this manner and the lack of sufficient information 
concerning the nature of the endoplasmic reticulum within the liver 
cell and its interactions with xenobiotics when compared to the inter­
actions with fragments of endoplasmic reticulum i.e. microsomes,
2.6. Xenobiotic Metabolism in Isolated Hepatocytes
In addition to those biochemical studies carried out in isolated 
hepatocyte suspensions (Table 2.2.) the metabolism of xenobiotics has 
also been investigated using this system.
The first report of xenobiotic metabolism in isolated hepatocytes 
was by Henderson and Dewaide (1969) who demonstrated the N-denethylation 
of aminopyrine, p-hydroxylation of aniline and the glucuronidation of 
p-nitrophenol. However these chemically dissociated rat liver cells 
required the presence.of exogenously added cofactors (NADPH and 
UDPGA) for maximal activity, a face which again reflects the functional 
differences which can be produced in isolated liver cells as a 
consequence of the isolation procedure. Collagenase/hyaluronidase 
dissociated liver cells show.ed the same high level of enzyme activity 
whether or not exogenous cofactors were added (Fry ^  1976).
During the last 5 years xenobiotic metabolism in liver cells 
prepared by collagenase digestion has been studied using a wide 
variety of model substrates (Table 2.4.). Some of these investigations 
deal with only the phase I metabolic fate of the xenobiotic 
(Holtzman . et al, 1972; Moldeus et al, 1974; Grundin, 1975; Junge
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Table 2.4. Model Substrates utilised in Xenobiotic Metabolian 
Studies in viable hepatocyte suspensions
Substrate Reference
Alprenolol Moldeus ei al (1974) Grundin (1975)
Aniline Holtzsmn et al (1972) Kao (1977)
Antipyrine Hayes and Brendel (1976)
Benzo(a)pyrene Holtzman et al (1972) Vadi et al (1975) Jones et ^  (1978) Fry et ad (1978)
Benzoic Acid Kao (1977)Fry et ^  (1978)
Biphenyl Gerayesh-Nejad et al (1975) Fry et a]^  (1978)
Dansylamide Hayes and Brendel (1976)
Diphenylhydantoin Inaba et ^  (1975)
Ethanol Grundin (1975)
Ethylmorphine Holtamn et ^  (1972) Erickson and Holtzman (1976)
Ethoxy coumarin Fry et aJ (1976)(1978)
Hexobarbital Junge and Brand (1975)
Naphthalene Bock ei^  ^  (1976)
p-Nitroanisole/p-1^  itrophenol Moldeus et ^  (1976)
Phenol Kao (1977)
Quinine sulphate Hayes and Brendel (1976)
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and Brand, 1975; Ericlcson and tt>ltzinan,1976; Hayes and Brendel,
1976). Orrenins and his coworkers have shown that isolated hepatocyte 
suspensions provide a valuable tool in drug metabolism linlced to 
cytochrome P-450, its intracellular regulation (Moldeus et al,
1974), interaction with other substrates (Grundin, 1975) and cytochrome
P-450 product complexes (Hirata et 1977). The subsequent conjugation
of the phase I metabolites produced by isolated liver cells however has
been largely neglected, although more recently a few reports are to
be found in the literature. 5-(p-Hydroxyphenyl)-5-phenylhydantoin
f î(\tglucuronide was detected in the medium ©v isolated cells .
which had been incubated with diphenylhydantoin (Inaba et al,
1975). Conversion of naphthalene into naphthalene dihydrodiol,
1-naphthol and their glucuronides has been reported by Bock et al 
(1976). Vadi ^  al (1975); Jones ^  ^  (1978) have used the polycyclic 
aromatic hydrocarbon, benzo(a)pyrene as substrate and have demonstrated 
this carcinogen to be readily metabolised by isolated rat hepatocyte 
suspensions into various phenols, dihydrodiols and their conjugates 
(glucuronide, sulphate and glutathione). An extensive study into 
oxidative and conjugative metabolism of p-nitroanisole and p-nitrophenol 
in isolated rat liver cells has been carried out by Moldeus et ^  (1976). 
The 0-dealkylation and subsequent conjugation of £-nitroanisole with 
glucuronic acid and sulphate as well as the conjugation of p;-nitrophenol 
was investigated with special anphasis on the regulation of the UDP- 
glucuronyItransferase catalysed reaction, 7-Ethoxycoumarin-O-deethylase 
activity has been demonstrated in isolated rat hepatocytes in suspension 
both kinetically (Fry et al, 1976) and by the static assay (Fry et al, 
197g). '■ Tlie phase I metabolite 7-hydroxy coumarin is extensively
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conjugated to its glucuronide and sulphate ester. Rat liver cells 
have been shown to metabolise phenol to phenylglucuronide, quinpl- 
glucuronide and phenyIsulphate (Kao, 1977). The same author has 
demonstrated that aniline is also extensively metabolised by isolated 
rat hepatocytes to N-acetyl-p-aminophenol, its glucuronide and sulphate 
conjugates and acetanilide. The direct conjugation of some phase I 
metabolites ha& also been reported in isolated hepatocytes, 
p-nitrophenol to its sulphate and glucuronide (Moldeus ^  al, 1976), 
4-methylumbelliferone to its sulphate and glucuronide conjugates and 
benzoic acid to its glycine and glucuronic acid conjugates (Fry et al . 
1978). The injurious effects of a particular xenobiotic in vivo is 
governed by not only the biological properties of the compound and its 
metabolites but also the relative rates of its phase I and phase II 
metabolism by the liver and the ease with which the parent campound, its 
phase I or phase II metabolites can enter and/or leave the cell.
Isolated liver cells allow the investigation of the sequential metabolism 
of xenobiotics which may involve the participation of different organelles 
within the liver cell, which is not easily achieved using subcellular 
fractions.
The different reactions involved in the metabolism of xenobiotics 
that have been demonstrated in isolated hepatocyte preparations 
(Table 2.5.) serve, to indicate the potential this system possesses for 
assessment of xenobiotic metabolism-mediated toxicity vitro, closely 
reflecting the situation in vivo. Jones ^  ^  (1978) illustrate this 
point very well. Using isolated cells from untreated rats, incubated 
with a non-cytotoxic level of benzo(a)pyrene (80 pM), they showed a 
wide range of phase I and phase II metabolites were produced. They
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also showed that 3-hydroxybenzo(a)pyrene, its sulphate conjugate,
4,5- and 7,8-dihydrodiol were selectively retained by the hepatocytes, 
possibly binding to intracellular proteins or lipid membranes. The 
in vivo significance of these findings were, in the opinion of the 
authors uncertain, however they speculated that this selective 
retention could lead to the maintenance of high intracellular levels 
of substrates capable of being metabolised to the ultimate.carcinogen.
2.7. Xenobiotic Metabolism in Isolated Cells other than Hepatocytes
Cantrell & Bresnick (1972) have shown that non parenchymal 
(reticuloendothelial) rat liver cells contain only 8% of the drug 
metabolising capability (as measured by aryl hydrocarbon hydro5Q7lase 
(AHH) activity) of parenchymal cells. This activity however can be 
induced by 3-MC (17-fold) and g-naphthaflavone (5-fold) and has lead 
the authors to postulate that the non-parenchyraal cell types may 
provide the 'first line of attack' against circulating polycyclic 
hydrocarbons since the cells presence in specified regions of the liver 
would allow early interaction and response,
Freshly lavaged human puHnonary aveolar macrophages have been 
shown to possess AHH activity (Cantrell ot 1973). Higher levels 
of activity were detected in macrophages fron smokers when compared 
to those from non-smokers which was attributed to enzyme induction by 
constituents of tobacco smoke.
Viable renal tubule fragments have been used for xenobiotic 
metabolism studies m  vitro (Fry ot 1978 ). Three substrates 
(biphenyl, benzo(a)pyrene and 7-ethoxycoumarin) were used to compare 
phase I metabolism in rat liver and kidney cell suspensions. Of 
these substrates only 7-ethoxycoumarin was metabolised significantly
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by the kidney cell suspension, although the level of metabolism was 
extremely low compared with the liver cells. Indeed, calculation of 
the maximal rate of total 7-hydroxy coumarin production indicated 
that kidney cells possessed only 3% of the 7-ethoxycoumarin 0-deethylating 
activity of liver. However the pattern and extent of conjugation of the 
newly fomed 7-hydroxy coumarin was very similar in the liver and kidney 
cells. The resemblance in hepatic and renal system of phase II 
metabolism, not so much in the level of activity, but in the nature and 
relative proportion of conjugated metabolites produced was confirmed 
by the direct conjugation of 4-methylumbelliferone (with sulphate and 
glucuronic acid) and benzoic acid (with glycine and glucuronic acid).
Shirkey (1977) has reported the isolation of viable cells from
rat intestinal mucosa using subtilislnand shown them capable of metabolising
7-ethoxycoumarin in a manner similar to rat liver cells, initial 0-dealkyl-
cfat ion followed by conjugation, although the extent^metabolism was much 
lower in the intestinal cells. Rat intestinal cells prepared in this fashion 
have been shown by Kao (1977) to convert phenol into phenyIglucuronide 
together with traces of phenyIsulphate, and aniline to acetanilide and 
trc.ce amounts of N-aeetyl-£-aminophenol, again the level of activity 
was much lower than that found in rat liver cells. Metabolically active 
intestinal epithelial cells isolated using collagenase and hyaluronidase 
(Stohs et 1977) have been shown to metabolise the carcinogen 
benzo(a)pyrene to a wide range of phenolic metabolites, this activity 
is inducible by 3-M3.
Such studies highlight the value of intact cell systems in 
assessing quantitative inter-organ differences in xenobiotic metabolism 
as it is now becoming recognised that extrahepatic metabolism of 
various drugs and carcinogens may be extremely important in tie local
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ft'\«L'Cb.V>c5\ vVâSgeneration of reactive^responsible for organ-specific toxicity and 
carcinogenicity.
2.8. Xenobiotic Metabolism in Cultured Cells
There has been a vast amount of research directed towards the 
study of the effects of drugs and xenobiotics on cells in culture 
(Dawson, 1972). Freed from the imny obfuscating in vivo influences, 
the cultui'e conditions are easily manipulated and monitored. 
Cytotoxicity, transformation and impairment of cellular metabolism 
can be readily assessed in cultured cells. Techniques are well 
documented and sufficiently developed to cope with the small numbers 
of cells used. There is however, with the exception of the polycyclic 
hydrocarbons, a paucity of information on the effects of cells on 
xenobiotics, i.e. the way in which the cells modify the drugs. A 
major reason for this is the difficulty that is generally experienced 
in culturing functional adult mammlian hepatocytes, the major cell 
type responsible for drug metabolism ^  vivo.
Cell culture techniques offer distinct advantages over cell 
suspensions. Structiure-activity relationships in enzyme induction 
studies may be elucidated by virtue of their much longer useful time. 
The effects of drug metabolism on cellular function may be studied 
and the use of primary cultures allows for a period of recovery after 
the trauma of cell isolation. Lastly, but by no means least important, 
culture systens provide the most promising approach to the use of 
human tissue in xenobiotic studies in vitro as such investigations 
do not have to be carried out immediately following cell isolation 
as with cell suspension studies.
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Cells in culture, from many different species, tissues and organs, 
both foetal and adult have been used in xenobiotic metabolism studies 
(for a comprehensive review see Fry and Bridges, 1977a). This treatise 
will be confirmed to those studies in which liver-cell systems have 
been utilized, highlighting the advantages and problems a cultured 
hepatocyte model possesses for such studies.
2.8.1. Xenobiotic Metabolism in Foetal Liver Cell Cultures and 
Liver-derived Cell Lines
Cells from embryonic liver, as well as cell lines derived from 
normal liver or hepatoma tissue have been extensively used in xenobiotic 
metabolism studies mainly because they are much easier to culture than 
cells from adult liver. Unfortunately, the levels of the various 
enzymes responsible for the metabolian of xenobiotics are generally 
very low in the foetal or neonatal state (Jondorf ^  1958;
Basu et 1971; Fouts and Devereux, 1972; Macleod et al, 1972;
Pelkonen, 1973,1977) and the pathways develop at different rates
giving rise to a misleading picture of the adult situation.. Holtzman 
et al (1972) point out that since foetal liver cells grow rapidly and 
are relatively undifferentiated with little endoplasmic reticulum, 
they may be a poor model for the study of the mechanisms involved in 
drug metabolism by the relative stable adult hepatocyte. Dedifferentiation 
is another problem encountered when using foetal cells both in primary 
culture or as cell lines. Such a drawback is also inherent in cell 
lines derived from adult tissue, since these cells are usually 
proliferative in nature and tend to lose their iu vivo morphological 
and functional characteristics. Various enzymes are lost during 
prolonged culture (e.g. A^-desaturase of linoleate, Dunbar and Baile;^
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1975). The metabolism of xenobiotics may be regarded as a very 
sophisticated differentiated function, which would tend to be lost 
during prolonged culture. The reversion of cultured adult cells 
to a state resembling that of the foetal state is yet another problem 
that arises (Chapter 1) which must not however be confused entirely 
with that of dedifferentiation.
Foetal liver cells in culture and adult liver cell lines have 
been widely used in studying the mechanisms of enzyme induction, but 
a great deal of caution must be exercised if extrapolation of the 
results obtained with such systems to the normal adult situation is 
attempted. It is doubtful whether it is valid to extrapolate at all.
The chick-embryo liver cell culture system has been used by 
several research workers as a cellular nx^ del for studying various 
aspects of drug metabolism. The main advantage of this particular 
system is that this readily available tissue possesses a known high 
level of drug metabolising capability involving an MFO system believed 
to be very similar to that found in mammals. Poland and Kappas have 
studied the effects of various inducers and inhibitors of the 
metabolism of antipyrine (Poland and Kappas, 1971) and chlorocyclizine 
(Poland and Kappas, 1973). Aminopyrine was N-demethylated to 
d'-aminoantipyrine, which was released into the culture medium. The 
reaction could be inhibited by a variety of competitive substrates 
such as SKF 525A, piperonyl butoxide, hexobarbitone, 1 auric acid 
testosterone, as well as by carbon monoxide. Poland and Kappas (1973) 
'Skwdwui the inducibility of chlorocyclizine N-demethylase in chick 
embryo hepatic cell cultures. They showed that treatment of cells
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with allylisopropylacstaniide, phenobarbitone and various steroids
<xthov^induced the N-demethylation^and also the P-450 content of the cells, 
and that this induction process involved ^  novo RNA and protein 
synthesis. Attempts were also made by these workers, using this 
system, to study the development of the endoplasmic reticulum during 
embryonic life. Although the extent of inducibility was identical 
in 12 to 18 day embryos the basal level fell of sharply at 18 days 
coinciding with poor cell attachment and growth. This contrasted 
with the in vivo situation in which MFO activity increases with foetal 
age.
Induction of 6 aminolaevulinic acid (ALA) synthetase activity 
has been studied in this system (Poland and Kappas, 1973) and is 
proposed to be an essential step in the induction of microsomal 
MFC activity providing the haera needed for extra P-450. Racz and 
Moffat (1974) have thrown some light on AIA-synthetase induction 
in chick embryo liver cultures. By the use of sterically hindered 
and unhindered analogues of 3,5-diethoxycarbonyl-l,4-dihydro-r2,4,6- 
trirnethylpyridine (a lmo\«n inducer of ALA-synthetase), they were 
able to show that the rate of hydrolytic inactivation of the substituted 
pyridine governed the extent of induction. Thus, the slowly inactivated 
sterically hindered analogue was a good inducer wheresis the rapidly 
inactivated, unhindered analogue was a poor inducer. Rif kind et al 
(1976) have shown that chemical induction of ALA-synthetase activity 
can be inhibited by a partially purified human chronic gonadotrophin 
preparation. The effect of insulin, hydrocortisone and triiodothyronine 
on the induction of ALA synthetase and poiphyrins by allylisopropyl- 
acetamide (AIA) in cultured embryo liver cells has been investigated 
by Sassa and Kappas (1977). In the absence of these hormones AIA
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produces only a slight increase in AIA synthetase activity and 
porphyrin production, while when they are added to the culture medium 
marked increases are produced in enzyme activity and porphyrin content 
by AIA. The maximally induced levels of ALA-synthetase in these 
cultured cells grown in the chemically defined medium were comparable 
to the induced levels of the enzyme in ovo.
Foetal rat liver primary cultures and cultures derived from 
hepatoma tissue have been extensively used by Nebert and his coworkers 
for the study of induction of AHH activity. The induction studies 
with the foetal cells pointed to some similarities between the culture 
system and the in vivo adult situation. Polycyclic hydrocarbons, 
phenobarbitone and DDT are all capable of inducing AHH activity in the 
cultured foetal cells (Gielen and Nebert, 1971a, fo) and the inductive 
effects of 3-MC and benz(a)anthracene (BA) on one hand and of DDT 
and PB on the other were additive as they are in vivo (Conney, 1967). 
Proliferation of the endoplasmic reticulum occurs only on PB induction 
and not with DDT or polycyclic hydrocarbons (Conney, 1967). Gielen 
and Nebert (1971a) claimed that this was indeed the case in cultured 
foetal rat liver cells, but the findings were reported to be based 
on evidence from light microscopy studies. Needless to say with such 
poor evidence, little credence could be attached to such claims.
Owens and Nebert (1975) however have subsequently reported no such 
proliferative changes in the endoplasmic reticulum were detectable 
in this system. By the use of inliibitors of RNA and protein 
synthesis Nebert and Gielen (1971) demonstrated that induction of 
AHH activity is effected primarily at the level of transcription with 
a secondary effect of lesser importance at the post-translational 
level in which the normal rate of decay of the induced enzyme is
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delayed, Gielen and Nebert (1972) have also shown that AHH activity 
in foetal rat liver cells could be induced by the presence of biogenic 
amines in the medium, and that the mode of induction by these biogenic 
amines was similar to that of PB and 3-jVE.
Studies into the induction of AHH activity have been carried out 
using primary human liver cell cultures (Pellconen et 1975) and 
cells lines derived from hepatoma or normal liver tissue (Benedict 
^  1973; Whitlock and Gelboin, 1973, 1974; Whitlod.'i et al, 1974;
1976; Owens and Nebert, 1975,1976). Although regulation of induction 
of AHH activity in these systems has been shov/n to be basically the 
same as in the foetal liver cells in culture (Whitlock and Gelboin, 
1973,1374). Owens and Nebert (1976) have demonstrated that hydroxy­
lase-specific mRNA synthesis, processing or stabilisation is very 
different in hepatoma cell lines and normal rat foetal primary 
hepatocytes in culture. Using 10 established cell lines including 
several derived from liver, as well as foetal primary cultures from 
different species and human lymphocytes, Nim ^  ^  (1975) have
investigated the kinetics of AHH induction by the toxic herbicidal con­
taminant 2,3,7,8-tetrachlorodibenzo-£-dioxin (TCDD)^  and found it to 
be similar to the time course of hydroxylase induction by 3-MC.
Owens and Nebert (1975) have claimed that all liver cell lines 
and cultures of foetal liver cells contain cytochrome P-448 and not 
cytochrome P-450, which is the form found in normal adult animals. 
Furthermore, they point out a major difference that appears to exist 
between induction in vivo and in cell culture. In proliferating cell 
cultures derived from liver (foetal and adtilt) or hepatoma tissue, 
phenobarbitone induction, as with induction by polycyclic hydrocarbons 
leads to the formation of P-448 as opposed to an increase in normal
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P-450, as found, after phenobarbitone induction in vivo (Conney, 1967; 
Orrenius et 1968). This may represent a reversion in the adult 
liver cells since P-448 is thought by many workers to be a more 
primitive form of P-450. Guenther and .'.lannering (1977) have suggested 
that a control mechanism operates in the foetal rat liver utero 
which selectively suppresses the induction of cytochrome P-450, but 
allows induction of cytochrome P-448. They show that foetal rat 
liver is refractory to phenobarbitone induction of aminopyrine and 
ethylmorphine N-demethylase, cytochrome P-450 dependent monooxygenases 
but not to 3-methylcholanthrene induction of benzo(a)pyrene hydroxylase, 
a cytochrome P-448 dependent mono-oxygenase. Foetal rat liver 
in utero is refractory to phenobarbitone induction of benzo(a)pyrene 
(Geunth«is* and Mannering, 1977) but when these cells are cultured 
for periods between 6 hours and 6 days they do respond to this inducer 
with an increase in benzo( a)pyrene hydroxylase activity (Gielen and 
Nebert, 1971a,b). This alteration of cellular responsiveness may be 
due to the trauma of the œil isolation procedure, or an example of 
a change in control mechanisms in culture. As œrtain compounds are 
known to be metabolised differently by P-448 than by P-450 e.g. biphenyl, 
Creaven and Pai’ke . (1966); testosterone, Kimtzman et ^  (1968); bromo- 
benzene, Zampaglione et al (1973); n hexane, Fraimer et al (1974). 
Owens and Nebert (1975) suggest caution when using liver-or hepatcma- 
derived cell lines and foetal liver primary cultures for studies of 
cytotoxicity, drug metabolism or chemical carcinogenesis involving 
xenobiotics known to be metabolised via the JÆPO system and extrapolating 
these results to the situation in the intact adult animal.
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Grayzel and Beck (1975) have shown that cell lines from 
embryonic rat liver are capable of metabolising the anti tumour 
agent cyclophosphamide. Inhibition of growth and reduction of 
plating efficiency of these cells was detected and was considered 
to be due to its metabolites since cyclophosphamide itself is 
relatively non-toxic to cells in culture (Phillips, 1974).
As well as phase I metabolism of xenobiotics studied in
these cultured cells, conjugating (phase II) reactions have also
ofbeen detected in a limited numberj^ liver culture systems. In addition 
to the conjugation of bilirubin in two established cell lines derived 
from rat hepatcmas (Rugstad et al, 1970; Wolf et 1974),
£-nitrophenol and £-aminophenol glucuronidation has been detected in 
one of these cell lines (î>'IHqC^) (Dybing, 1972). Sandstrcm (1973) 
has also reported the conjugation of o-aminophenol with glucuronic 
acid in the outgrowths of adult human liver explant cultures.
Using a chick-eribryo liver organ culture system, Dutton and his group 
have studied the in ovo development and induction of glucuronidation 
(Dutton, 1973; Dutton and Burchell, 1974; Burchell et al, 1974; Dutton 
and Burchell, 1977). Fran the findings obtained with this system,
Dutton has postulated that UDP-glucuronyltransferase is normally repressed 
in ovo but that this repression can be over-ridden with phenobarbitone. 
Using foetal mamnalian-liver cell cultures, they have shown (Dutton,
1973; Dutton and Burchell, 1977) that there is no such repression of 
UDP-glucuronyltransf erase in foetal maiimalian liver, the enzyme being 
refractory to phenobarbitone induction in culture, a situation believed 
to exist in utero. These studies illustrate the value of culture
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systems in induction and developrrental studies and also the caution 
required in extrapolating from one species to another.
2.8.2. Xenobiotic Metabolism in Adult Primary Liver Cell Cultures
The development, in recent years of primary culture systems of 
non-replicating adult rat hepatocytes which maintain adult liver 
functions have made possible the investigation of differentiated 
biochemical functions vitro (Bissell et 1973; Bonney et al,
1974; Michalopoulos and Pitot, 1975). These have included the 
metabolism of xenobiotics.
Hie levels of cytochrome P-450 and drug metabolising enzymes 
in monolayers of adult rat hepatocytes maintained on standard or 
collagen-coated petri dishes, were examined by Bissell and his co­
workers (Bissell et al, 1973; Bissell and Guzelian, 1975; Guzelian, 
et al, 1977). The cells were isolated by collagenase perfusion of 
rat liver, on the 4th day after partial hepatectcmy. Whether these 
cells reflect the metabolic state cf resting liver must be asked^  
for it is well loiown that the activity of the microsomal enzymes 
concerned with drug metabolism may be markedly altered or temporarily 
lost during early liver regeneration (Gram et al, 1968; Henderson 
and Kersten, 1970; Hilton and Sortorelli, 1970). However, 4 days 
after partial hepatectcmy, the activity of the enzymes return 
towards normal values and they respond normally to inducing chemicals 
(Bissell et al, 1973).
It was shown that, in contrast to a variety of liver-associated 
functions (e.g. albumin synthesis and secretion, gluconeogenesis, 
haem catabolism etc. ) that were maintained in the cultured cells 
in vitro at levels comparable to those of the liver in vivo for several
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days, the level of cytochrome P-450 dropped considerably within 
24 hours after isolation and plating of the hepatocytes. The 
level of P-450 in hepatocytes cultured for 24 hours was 21% of 
that of the freshly isolated hepatocytes or of normal liver and only 
10% after 48 hours in culture (Bissell and Guzelian, 1975; Guzelian 
et al, 1977). Diuring the same 48 hour culture period, the activity 
of aminopyrine N-demethylase and aniline hydroxylase also fell, 
paralleling the level of cytochrome P-450. By contrast, £-nitroanisole 
O-damethylase activity was unchanged in cultured hepatocytes despite 
evidence that £-nitroanisole 0-demethylase is a cytochronfô P-450 
enzyme. NADPH-cytochroiie c reductase activity was only moderately 
reduced and glucose-6-phosphate activity remained unchanged. In 
culture, as in vivo aromatic polycyclic hydrocarbons stimulate 
£-nitroanisole 0 -demethylase and AHH activities, however, this effect 
was unaccompanied by a detectable increase in total carbon monoxide 
binding haemoprotein. Treatment of these hepatocyte cultures with 
phenobarbitone faiisto increase cytochroiæ P-453, cytochrome c reductase 
and numerous enzyme activities in contrast to the in vivo situation.
Supplementation of the culture medium with serum, hormones 
(insulin, corticosterone), drugs (phenobarbitone, benzo(a)pyrene) or 
nutrients such as glucose, galactose or fatty acids does not prevent 
the drop in levels of cytochrome P-450 (Guzelian and Bissell, 1974). 
Addition to the medium of other corrpounds such as 6 -aminolevulinic 
acid, fructose, sorbitol, dihydroxyacetone, ascorbic acid and adenine 
however partially prevents the marked decrease in the levels of P-450. 
Haen oxygenase, an enzyme converting haon to bilirubin was found to 
increase after the drop in cytochrome P-450 levels. The conpounds
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that partially prevented the drop in cytochrome P-450 levels also 
partially inhibited the rise in the activity of haem oxygenase.
This inverse relation between the levels of cytochrome P-450 and 
haem oxygenase was also demonstrated by Bissell in the rat liver 
in vivo (Bissell et al, 1974).
These studies indicate that the initial decrease in the levels 
of cytoclirome P-450 in cultured hepatocytes is an active phenomenon 
associated with the rise of specific degradative enzymes, possibly 
related to nutritional imbalances in the medium of the cell culture 
or trauma of isolation. However, the low levels of cytochrcme P-450 
and the lack of responsiveness to conpounds such as phenobarbitone 
and polycyclic hydrocarbons have limited the applicability of this 
hepatocyte culture system for the study of in vitro xenobiotic 
metabolism.
One of the principal disadvantages of primary cultures of adult 
rat hepatocytes described above is their relatively limited life-span. 
The hepatocytes, after a period of relative stability during the 
second and third day of culture, enter a period of degeneration in 
which most of the measurable hepatic cell functions decline and 
disappear aVitC twelve days in culture (Bissell et al, 1973).
Michalopoulos and Pitot (1975) have recently reported a system 
for the primary culture of non-proliferating rat hepatocytes on 
floating collagen membranes. These collagenase dissociated liver 
cells, unlike those of Bissell's group, were prepared from rats that 
had not been subjected to partial hepatectcmy. By the third to 
fourth day in culture the hepatocytes establish a continuous monolayer 
and retain epithelial morphology and viability for a period of more
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than 20 days. As well as retaining m  vivo characteristics of 
parenchymal cells, e.g. responsiveness of tyrosine aminotransferase 
(TAT) to hydrocortisone and cyclic AMP, the most striking characteristic 
of these cells is their maintenance of relatively high levels of 
cytochrome and P-450 (Michalopoulos et al, 1976a). In this 
study the authors showed thatj^ hepatocytes cultured on floating 
collagen membranes in L-15 medium, supplemented with albumin, 
glucose, insulin and foetal calf serum, the levels of cytochrome 
P-450 drop to about one-third of the values seen in vivo within 
24 hours. The concentration of cytochrome system declines slowly 
thereafter, until after 10 days in culture the level is only 5% of 
the value seen in vivo. In the presence of high levels of hydro­
cortisone (10""^ M), the levels of cytochrome remain much higher at 
the end of the first day in culture, being approximately 75% of the 
value in vivo. It has been suggested that adrenal hormones are 
required for the maintenance of normal levels of cytochrome P-450 
in the livers of experimental animals (Orrenius et al, 1968). A 
further decline between the second and fifth days in culture was 
noted, which reached values found in the hepatocytes grown in the 
absence of hydrocortisone. After the fifth day in culture, however, 
the levels of cytochrome P-450 slowly increase in the hydrocortisone- 
treated cells until by 10 days in culture the levels reach approximately 
25% of the value iu vivo. These high levels of hydrocortisone were 
shown to induce cytochrome P-448 whereas cytochrome P-450 is 
maintained in the control cells (Michalopoulos et al,1976a). The 
levels of cytochrome bg, however were not significantly affected by 
the presence of hydrocortisone in this culture system.
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Phenobarbitone (PB) and Snmethylcholanthrene (3-îCî), thé most 
frequently studied of the chemical inducers of the liver microsomal 
enzymes were studied by Michalopoulos and coworkers (1976b). They 
used hepatocytes that had been maintained in culture for 5 days, 
due to the stability of the P-450 complex between 5 and 10 days in 
culture. The kinetics of induction for both compounds was very 
similar to the vivo situation and was dependent on their 
concentration in the medium. 3-MC was shown to induce high levels 
of a cytochrome absorbing maximally at 448 nm, vhereas after PB 
induction, the peak was at 450 nm (see figure 2.4.). Thus, in 
hepatocytes cultured on collagen membranes, as ir. vivo, 3-MC induces 
cytochrane P-448, \diereas PB induces cytochrome P-450 (Remmer, 1972). 
Unlilœ previous reports (Owens and Nebert, 1975) addition of PB 
(2 X 10"%) to hepatocytes from 5 to 10 days also resulted in a 
significant proliferation of membranes of smooth endoplasmic reticulum 
(Michalopoulos et 1976b). Tlie distribution of these membranes 
and their morphology were similar in most of the PB-treated cells. 
Similar aggregates of smooth membranes were not seen in the untreated 
cells. This proliferation of membrane of the smooth endoplasmic 
reticulum is characteristic of the induction of cytochrome P-450 by 
PB in normal liver in vivo (Orrenius et al, 1965,1968; Conney, 1967).
These studies demonstrate the remarkable similarity between the 
effects of PB and B-Î/KC op hepatocytes cultured on floating collagen 
membranes and the. effects of the same compounds in normal liver 
in vivo. Furthermore, such findings strongly suggest that this 
particular system may be the best presently available for the study 
of xenobiotic metabolism in liver cells in vitro.
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Figure 2.4. Corapaxison of 00-difference spectra of dithionite-reduced 
microscmes of normal rat liver (A), 3MC-treated'cells (B), 
PB-treated cells (0), and control cells (D) (taken from 
Michalopoulos et al, 1976(c)).
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Poole and Urwin (1976) have described the isolation and culture 
of nonproliferating hepatocytes.from adult rhesus monkeysyin poly­
carbonate bottles. Hie authors claim these primary cultures may be 
maintained in culture for relatively long periods (up to 35 days).
The cells retain their ultrastructural resemblance to hepatocytes in vivo 
and their ability to metabolise nicotine to continine and nicotine- 
N-oxide which are major metabolites in vivo (McKennis, 1960). This 
primate hepatocyte culture system may have the potential for use in 
a wide variety of biochemical investigations, including the assessment 
of the metabolism of xenobiotics in vitro and relationships with cell 
toxicity, although extensive validation is needed.
As with the foetal liver culture systems and adult liver- and 
hepatoma-derived cell lines, there has been very little work carried 
out using adult hepatocytes in primary culture for the study of 
phase II metabolism of xenobiotics in vitro. Henderson (1971) 
however, has reported that rat liver cells maintained in suspension 
culture for 6 days retain ' at least some of their UDP-glucuronyl- 
transferase activity and that the presence of phenobarbitone in the 
medium results in an increase of the enzyme wliich is blocked by 
cycloheximide. During the six day culture period, there is a gradual 
fall in enzyme activity to only 20% of the original level in 
untreated cells, but 45% in the phenobarbitone-treated cells. This 
fall off in enzyme activity arises, in all probability, as a result 
of the very damaging medianical/chonical cell isolation procedure 
employed. The increase in activity brought about by phenobarbitone 
may be a result of increasing cell integrity, rather than a result 
of de novo protein synthesis as the author suggests.
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The development of methods for the establishment of primary 
cultures of non-replicating adult hepatocytes described here are 
perhaps the most relevant in vitro models for the investigation 
of adult biochemical liver functions and the effects of xenobiotic 
metabolism mediated toxicity on these cellular functions. Perfusion 
of the organ (the method employed to isolate these cells) is a 
teclniique that possesses serious problems, especially when general . 
applicability to other species is considered. With this in mind, 
hepatocytes were isolated by a method that obviated the use of a 
perfusion stage. Using the technique devised by Fry and coworkers 
(1976) primary cultures of non-proliferating adult rat hepatocytes 
were successfully established from the collagenase/hyaluronidase 
dissociation of rat liver slices. Such primary cultures were used 
throughout the present studies.
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CHAPTER 3
Biphenyl Metabolism in Isolated Adult Rat 
Hepatocyte Suspensions
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ŒAPTER 3
3.1. INTRODUCTION
Isolated viable hepatocytes are capable of carrying out the 
complete range of biotransformtions catalysed by the hepatic MFO 
systen (Chapter 2). The advantages to the use of this cellular 
model in drug metabolisn studies are numerous and have been discussed 
at length in the previous chapter. However, in few of the reported 
studies has there been any attempt either to assess the toxicity 
due to the substrate or primary or secondary metabolites or to 
examine the relationship between the various metabolic pathways 
involved. Clarification of these problems may prove to be especially 
important ^plications of isolated viable hepatocytes to drug metabolism 
studies. Biphenyl metabolism has therefore been studied using isolated 
viable adult rat hepatocytes in ordUiC to investigate both phase I 
(biotransformation) and phase II (conjugation) reactions in sane 
depth because its metabolite profile is sensitive to changes in the 
cells cytochi'ome P-450 content.
Biphenyl is a v/idely used agricultural funglstat and as such can 
enter the human diet. Its polychlorinated derivatives (PCB) have been 
used as industrial plasticizers, and are widely dispersed in the 
environment. Polybrominated biphenyls have been used as flame 
retardants and have caused serious environmental contamination in sane 
areas notably in the state of Michigan.
The metabolism of biphenyl iu vivo is fairly well documented. Tlie 
major metabolites of biphenyl in rabbit urine are 4-hydroxybiphenyl and 
its conjugate (Blodc and Cornish, 1959; Raig and Annon, 1970; 1972).
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Minor metabolites (less than 10% total metabolic output) include 
2~ and 3-hydroxybiphenyl4,4'-dihydroxybiphenyl, 3~hydroxy~4-methoxy- 
and 3-methoxy-4-hydroxybiphenyl (Raig and Ammon, 1970; 1972). Hie 
3-hydroxybiphenyl metabolites probably arise as a result of an NIH 
shift from the 3,4-biphenyl oxide intermediate.
In urine from adult rats treated with biphenyl the major metabolite 
is 4-hydroxybiphenyl with 4,4’-dihydroxy- and 3,4-dihydroxybiphenyl 
and biphenyImercapturic acid being minor metabolites (West et 1956) ; 
2-hydroxybiphenyl was not found in this study. These metabolites are 
largely present in the urine as glucuronide ethers. Meyer and his 
group have extensively studied the metabolism of biphenyl in several 
different species in vivo, the rat (Meyer et 1976a; Meyer and 
Scheline, 1976), pig (Meyer et 1976b), guinea pig and rabbit 
(Meyen^  1977) and some marine organisms (Meyer and Bakke, 1977). They 
found the major urinary metabolite to be 4,4' -dihydroxybiphenyl in the 
rat and 4-hydroxybiphenyl in the pig, guinea pig and rabbit while 
2-hydroxybiphenyl was the major metabolite formed by the marine 
organisms. Gran-n^ative bacteria form 2,3'-dihydroxy and 2,3-dihydro-
2,3-dihydroxybiphenyl (Catelani et 1973; Lunt and Evans, 1970).
Biphenyl metabolism in vitro has also been extensively studied 
(Creaven et 1965; Creaven and Parke, 1966; Parke and Rahman, 1970; 
Burke and Bridges, 1975). The major metabolite in vitro 4-hydroxybiphenyl 
is a product of the liver ]VIFO system, as is also the lesser metabolite,
2-hydroxybiphenyl, together with 4,4’-dihydroxybiphenyl and other 
unidentified metabolites.
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3.2. MATERIALS AND MEIHCD8
3.2.1. Animals and Pretreatment
Male Wistar Albino rats in the weight range 60-100 g were used 
throughout the present study, for it has been reported that biphenyl
2-hydroxylase activity in rats reaches a maximum at 21 days of age
( w, 100 g body weight) and that this activity is not normally detectable 
in rats of 70 days or older (Basu et 1971). They were allowed 
unlimited access to Spillers No. 1 Laboratory Diet (fillers Ltd., 
Croydon) and water. 'Sterolit' (Engelhard, New Jersey) was used as 
bedding to eliminate any possible interference from enzyme induction 
caused by wood shavings. (Fujii ^  1968).
Treated rats were given a daily intraperitoneal dose of either 
sodium phenobarbitone in 0.9% NaCl, 80 mg/kg body weight for 3 days,
3-^ nethylcholanthrene in arachis oil, 30 mg/kg body weight for 2 days 
or 3,4-benzo(a)pyrene in arachis oil, 28 mg/kg body weight for a 
single day. At least hours were always allowed to elapse between 
the last injection and sacrifice of animals.
3.2.2. Chemicals
Biphenyl (HDH Ltd., Poole, Dorset) ra.p. 70°, was purified by 
twicerecrystallising from 96% ethanol; 4-hydroxybiphenyl (Aldrich 
Chemical Co., London), 2-hydroxybiphenyl, 4,4'-dihydroxy- and 2,2'- 
dihydroxybiphenyl (HDH Ltd., Poole, Dorset) were used as purchased. 
7-ethoxycoumarin was synthesised according to the method of Ullrich 
and Vfeber (1972), 7-hydroxycoumarin was obtained from Fluka A.G.,
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Switzerland. 3,4-benzo(a)pyrene was purchased fran Aldrich Chemical Co., 
London while quinine sulphate, 4-imethylumbelliferone (sodium salt),
2,4-dinitrophenol, menadione and rotenone were all purchased from 
Sigma, London. Enzymes were obtained from various sources; Worthington 
(Cambrian Chemicals, Croydon)(collagenase, type CLSI) Sigma, London 
(collagenase, type IV; hyaluronidase, type II, g-glucuronidase, 
containing some sulphatase activity, type HI, arjgulphatase, type HI). 
Pure P-glucuronidase ('Ketodase') was obtained from William Warner and 
Co. Ltd., Hanpshire. NADPH (type III) and saccharo-1-43 lactone were 
both obtained from Sigma. SKF 525A (2-diethylaminoethyl-2,2-diphenyl- 
valerate HCl) was kindly donated by Smith, Kline and French Ltd.,
Welwyn Garden City, and the [^ C^] biphenyl (specific activity 0.416 y Ci/ 
mmol) was a generous gift from Dr. A. Munro, Pfizer Ltd., Sandwich, Kent. 
Thin layer chromatographic analysis showed that this I^ "^ C] biphenyl was 
99% pure and it was used without fui'ther purfication. [^ "^ C] biphenyl 
(specific activity 0.6 yCi/ymol) was obtained from the Radiochemical 
Centre, Amersham, Bucks (> 99% pure as judged by t.l.c.) and used as 
purchased. All tissue culture media and supplements were obtained fiom 
Gibco-Biocult, Scotland. All other reagents and solvents used were of 
the highest grade obtainalDle.
3.2.3. Instruments
Fluorlmetric measurements were performed using a Perkin Elmer ÎÆPF3 
^ectrofluorimeter. High pressure liquid chromatography studies were 
carried out using a Costametric IIG (manufacturers LDC) with a Sperisorb, 
25 cm bonded phase aminopropylsilica column (5 y particle size). 
Radioactivity measurements were performed using a Packard Tri-Carb 
spectrometer. Model 3320. A Clarke electrode coupled to a Heathkit chart
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recorder, Model 1R-18M was utilised in oxygen uptake studies. 
Spectrophotometers used comprised the P^ e^-Unicam SP500 or 8P1800 
or Cecil CE272. For low speed centrifugation an MSE Minor bench 
centi'ifuge and Mistral 65 were used whereas for high speed 
centrifugation an MSE High Speed 18, Superspeed 50 and Bectonan 
Model L5-65 ultracentrifuges were employed.
3,2.4. Cell Isolation
Hepatocytes were isolated according to the method of Fry ^  ^  
(1976), of which a full description is given here.
Rats were killed by cervical dislocation, and the liver lobes 
were removed into Dulbecco's (Ca^ -^ and Mg"^free phosphate buffered 
saline (PBS'A') (Paul, 1973). The liver lobes were briefly dried 
between filter papers (to remove the excess blood) and were then cut 
with a heavy-duty blade (American Optical Cb., Buffalo N.Y. USA) so 
that slices 0.5-1.0 ram in thickness were obtained. During this time 
the lobes rested on a piece of filter paper supported by a square 
sheet of glass; this simplified the cutting, and the filter paper 
acted as an 'anchor' for the liver lobes. These slices were then 
placed in a 250 ml conical flask (3 g tissue per flasl^;) containing 
10 ml PBS'A' , and the flask was shaken for 10 minutes in a shalcing 
water bath at 37°C (approx. 100 oscillations/minute). The supernatant 
was discarded, and this washing was repeated twice more. This was 
followed by two lOnminute incubations with 10 ml PBS'A* containing 
0.5 miM ethyleneglycol-bis-(g-aminoethylether)N,N'-tetraacetic acid 
(EGTA) (Sigma, London). After the treatment with EGTA, each flask 
received 10 ml of Hanlc's Mg -free balanced salt solution (Paul, 1973)
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containing 5 mM CaCl^ and collagenase/hyaluronidase (0.05%/0.10% w/v). 
These flasks were incubated for 60 minutes at 37°C in the shaking 
water bath. The resulting cloudy supernatant was filtered through a 
layer of Bolting cloth (John Staniar and Co., Manchester, 125 y 
pore size) so as to remove large cell clumps and undigested material. 
The filtrate was centrifuged at approximately 50 gay for 1 minute, 
and the pellet washed twice in PBS'A' (lacking Ca*^  ^and Mg^^ salts).
Tlie cells were finally resuspended in L-15 medium (Leibovitz, 1963) 
supplemented with 10% foetal calf serum or in Minimal Essential 
Medium (Eagle, 1959) supplemented with 10% calf serum, counted, and 
diluted to an appropriate cell density (usually 2 x 10^  viable 
hepatocytes/ml). Cells isolated by this method have been shown to be 
in a viable and functional state, as judged by dye exclusion, retention 
of sensitive hormone receptor sites and retention of soluble enzymes 
(Fry et al, 1976) and good preservation of cell ultrsistructure (Lowing 
and Fiy, unpublished data).
Fry and his coworkers (1976) reported viable cell yields of 
12.2 + 0.7 X 10^ /g liver and a viability index of 84 + 2%. Similar 
yields and viabilities were obtained throughout the present studies. 
Bellemann et al (1977) have since described an improvement of this 
teclinique which produces a pronounced increase in the yield of viable 
cells (30 X 10^  cells/g liver) and viability index (> 96%) when the 
media used throughout the cell isolation was supplemented with glucose 
and bubbled with Carbogen (95% 0„ and 5% 0D„) and finished by a short 
trypsin-DNase incubation, which selectively removes the trypan blue 
dyoable cells.
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3.2.4.1. Assessment of Cell Viability and Yield
Viability was routinely based on the ability of the cells to 
exclude the dye, trypan blue, as described by Cummin^(1970). All 
counts were carried out using an Improved Counting Chamber (Gelman 
Hawksley, Lancing, Sussex).
3.2.4.2. Preparation of Non-viable Cells
Non-viable cells were obtained by canot ic shock. Diluted cell 
suspensions were centrifuged, the nedium removed and replaced with 
the same volume of water. The cells were resuspended in the water, 
mixed thoroughly, recentrifuged and washed mth PBS'A'. The cells 
were finally resuspended in the original volume of culture medium.
A sample of the cell suspension was removed at this stage to check 
the viability of the preparation. The cell population was completely 
non-viable after this treatment, as judged by the failure of all cells 
to exclude trypan blue.
3.2.5. Biphenyl hydroxylase Assay
3.2.5.1. In Isolated Rat Hepatocyte Suspensions
Samples (5 ml) of the diluted cell suspension (2 x 10^  viable 
hepatocytes/lol) were placed in 50 ml conical flasks and incubated 
with shaking, in a water bath at 37° (approx. 100 oscillations per 
minute). The reaction was initiated by the addition of 10 yl of 
solutions of biphenyl, of various concentrations, dissolved in dimethyl- 
formaraide (DMF) (G.L.C. spectroscopy grade BDH Ltd., Poole, Dorset). 
This final 0.2% v/v concentration of DMF had no effect on cell viability
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over the incubation times studied. Hie 2-hydroxy- and 4-hydroxy­
biphenyl standard solutions were also added in 10 yl of DMF. Hie 
reaction was stopped by placing the flasks on ice and the free 
(i.e. unconjugated) and conjugated metabolites were extracted as 
outlined in figure 3.1. The metabolites were first extracted in 
7 ml n-heptane (containing 1.5% v/v isoamyl alcohol) and 2 ml of 
the organic phase was back extracted into 5 ml of 0.1 N NaOH.
Metabolite conjugates were subjected to a 'deconjugation' procedure 
before extraction and measurement. To the aqueous phase remaining 
after the organic extraction of the free metabolites were added 1 ml 
of 0,.2j^yl acetate buffer pH 4.5 and approximately 1 ng ^-glucuronidase 
(275 Fishman units), and the whole was incubated overnight in a shaking 
water bath at 37°C. H e  biphenyl hydroxylation products were determined 
in the whole cell suspensions fluorlmetrically by the technique of 
Creaven et ai (1965).
The 'deconjugation' procedure described above does not resolve 
the nature of the conjugates produced by the cell suspensions, since 
it is known that the g-glucuronidase preparation used contains 
approximately 10% sulphatase activity. It was therefore modified in 
order that the extent of sulphation and glucuronidation could be 
determined separately. The 'modified deconjugation' involved the 
treatments of 1 ml aliquots of the aqueous phase remaining after the 
heptane extraction. (3.5 ml) of the free metabolites with either 
'ketodase', which was found to be free of aryl sulphatase activity 
(2,500 units) or aryl sulphatase (375 units). Saccharo-l~43 lactone 
at a final concentration of 20 mM was incorporated into the aryl 
sulphatase incubation in order to inhibit the contaminating
Q
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Figure 3.1. Scheme for the deconjugation and extraction of metabolites 
produced by incubation of biphenyl, and 2-, 3- or 4-hydroxy­
biphenyl with isolated rat hepatocytes.
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3-glucui'onidase activity that is present in the arylsulphatase preparation 
used. The arylsulphatase .and sacchar0-1-4 glactone were borh dissolved 
in 0.2 M acetate buffer pH 4.5, the ketodase was purchased as a solution 
in the same buffer. Tubes were incubated overnight in a shaking water 
bath at 37°C and the biphenyl hydroxylated products released by the 
enzyiie treatments determined as before. For a modified schsne of extraction 
and deconjugation procedure see Figure 3.2.
In experiments in which preincubation with 4-methylumbelliferone was 
carried out, the cells were centrifuged (50 g for 1 minute) after 60 minutes 
treatment at 37°C, the medium removed, replaced with the same volume of 
fresh medium and then incubated with biphenyl.
High pressure liquid chramtographic analysis of hydroxylated biphenyl 
products fran hepatocytes incubated with biphenyl was carried out by the 
method of Burke and Prough (1978) as modified by Benford (1978) (unpublished 
data). 1 ml samples of cell suspension (2 x 10  ^viable hepatocytes) were, 
after incubation with biphenyl, extracted with 7 mis of hepxane (no 
iso-amyl alcohol). 6 ml of the heptane layer was then filrered through 
a millipore filter and evaporated to dryness. The residue, containing 
the free biphenyl hydroxylated products was redissolved in 50 ul of the 
column solvent (iso-octane: iso-amyl alcohol : acetonitrile; 100 : 10 : 7v/v), 
of which a 30 yl aliquot was injected into the HPLC column. The aqueous 
samples regaining after the organic extraction were subjected to the 
'modified deconjugation' procedure as already described and the conjugated 
metabolites treated as before.
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Figure 3.2. Modified scheme for the deconjugation and extraction
of metabolites produced by incubations of biphenyl and
2-, 3- or 4-hydroxjt)iphenyl m t h  isolated rat hepatocytes.
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3.2.5.2. In Rat Liver Slices
Slices of rat liver (4 or 5) were first equilibrated at 37°C for 
30 minutes in a shaldLng water bath in 5 mis of complété medium (L-15 
plus 10% foetal calf serum) before incubation with biphenyl (70 y M) in 
50 ml conical flaslis for various time periods. The reaction was stopped 
by putting the flasks in ice and four 1 ml aliquots of the medium were 
taken from each flask for fluorlmetric determination of the 4-hydroxy- 
biphenyl metabolites produced (Creaven et al, 1965). To quantitate the 
results the slices remaining in the flask were homogenised in 1.15% KOI 
(5 ml), SI 0.1 ml aliquot of this hcmogenate was taken and made upto 10 ml 
in 0.5 N NaOH. 250 y 1 aliquots were then used for protein estimations 
(Lowry, ^  al, 1951).
3.2.5.3. Further Metabolism Studies in Isolated Rat Hepatocyte Suspensions
Methods were used as for the fluorlmetric biphenyl hydroxylase assay
except that the reaction was initiated with 10 y 1 of a solution of 2-hydroxy-,
3-hydroxy- or 4-hydroxybiphenyl (concentration range 7-140 yM) in DMF. For
studies in which only the conjugation of the hydroxybiphenyIs was investigated,
the cell suspension was heptane extracted, after incubation, to remove the,
unmetabolised substrate and the remaining aqueous phase deconjugated by the
enzyme procedures already described. The released free hydroxybiphenyIs
were then extracted and determined fluorlmetrically. 2-hydroxybiphenyl,
X 290 nm, X 405 nm; 3-hydroxybiphenyl, X 310 nm, X 420 nm; 4-hydroxy- ©X on ©X ©m
biphenyl, X 275 nm, X ^ 330 nm. ex ' em
3.2.5.4. Thin Layer Chramatography of Biphenyl Metabolites
After incubation for 1 hour with biphenyl, 2- or 4-hydroxybiphenyl as 
outlined above, the cell incubation mixture was extracted twice with
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diethyl ether (10 ml). The ether fractions were pooled, evaporated 
to dryness, the residue talcen up in 50 ul ether and plated onto a 
silica gel plate (Merck). Tlie plate was then subjected to
ascending chromatography using a solvent system of benzene-ethanol 
(95 : 5 v/v). Appropriate standards were run simultaneously on the 
sane plate. Deconjugation of the aqueous phase after ether extraction 
was carried out by the original 'deconjugation' ræthod, described in 
figure 3.1. and the resulting deconjugated material was extracted and 
chramtographed as described for the free metabolites.
In some experiments the residue remaining after evaporation of 
the ether was dissolved in acetone and subjected to a dansylation 
procedure described by Frei-HaMsler et (1973). Thin layer 
chromatography of the dansylated derivatives was carried out using a 
silica gel G plate (Merck) and solvent system of benzene-chloroform 
(1 : 1 v/v).
3.2.5.5. Studies with[^^C]biphenyl
(i) Samples (5 ml) of cell suspension (2 x 10^  viable hepatocytes/ml) 
were incubated as previously described. The reaction was initiated hy 
the addition of 0.27 y Ci of biphenyl (specific activity 0.416 yCi/mmol) 
in 10 yl of D]MF (equivalent to a final concentration of 130 yM in the cell 
incubation mixture). In controls, the labelled biphenyl was added after 
the incubation.
In seme experiments the metabolites were extracted with heptane, 
deconjugated by the original method (figure 3.1), and samples of each 
phase were counted using a scintillant of 0.4% w/v PPO and 0.01% w/v POPOP in
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sulphur-free toluene. In other experiments the metabolites were 
ether-extracted, deconjugated (figure 3.1.) and subjected to t.l.c. 
analysis as already described. After t.l.c. the silica was scraped 
from the plate in 5 ran strips into glass scintillation vials, 10 ml 
of scintillant added and the vials counted. The scintillant consisted 
of 4% w/v Cab-O-Sil (Packard Ltd. , Reading) , 0.4% w/v PPO (2,5-diphenyl 
oxazole) and 0.07% w/v POPOP (l,4-bis~(5-phenoxazol-2-yl)benzene) in 
sulphur-free toluene.
(ii) One ml samples (four at each time point) of cell suspension 
(2 X 10^  viable hepatocytes/ml) were incubated in 10 ml conical flaslcs 
as described previously. The reaction was initiated by the addition 
of 0 . 4 Ci of [^ C^]biphenyl (specific activity 0.6 yCi/ymol) in 3 yl 
of DMF (equivalent to a final concentration of 70 yM in the cell 
incubation mixture). The increased level of DMF in the incubation 
mixtures (0.3%) was shown to have no effect on the cell viability 
over the incubation period used. After the incubation the cell samples 
were centrifuged for 45 seconds at 50 gav. to separate the cells from 
the medium. The cell pellet was washed twice with medium (2 ml), the 
washings being added to the original 1 ml sample of medium. The cells 
were resuspended in 5 ml of water and thoroughly mixed on a 'IVhirlimixer" 
to ensure cell disruption. Two samples of the resuspended cells and 
medium plus mshings were then pooled to give two 10 ml samples of 
cells and medium at every time point. A sample (100 yl) of the aqueous 
phase of both cells and medium was taken and counted together with 0.5 ml 
Soluene-350 (Packard Instrument Co.). The aqueous phase was then 
extracted with n heptane (2 x 10 ml) (with no iso-amyl alcohol). The 
organic layer containing the free metabolites was sampled for radio-
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activity counting, put through millipore filters, evaporated to 
dryness, redissolved in 50 y 1 of HPLC solvent and treated as described 
previously. The aqueous saiiples of the cells and medium remaining 
after the organic extraction were again sampled for counting and 
stored at -20°C until the 'deconjugation' was performed (as described 
In figure 3,2.). The released metabolites were then treated
as before. Each cell or medium sample, after passing through the HPIC 
colunm was collected in 20-21 fractions (0.5 ml, vol) using an LKB 
Ultorac 7000 Fraction Collector and after addition of scintillant, 
counted for radioactivity present. The scintillation cocktail contained 
0.02% w/V DMPOPOP (1,4-bis-2- ( inmethy 1- 5-phenyl~oxazoyl ) -benzene) ,0.5% 
w/v PPO(2,5-diphenyloxazole) in sulphur-free toluene.
3.2.6. 7-Ethoxycoumarin 0-de-ethylase Assay
6Samples (1 ml) of the cell suspension (2 x 10 viable hepatocytes 
/ml) were incubated in 10 ml conical flasks as described previously.
The reaction was initiated by the addition of 2 ^ 1 of 7-ethoxycoumarin 
(35 nAÎ) dissolved in DÎÆF, to give a final concentration of 70 yM in the 
cell incubation mixture. The reaction was stopped by placing the flasks 
on ice and the cell sample was then diluted (x 5) with a suitable isotonic 
solution (PBS*A’). 1 ÎÜ aliquots of the diluted cell suspension were
extracted with diethyl ether/1.5% iso-amyl alcohol (5 ml) to remove the 
free 7-hydroxycoumarin produced. 1 Hi of the organic layer was then 
back extracted into 0.2 M glycine/NaOH buffer pH 10.4 (Jacobson et al, 1974) 
Conjugated material was determined by suitable enzyme treatment and 
measurement of the resulting free material after extraction and alliali 
back extraction. Free 7-hydroxycoumarin was measured fluorimetrically 
using 1 370 nm and?^ 450 nm.
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3.2.6.1. 7-Hydroxycoumarin Conjugation Assay
6Cell suspension (1 ml) (2 x 10 viable hepatocytes/ml) were 
incubated with 7-hydroxycoumarin (final concentration 70y M in DMF) 
for various time periods and the cell sanple diluted (x 5) as 
described before. 1 ml aliquots of the diluted cell suspension were 
ether extracted to remove unmetabolised 7-hydroxycoumarin and the 
aqueous phase remaining was then deconjugated using the modified 
procedure (figure 3.2.). The resulting free 7-hydroxycoumarin was 
extracted with diethyl ether as before and 1 ml of the ether phase 
was back extracted into the 0.2 M glycine/NaOH buffer pH 10.4 and 
estimated as before.
3.2.7. Benzo(a)pyrene hydroxylase Assay
Samples (1 ml) of cell suspension (2 x 10^  viable hepatocytes/ 
ml) were incubated in 10 ml conical flasks as described before, the 
reaction initiated by the addition of 2 y 1 of benzo(a)pyrene (40 rrfl) 
dissolved in DMF, i:o give a final concentration of S3 y M in the cell 
incubation mixture. The reaction was stopped by placing the flasks 
on ice and by the addition of the cell suspension to 1 ml of acetone. 
The free phenolic metabolites produced were extracted into n-hexane 
followed by back extraction into 1 N NaOH and measured fluorimetrically 
by the method of Nebert and Gelboin (1968). The conjugated phenolic 
metabolites were hydrolysed enzymically using methods already described 
and the released free material determined as before. %iinine sulphate 
was used to quantitate experiments, employing the relationship that 
0.036 nmoles of 3-hydroxybenzo(a)pyrene in IN NaOH gives a fluorescence 
intensity that is equivalent to a 0.3 y g quinine sulphate/ml in 0.1 N 
HgSO^ (Uemura and Chiesara, 1976).
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3.2.8. 2,4~Dinitrophenol and p-Nitrophenol Assay.
Cell suspensions (2 x 10^  viable hepatocytes/ml) were incubated 
in 5 ml volunes in 50 ml conical flasks as described before. The 
reaction was initated by the addition of 2,4-dinitrophenol or 
p-nitrophenol (final concentration 200 /i in PBS'A'). After termination 
of the reaction by placing* the flasks in ice, 1 ml aliquots of the 
cell suspension were removed and mixed with 0.2 ml of acetate buffer 
pH 4.5 and then extracted with diethyl ether (5 ml). The unmetabolised 
substrate was back extracted into alkali (0.1 N NaOH) and estimated 
spectrophotonetrically. The conjugated metabolites were b^idrc\pi>c\, by 
separate enzymic hydrolysis with ketodase or aryl sulphatase (plus 
saccharo 1-4 g lactone) of the remaining aqueous phase, extracted and 
estimated as b e f o r e 2,4-diniti’ophenol was measured at X360 nm, £-nitro- 
phenol at A400 nm.
3.2.9. Oxygen Uptake Studies
Cells (2.5 mis) in suspension (1 - 2 x 10^  viable hepatocytes/ml) 
were equilibrated at 37°C in the oxygen electrode for 2-3 minutes 
before it was sealed, ensuring all air bubbles had been expelled. The 
control rate of oxygen uptalce of isolated rat hepatocytes was obtained, 
once linearity had been attained (usually after about 2 minutes), and 
the effect of inhibitors and/or biphenyl on this rate was then 
monitored.
3.2.10. ATP Estimation
The procedure adopted was based on the Boehringer kit for the 
estimation of ATP in blood (Cat. No. 123897) derived frcm the method 
of Adam (1962).
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5 mis of cells suspension (2 x 10^  viable hepatocytes/ml)
were incubated in 50 ml conical flasks at 37°C as described in
the results section. After which the flasks were cooled on ice
and the cells treated as described by Parker (1977), the ATP
content being estimated by measuring the change in fluorescence
at X 365 nm and X ^  420 nm. ex em
3.2.11. NAPPE Extraction and Estimation
The method used for the estimation of NADPH was based on the 
suggested scheme of Klingenberg (1971).
NADPH and NADH were extracted by allcaline extraction, which 
causes the deccmposition of the oxidised forms NAD and NADP and 
the remaining reduced cofactors were then used to measure the 
reduction of oxidised glutathione ' to glutathione in the presence 
of glutathione reductase.
G - S - S - G  + NADPH + H*^   --  2G8H + NADP"^
The equilibrium for this reaction is strongly to the right and 
glutathione reductase is unable to use NADH.
5 mis of cell suspension (2 x 10^  viable hepatocytes/ml) were 
incubated in 50 ml conical flasl<s at 37°C as described in the results
( p Wsection j(. At the end of the incubation period the flasks were cooled 
on ice and the cells treated as described by Parker (1977), the NADPH 
content being estimated by the change in fluorescence at X 365 nm 
and Xg^ 420 nm.
86
3.2.12. Microsomal Studies
Liver microsomes from untreated rats were isolated at 0-4°C 
using conventional differential ultracentrifugation tecliniques 
(Fry, 1374). Incubations were carried out at 37°C using 0.2 ml 
microsanal suspension (approx. 10 mg protein/ml) in the presence of 
a NADPH-regenerating system in 0.1 M phosphate buffer pH 7.6, con­
sisting of InADP (1.2 y moles) glucose-6-phosphate (15 y moles) and 
glucose-6-phosphate dehydrogenase (1.5 units) in each incubation.
The final incubation volume was 2.0 ml in each case. After incubation 
with biphenyl (70 y M) with or without inhibitor, hydroxy metabolites 
were extracted and measured fluorimetrically as already described.
3.2.13. Protein Estimation
Protein was assayed by the method of Lowry et ^  (1951). A 
suitable dilution of sanple to be assayed was prepared in 0.5 N NaOH. 
To 1 ml aliquots of the solution, 5 ml of freshly prepared Lowry 
Reagent C (100 parts 2% Na^ OO^ , 1 part 1% CuSO^.SH^O and 1 part 2% 
sodium potassium tartrate) was added and mixed. After at least 10 
minutes 0.5 ml of Folin-Ciocalteu reagent (diluted 1 in 2) was added 
and irrmediately mixed. Suitable blanks (1 ml, 0.5 N NaOH) and protein 
standards (bovine serum albumin in 0.5 N NaOH, range 0-200 y g/ml) were 
also carried through the above procedure. After 30 minutes the amount 
of protein in each tube was estimated by measurenent at 720 nm. .
3.2.14. Analysis and Presentation of Results
'tVhenever 3 or more samples were being assessed, the results are 
given as means + SEM. Statistical analysis was carried out using the
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Students t-test. Sane of the data presented in the subsequent tables 
and figures describe e^ gerimentSg
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3.3. RESULTS
3.3.1. Toxicity of Biphenyl and its Primary Metabolites to Isolated 
Viable Rat Hepatocytes
An initial calculation indicated that, for metabolism studies
7involving an inoculum of 10 viable hepatocytes in a 5 ml volume, a 
final biphenyl concentration of 1.4 mM would be roughly conparable 
to that used in microsanal assay systems, based on the assumption 
that 1 g of liver contains 1.2 x lO^hepatocytes, (Daoust, 1958).
However, incubation of isolated hepatocytes with 1.4 nM biphenyl for 
45 minutes produced a gi’eat decrease in cell viability as compared 
with the dimethylformamide control (figure 3.3.) as judged by trypan 
blue dye exclusion. This effect of 1.4 mM biphenyl was accompanied 
by marked ’ballooning’ of the cell membranes and vacuolation of the 
cytoplasm of treated cells, as judged by light microscopy. These 
manifestations of cytotoxicity induced by biphenyl were not observed 
in the concentration range 14 - 140 yM (figure 3.3.). Measurements 
of release of soluble enzymes e.g. alanine aminotransferase (EC 2.6.1.2.), 
from the hepatocytes in response to biphenyl treatment supported these 
findings. Concentrations of biphenyl in the range 14-140 yM were 
consequently used in subsequent metabolic studies.
Incubations were also carried out with isolated rat hepatocytes 
over a range of concentrations (7-700 yM) of the 3 primary metabolites 
of biphenyl, 2-, 3- and 4-hydroxybiphenyl. The upper concentration of 
the major primary metabolite, 4-hydroxybiphenyl which could be studied 
was limited by the toxicity of this compound to the cells; thus when 
isolated viable rat hepatocytes were incubated at a concentration of
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Legends to Figures
All incubations were carried out at a cell concentration of 
2 X 10^  viable hepatocytes/ml at 37°C for time periods indicated 
on each figure or in the script. Bars where shown, represent the 
S.E.M. of values, and these values the means of 2 or 3 separate 
estimations differing by less than 10(o from each other.
Figure 3.3.
Biphenyl concentrations:- ©---# none;------ v---v 14 yM;
— m 140 yM; O--O 1.4 mM.
Figure 3.4.
2-, 3“ and 4-Hydroxybiphenyl concentrations : - m---ü none;
□--□ 7 yivîj------ V--V 70 yM; v v 140 yM;
© — -© 700 yM.
Figure 3.7.
A  A Total 4-hydroxybiphenyl ;  ^ # ---# Conjugated 4-hydroxy­
biphenyl; O -- O Free 4-hydroxybiphenyl.
Figure 3.8. - As for Figure 3.7.
Figure 3.9.
©-- © Total 4-hydroxybiphenyl; O O 4-hydroxybiphenyl sulphate;
A  A 4-hydroxybiphenyl glucuronide; a  a Free 4-hydroxy­
biphenyl .
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Figure 3.10.
A  A Total 2- and 3-hydroxybiphenyl; 0 Conjugated 2-
and 3-hydroxybiphenyl; O  O Free 2- and 3-hydroxybiphenyl.
Figure 3.11.
@ --# Total 2- and 3-hydroxybiphenyl;
A — -A 2- and 3-hydroxybiphenyl 
glucuronide; ^ ---A Free 2- and 3-hydroxybiphenyl.
Figure 3.13.
4-Hydroxybiphenyl concentrations:- □-- □ 14 yM;
O O 35 yM; ® @  70 yM; A ---A 140 yM.
Figui'e 3.14(a) - As for Figure 3.13.
Figure 3.15.-3.17. - As for Figure 3.9.
Figure 3.18. - As for Figure 3,11.
Figure 3.19.
A A 4-hydroxybiphenyl sulphate;
biphenyl glucuronide.
A  A 4-hydroxy-
Figure 3.20. - As for Figure 3.19,
Figure 3.21.
A A 2-hydroxybiphenyl sulphate ;
biphenyl glucuronide.
A  A 2-hydroxy-
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Figure 3.22.
A -A 3-hydroxybiphenyl sulphate; a---A 3-hydroxy­
biphenyl glucuronide.
Figure 3.23. - As for Figure 3.9.
rlgure 3.25.
Figure 3.26.
2,4-Dinitrophenol concentrations:- A-- -A 2 x 10
0 -- © 2 X  10"^ M; m---# 1 X  10“ M^.
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Figure 3.3. Effect of biphenyl on viability of isolated rat hepatocytes 
from untreated animals.
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7CXD ijM for 45 minutes a significant decrease in cell viability was 
noted when coïïpared with the dimethylforraamide control (figure 3.4(a)). 
as judged by dye exclusion. In the concentration range (7-140 yM) 
4-hydroxybiphenyl induced no detectable cytotoxic response from the 
cells. As with 4-hydroxybiphenyl, the two minor primary metabolites 
2- and 3-hydroxybiphenyl at a concentration of 700 yM was found to be 
cytotoxic to the cells after 45 minutes incubation whereas over the 
concentration range (7-140 yM) it was not (figures 3.4(b) and (c)). 
Accordingly, concentrations in this range were used for the subsequent 
metabolic studies.
3.3.2. Metabolism of Biphenyl in Isolated Viable Rat Hepatocytes
3.3.2.1. Thin-layer Chromatography and Labelled Studies
Preliminary experiments strongly suggested that the primary 
metabolite(s) of biphenyl produced by rat hepatocytes in suspension 
were extensively conjugated. Thin-layer chromatographic analysis 
of ether extracts of 'free' and 'deconjugated' samples of hepatocyte 
suspensions incubated with 140 yM biphenyl at 37^C for 60 minutes 
demonstrated that the primary metabolite produced was 4-hydroxybiphenyl 
which was present largely as conjuga.tes, probably a mixture of glucuronide 
and sulphate (Table 3.1). This was confirmed by t.l.c. analysis of 
dansylated derivatives of the metabolites (Table 3.1.).
V^hen [^ C^]biphenyl, (specific activity 0.416 yCi/nmol) final
7concentration 130 yM, was incubated with 10 viable hepatocytes at 
37^C for 45 minutes and the metabolites extracted and quantitatively 
determined as already described, it was confirmed that the major 
metabolite produced was 4-hydroxybiphenyl which was largely present as 
the conjugate. A small amount of 4,4'-dihydroxybiphenyl was also
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Figure 3.4. Effect of 4-hydroxybiphenyl (A), 2-hydroxybiphenyl (B) 
and 3-hydroxybiphenyl (C) on viability of isolated 
rat hepatocytes from untreated animals.
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Table 3.1. Chromatographic Properties of Metabolites from Suspensions of 
Hepatocytes Incubated with Biphenyl, 2- or 4-hydrox\~biphenyl
7Viable rat hepatocytes (10 cells in 5 ml vol) were incubated with 
biphenyl, 2- and 4-hydr*oxybiphenyl (final concn. 140 lM) at 37°C for 1 hour 
after which time the samples were deconjugared (g-glucuronidase) and ether 
extracted. The residue remaining after evaporation of ether extracts was 
subjected to t.l.c, or dansylation then t.l.c.
Substrate Fraction Studied Rf of Underivatised Rf of Dansylated 
Canpounds* Derivatives**
Biphenyl Free
Conjugates
2-Hydroxyb ipheny1 Free
Conjugates 
4-Hydroxybiphenyl Free
Conjugates
0.95 (strong)* 
0.53 (strong)
0.73 (strong) 0.17 (v.weak)
0.75 (moderate)
0.52 (moderate) 0.14 (v.weak)
0.52 (strong)
0.42 (weak) 
0.42 (strong)
0.37 (strong)
0.37 (weak) 
0.42 (strong)
0.42 (strong)
Standards :-
Biphenyl
2-Hydroxybiphenyl 
4-Hydroxybiphenyl 
2,2' -Dihydroxybiphenyl 
4,4' -Dihydroxybiphenyl
0.94
0.75
0.53
0.40
0.14
0
0.37
0.42
0.25
0.28
* Solvent system: benzene-ethanol (95 : 5 v/v)
** Solvent system: benzene-chloroform (1 : 1 v/v)
$ Assessments of the intensity of fluorescence are given in parenthesis
96
present in the 'conjugated' fraction (figure 3.5.). It is possible 
that some free 2-hydroxybiphenyl was present (Rp 0.75) but 4,4'- 
dihydroxybiphenyl was quantitatively a more inport ant metabolite than 
2-hydroxybiphenyl. An analysis of the radioactivity present in the 
various fractions (see figure 3.1.) obtained by the hept ane-ext ract ion 
of a cell suspension previously incubated with biphenyl for 45 
minutes as described above is shown in Table 3.2. Of the total radio­
activity recovered 82% was present in the organic phase (A) of the free 
fraction and represented unmetabolised biphenyl. Approximately 2% 
of the radioactivity was associated with fraction B and probably 
consisted of free metabolites. Nearly 16% of the radioactivity recovered 
was present in the various fractions derived from the deconjugation 
procedure. Only 1.6% of this was present in the organic phase (D) 
whereas 9.1% was associated with the alkali phase (E) and consisted 
of the hydrolysis products of conjugated metabolites. The unextractable 
radioactivity (4.8%) may represent incorplete hydrolysis of conjugate 
by the crude 3-glucuronidase/sulphatase preparation or the presence of 
conjugates other than glucuronides/sulphates (e.g. mercapturic acid).
3.3,2.2. Fluorimetric and High Pressure Liquid Chromatographic Studies
Fluorimetric analysis of products from incubations of isolated 
rat hepatocytes with biphenyl confirmed the results from the radioactive 
and t;l,c. studies. In addition to 4-hydroxybiphenyl, a verj,- small 
amount of 2-hydroxybiphenyl was also produced, although the detection 
and amount of this very minor metabolite appeared to depend on the 
age of the animal from which the hepatocytes were derived, young animals 
producing greatest amounts of 2-hydroxybiphenylj 3-hydroxybiphenyl is 
also produced in such incubations but only in very snail quantities,
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Figure 3.5. Cliromatographic patterns of radioactivity recovered after 
45 minutes incubation of [^X]biphenyl (0.27 yCi, 130 yM) 
with isolated rat hepatocytes from untreated animals.
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Table 3.2. Distribution of Radioactivity in Fractions Obtained by Heptane 
Extraction after Incubation of Viable Rat Hepatocytes with 
Biphenyl.
Viable rat hepatocytes (10 cells in 5 ml vol) were incubated with 
biphenyl (0.27 pCi final concn. 130 yM) at 37°C for 45 min, the 
samples were deconjugated ( g-glucmronidase), extracted with heptane and 
the heptane extracted with alkali. The various fractions were then counted 
for radioactivity. The control incubation had the [^ C^] biphenyl added 
immediately before extraction.
Fraction Analysed* Radioact ivity
(as % total recovered)
Control Hepatocytes ** Hepatocytes + Biphenyl
Free Metabolites A 99 82
B < 1 2.2
Conjugated C < 1 4.8Metabolites D < 1 9.1
E < 1 1.6
* See Figure 3.1.
** 1^ ‘^C] biphenyl added to hepatocyte suspension after incubation
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as revealed by high pressure liquid chromatographic studies (Table 3.3.). 
Fluorimetric analysis of the hydroxylated products of biphenyl metabolism 
does not resolve 2- and 3-hydroxybiphenyl. As 2-hydroxybiphenyl is 
generally a more dominant metabolite than 3-hydroxybiphenyl the 
fluorimetric analysis is generally regarded primarily as a measure of 
2-hydroxybiphenyl. High pressure liquid chromatographic analysis 
however can resolve all three hydroxybiphenyl rætabolites from such 
incubations, and a typical profile is shown in figure 3.6.
The time course for the production of free and conjugated 4-hydroxy­
biphenyl on incubation of isolated rat hepatocytes with 70 pM biphenyl 
at 37°C is shown in figure 3.7. The biphenyl is rapidly metabolised 
to free 4-hydroxybiphenyl and reaches a maximum concentration after 
10 minutes, after wiiich time the concentration of free 4-hydroxybiphenyl 
decreases and after 45 minutes is hardly detectable. The conjugation 
of the 4-hydroxybiphenyl shows an initial lag but increases so that 
after 45 minutes incubation almost all the 4-hydroxybiphenyl is 
conjugated. Further evidence for the lag in conjugation of newly formed 
4-hydroxybiphenyl is demonstrated by the amounts of free and conjugated 
4-hydroxybiphenyl formed an incubation of biphenyl (14-140 pM) for 15 
and 45 minutes at 37% (figure 3.8.), After 15 minutes incubation, 
increased substrate (biphenyl) concentration is accompanied by an increase 
of free 4-hydroxybiphenyl whereas at 45 minutes all the 4-hydroxybiphenyl 
formed, at any substrate concentration, exists as the conjugate. The 
precise nature of the conjugates of the hydroxylated biphenyl products 
on incubation of the hepatocytes with (70 pM) biphenyl was Initially 
uncertain since the g-glucuronidase preparation was found to contain 
10% sulphatase activity. Using the modified deconjugation procedure
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Table 3.3. Analysis of Metabolites produced by Suspensions of Rat
- Hepatocytes isolated from Untreated and S-Methylcholanthrene- 
treated animals incubated with Biphenyl . bu-. High Pressure 
Liquid Chromatography
Viable rat hepatocytes (2 x 10® cells) were incubated with biphenyl 
(final concn 70 yM) at 37% for 25 min. The cell samples (1 ml) containing 
the free and conjugated metabolites were extracted and estimated as 
described in Materials and Methods.
Treatment Metabolitesproduced
2-hydroxy­
biphenylproduced
3-hydroxy-
biphenylproduced
4-hydroxy­biphenylproduced
Untreated Free 0.006 (0.01)
Sulphate - 0.050 (0.07) 0.720 (1.00)
Glucuronide 0.007*(0.01)*** - 0.054 (0.07)
Free 0.021 (0.03) 0.016 (0.02) 0.234 (0.32)
Sulplmte 0.081 (0.11) 0.272 (0.38) 1.306 (1.81)
Glucuronide 0.178 (0.25) 0.135 (0.19) 2.082 (2.89)
* Amounts expressed as peak heights (cms).  ^Values are the mean of 2 separate 
determinations differing by less than 10% from each other.
** Hydroxylated biphenyl products were not detected.
*** Figures in parenthesis indicate approximate values expressed as nmoles6product/25 minutes/2 x 10 cells. Technical difficulties limited accurate 
quantitation of the pealî height values.
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Figure 3.6. Coiïparison of Profiles of Biphenyl and Hydroxylated 
Products of Biphenyl resolved by High Pressure Liqi.iid 
Chromatographic Analysis.
Trace of a standard solution of biphenyl, 2-, 3- and 4-hydroxybiphenyl 
(A) and a cell suspension incubated with biphenyl (70 uH) for 30 minute^B) 
(i) Biphenyl; (ii) 2-Hydroxybiphenyl; (iii) 3~Hydroxybipheny1
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Figiu-e 3.7. Time Course of the appearance of free and conjugated 4-hydrox^ -^ 
biphenyl in suspensions of hepatocytes from untreated rats 
incubated with biphenyl (70 yM)
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Figure 3.8. Effect of biphenyl concentration on the production, and
subsequent conjugation of 4-hydroxybiphenyl in suspensions 
of hepatocytes from untreated rats incubated with biphenyl 
(70 mM) for 15 (-- ) and 45 (.....) minutes.
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the time course of the production of free and conjugated 4-hydroxy­
biphenyl was again investigated (figure 3.9). It can be seen that 
4-hydroxybiphenyl sulphate is the major conjugated metabolite formed 
by isolated rat hepatocytes from untreated rats' 4-hydroxybiphenyl 
glucuronide is formed but to a far lesser extent. It is interesting 
to note there is an initial lag in glucuronide conjugation of the 
newly-produced free 4-hydroxybiphenyl, glucuronide formation being 
barely detectable over the first 10-15 minutes of incubation with 
biphenyl. Sulphate conjugation does not exhibit this 'lag' effect.
This time course differs slightly frcxn the one shown in figure
3.7. It is almost certainly due to the crude 3-glucuronidase 
preparation used in this earlier study. The use of the more sophisticated 
'deconjugation' procedure in which the pure enzyme preparations
were employed separately makes it possible to obtain results which more 
closely reflect the true profile of the time course,
2- And 3-hydroxylation of biphenyl by isolated rat hepatocytes 
occurs at very low levels and the time courses of the production of 
free and conjugated 2- and 3-hydroxybiphenyl by untreated cells are 
shown (figure 3.10) using the crude deconjugation procedure, and using 
the modified separate enzyme hydrolysis (figure 3.11). Again differences 
are detected but it is felt that the time course sho^ vn in figure 3.11. 
may reflect more closely the true situation, despite the very low levels 
of 2- and 3-hydroxybiphenyl metabolites detected. The picture is very 
similar to that of 4-hydroxylation of biphenyl, free 2- and 3-hydroxy­
biphenyl production reaching a maximum after 10 minutes incubation and 
decreasing to undetectable levels by 45 minutes. A lag in the onset 
of conjugation of the free 2- and 3-hydroxybiphenyl also exists but by
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45 minutes all the 2- and 3-hydroxybiphenyl is in the conjugated form. 
Fluorimetric studies and high presswe liquid chromatographic analysis 
of hydroxylated biphenyl produced on incubation of isolated rat 
hepatocytes with biphenyl (70 ) at 37°C revealed that in contrast to
4-hydroxybiphenyl conjugation, no 2-hydroxybiphenyl sulphate could be 
detected with the untreated cells; all the 2-hydroxybiphenyl conjugate 
present being in the form of the glucuronide (Table 3.3.). High 
pressure liquid chromatography studies revealed that 3-hydroxybiphenyl 
is produced as a minor metabolite of biphenyl metabolism in untreated 
rat hepatocytes. 3-hydroxybiphenyl, unlilce 2-hydroxybiphenyl did form 
a significant amount of the sulphate conjugate (Table 3.3.).
3.3.3. Metabolism of 2-Hydroxyblphenyl in Isolated Viable Rat Hepatocytes
In the time course of production of 2- and 3-hydroxybiphenyl from 
biphenyl (figure 3.10.), it appears that at 30-45 minutes a decrease 
in free 2- and 3-hydroxybiphenyl occurs with no corresponding increase 
in the conjugated phenol. This suggests that 2-hydroxybiphenyl might 
be metabolised other than by conjugation, possibly by further hydroxy­
lation to 2,2'-dihydroxybiphenyl. Therefore, 2-hydroxybiphenyl, final
w > Wconcentration 140 was incubated^viable rat hepatocytes for 15 and 
45 minutes and sainples were extracted, deconjugated and the fluorescence 
measured at pH 6.0 as already described. It was previously established
that 2,2'-dihydroxybiphenyl displayed very little fluorescence at pH 6.0 and 
thus any changes in the 2-hydroxybiphenyl fluorescence would not be interfered 
with by formation of 2,2' dihydroxybiphenyl (Bridges et al, 1965), The 
results of such studies are shown in Table 3.4. After 45 minutes incu­
bation at 37°C, 35% of the added 2-hydroxybiphenyl cannot be accounted 
for either as the free compound or its conjugate. It is possible that 
some of this phenol unaccounted for may represent material bound to
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7Viable rat hepatocytes (10 cells in 5 ml vol) were incubated with 
2-hydroxybiphenyl (final concn. 140 yM) ax 37^ 0 for 15 and 45 minutes, 
and the 2-hydroxybiphenyl as free and conjugated was measured.
Incubation 2-Hydroxybiphenyl determined (% zero time concn) 2-Hydroxybiphenyltime (min) unaccounted forFree Conjugated Total (% zero time concn)
0 100 - 100 0
15 82 11 93 7
45 35 30 65 35
Values are given as the mean of 2 separate determinations, which differ 
by less than 10% from each other.
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cellular membranes or macromolecules which is not removed by heptane 
extraction, but these findings are more lilcely to be due to further 
metabolian of 2-hydroxybiphenyl, and by routes other than conjugation. 
Thin-layer chranatography confirmed the presence of conjugated
2-hydroxybiphenyl when this phenol was incubated with rat hepatocytes, 
but 2,2' -dihydroxybiphenyl could not be detected either in the free 
or deconjugated fractions (Table 3.1.). A wealc spot (Rp 0.17-0.18) 
was observed in the free fraction (Table 3.1.) but the nature of this 
metabolite is uncertain.
3.3.4. Metabolism of 4-Hydroxybiphenyl in Isolated Viable Rat Hepatocytes
Thin-layer chromatography of products isolated from incubations 
of rat hepatocytes with 4-hydroxybiphenyl (Table 3.1.) demonstrated 
that this phenol is extensively conjugated and is also further 
hydroxylated to 4,4'-dihydroxybiphenyl. This metabolite is also 
detectable after incubation of rat hepatocytes with biphenyl 
(figiue 3.5. ).
4,4'-Dihydroxybiphenyl exhibited a strong fluorescence at pH 6.0 
at the wavelength maxima used to measure the 4-hydroxybiphenyl (57% that 
of 4-hydroxybiphenyl) so that changes in the fluorescence intensity at 
pH 6.0 cannot be used to determine the true rate of disappearance of 
4-hydroxybiphenyl from incubation mixtures. However, 4,4'-dihydroxy­
biphenyl has a very wealî fluorescence at pH 13.0 (less than 3% that of 
4-hydroxybiphenyl) so that at tliis pH the concentration of 4-hydroxy­
biphenyl can be satisfactorily determined in the presence of 4,4'-dihydroxy­
biphenyl. By measuring the fluorescence at pH 6.0 and 13.0 and subtracting 
the value obtained at pH 13.0 from that at pH 6.0 one can calculate the
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amount of 4,4*-dihydroxybiphenyl present. The results fran such 
studies are illustrated in figures 3,12 - 3.14. During 10 minute 
incubations the decrease in concentration of 4-hydroxybiphenyl in the 
incubation mixture is directly proportional to the initial concentration 
of 4-hydroxybiphenyl over the range 14-140 yM (figure 3.12.). This decrease 
is accompanied by a concentration dependent increase in the concentration of 
total 4,4'-dihydroxybiphenyl (figure 3.13), the bulk of which is present as 
the free metabolite. The pattern of conjugation of 4-hydroxybiphenyl is not 
simple. At the highest concentration of 4-hydroxybiphenyl (140 y M) 
there is a reduction in the extent of conjugation compared to the other 
concentrations used (figure 3.14 (a)) whereas at the lowest concentration 
(14 yM) there is evidence of a lag effect similar to that observed in 
the conjugation of 4-hydroxybiphenyl produced from biphenyl. This can 
be seen better from a study of the conjugation after the first minute 
of incubation (figure 3.14(b)). Below a concentration of 14 yM 4-hydroxy­
biphenyl no conjugation occurs and it is important to note that this 
lag effect is observed only at concentrations of 4-hydroxybiphenyl 
likely to be achieved in the early stages of the 4-hydroxylation of 
biphenyl (figures 3.7 and 3.9.). V/hether this lag effect was also 
present at the intermediate concentrations of 4-hydroxybiphenyl 
(35 and 70 yM) but of much shorter duration was not ascertained because 
of technical difficulties.
3.3.5. The Effect of Inducers on Biphenyl Metabolism in Isolated 
Viable Rat Hepatocytes
The effect of pretreatment of animals with phenobapbitone,
3-methylcholanthrene and 3,4-benzo (a )pyrene on biphenyl metabolism 
in isolated rat hepatocytes is shown in the time courses in figures
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Figure 3.12. Rate of disappearance of free 4-hydroxybiphenyl as a function 
of 4-hydroxybiphenyl concentration on .incubation with rat 
hepatocyte suspensions from untreated animals.
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Figure 3.13. Formation of 4,4’.-dihydroxybiphenyl from 4-hydroxybiphenyl 
by rat hepatocyte suspensions from untreated animals.
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Figure 3.14 (a) Time course of the conjugation of 4-hydroxybiphenyl by 
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Figiure 3.14 (b) Effect of 4-hydroxybiphenyl concentration on the amount
of 4-hydroxybiphenyl conjugated by rat hepatocyte suspensions 
from untreated animals in the first minute of incubation.
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3.15.-3.18. The yields and viabilities of the hepatocytes from the 
livers of the treated rats were similar to those obtained fran the 
untreated animals.
The amount of 4-hydroxybiphenyl produced is markedly increased 
and the pattern of 4-hydroxybiphenyl conjugates produced is altered 
quite significantly by these treatments. The major conjugate produced 
by both phenobarbitone and 3-methylcholanthrene-treated cells is
4-hydroxybiphenyl glucuronide (figure 3.15. and 3.16.). In 3,4-benzo(a)- 
pyrene-treated cells, the amounts of 4-hydroxybiphenyl glucuronide 
and sulphate are approximately equivalent (figure 3.17.)„ The lag in 
the onset of conjugation of free 4-hydroxybiphenyl is even more marked 
in the treated than in untreated cells. There is an 850% increase 
in the initial rate of total 4-hydroxybiphenyl production by pheno­
barbitone-treated hepatocytes, a 200% increase by 3-methylcholanthrene- 
treated cells and a 100% stimulation by 3,4-benzo(a)pyrene-treated 
cells when compared to untreated hepatocytes (Table 3.5.). Whereas 
the total production of 4-hydroxybiphenyl sulphate after 45 minutes 
incubation with 70 yM biphenyl at 37°C is increased to only a small 
degree in all treated cells, there is a massive increase in the production 
of 4-hydroxybiphenyl glucuronide (2375%) in phenobarbitone-treated cells 
(675 %) in Snmethylcholanthrene-treated cells and a 450% stimulation 
in 3,4-benzo(a)pyrene-treated cells when compared to untreated controls 
(Table 3.5).
Phenobarbitone pretreatment of animals did not affect the level 
or pattern of 2-hydroxylation of biphenyl in isolated rat hepatocytes. 
However 3-methylcholanthrene and 3,4-benzo (a )pyrene pretreatment resulted
113
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Table 3.5. Effect of Induction of Biphenyl 4-hydroxylation and
Subsequent Conjugation in Suspensions of Rat Hepatocytes 
incubated with Biphenyl
Viable rat hepatocytes (2 x 10^ cells/ml) from untreated and 
treated animals were incubated with biphenyl(final conc. 70 yM) at 
37°C for up to 45 mins. At various times suspensions were assayed 
for free and conjugated 4-hydroxybiphenyl.
Parameter
Measured
Treatment
Control PB 3MC BP
Initial Rate*
Total 4-hydroxybiphenyl 0.2 1.9(850) 0.6(200) 0.4(100)
4-hydroxybiphenylsulphate 0.07 0.œ(14) 0.05C-) 0.08(14)
4-hydroxj7-biphenylglucuronide 0.002 0.120(5900) 0.030(1400) 0.030(1400)
Overall Production**
Total 4-hydroxbiphenyl 2.1 12.8(510) 5.8(176) 4.9(133)
4-hydroxybiphenylsulphate 1.6 2.9(80)
2.0(25) 2.4(50)
4-hydroxybiphenylglucuronide 0.4 9.9(2375)
3.1(675) 2.2(450)
* Rates expressed as nmoles produced/min/2 x 10^  cells over the first 
10 minutes of incubation with biphenyl 6** Amounts expressed as nmoles produced/2x 10 cells in 45 minutes.
Numbers in parentheses are values as a percentage increase of control. 
Values are means of duplicate estimations differing by less than 
10% from each other.
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in a dramatic increase in the amounts of both free and conju^ted
2- and 3-hydroxybiphenyl produced after 45 minutes with 70 yM biphenyl 
(figure 3.18.). As with untreated cells (figure 3.11.) the amount of 
free 2- and 3-hydroxybiphenyl present is at a maximum at 10 minutes 
and returns to low levels by 45 minutes of incubation concomitant with 
a rise in conjugated products. The lag in conjugation is more marked 
in cells iron 3-methylcholantlirene and 3,4-benzo (a )pyrene animals than 
cells from untreated or phenobarbitone pretreated animals. High 
pressiure liquid chromatographic analysis of hydroxylated biphenyl 
products from 3-methylcholanthrene-treated cells after 25 minutes 
incubation with 70 ^ M biphenyl revealed that both 2-hydroxybiphenyl 
sulphate and glucuronide are formed, the glucuronide being the major 
metabolite. 3-hydroxybiphenyl is also produced to an appreciable 
extent in such cells and exceeds the total 2-hydroxybiphenyl produced. 
Both 3-hydroxybiphenyl sulphate and glucuronide are also formed, the 
major metabolite being the sulphate (Table 3.3.).
Y/hen the amount of total 4-hydroxybiphenyl produced after 45 minutes 
incubation of isolated rat hepatocytes with biphenyl is increased (as 
after induction), there is a marked change in the pattern of the 
4-hydroxybiphenyl conjugates produced (see above). At low rates of 
production of total 4-hydroxybiphenyl, as with hepatocytes from non­
induced animals, the sulphate conjugate predominates, while generation 
of large amounts of 4-hydrox5,^ biphenyl, as with hepatocytes from pheno­
barbitone, 3-methylcholanthrene or 3,4-benzo(a-)pyrene-induced animals, 
leads to the glucuronide conjugate becoming the major metabolite (figure 
3.19.). There is a ’cross-over' (i.e. \?hen the extent of sulphate and 
glucuronide produced is equivalent ), which occurs when both conjugates 
reach a value of a.bout 2.5 nmoles produced/45 minutes/2 x 10^  cells.
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To investigate this aspect further, incubations were carried
out with isolated rat hepatocytes over a range of concentrations
(7-140 yM) of the primary metabolites, 2-, 3-, and 4-hydroxybiphenyl.
The nature and extent of the conjugates produced after 45 minute
incubations of 4-hydroxybiphenyl with isolated rat hepatocytes is
sunmarised in figure 3.20. At low concentrations of 4-hydroxybiphenyl
the major metabolite is 4-hyroxybiphenyl sulphate, the glucuronide
being formed to a far lesser degree. However, with increase in
substrate concentration glucuronidation quickly takes over as the
majoi' route of conjugation. The 'cross over' point occurs when
both conjugation rates reach a value of approximately 3 nmoles
6produced/45 minutes/2 x 10 cells (figure 3.20.(b)), i.e. at a 
4-hydroxybiphenyl concentration of about 20 yM (.figure 3.20 (a) and 
(b)). In the 4-hydroxybiphenyl concentration range studied (7-140 yM) 
the total amount of sulphate and glucuronide conjugates increase with 
increasing substrate concentration ( figure 3.20.(b)), i.e. total 
saturation of the sulphate conjugation mechanisn is not obtained.
However the increase in the rate of glucuronic acid conjugation is 
approximately 4 times greater than that of sulphate conjugation.
Incubations were also performed v/ith 2-hydroxybiphenyl and 3-hydroxy­
biphenyl, the minor primary metabolites of biphenyl metabolism in isolated 
rat hepatocytes over the same concentration range (7-140 yM)(figures 3.21. 
and 3.22.). As with 4-hydroxybiphenyl,at low concentrations of both 
phenols, the sulphate conjugate was again produced to a greater extent 
than the glucuronide, but with increasing substrate concentration the 
glucuronide quickly takes over as the major route of conjugation.
The'cross-over' point in 2-hydroxybiphenyl conjugation in isolated rat 
hepatocytes occurs at a value of approximately 0.5 nmoles conjugate
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6produced/45 minutes/2 x 10 cells (figure 3.21.(b), i.e. at a 2-hydroxy­
biphenyl concentration of about 8 yM (figure 3.21(a) and (b)). With
3-hydroxybiphenyl this 'cross-over' occurs at approximately 2.4 nmoles 
conjugate produced/45 minutes/2 x 10^  cells (figure 3.22(b)), at a
3-hydroxybiphenyl concentration of approximately 10 yM (figure 3.22 (a) 
and (b)).
The total extent of conjugation of 2-hydroxybiphenyl over the 
concentration range studied (7-140 yM) is the same as occurs with 
4-hydroxybiphenyl, but the 'cross-over' point of the conjugates obtained 
is much lower. There is a marked reduction in the sulphate conjugates, 
together with a concomitant increase in the glucuronide conjugates of
2-hydroxybiphenyl to that produced at an equivalent 4-hydroxybiphenyl 
concentration. Total saturation of the sulphate conjugation is again 
not obtained with 2-hydroxybiphenyl in the concentration range studied 
(7-140 yM) as the amount of sulphate and glucuronide conjugates both 
increase with increasing substrate concentration (figure 3.21 (b). 
However, the increase in the rate of glucuronic acid conjugation %vith 
increase in 2-hydroxybiphenyl concentration is 30 times that of sulphate 
conjugation.
The pattern and extent of 3-hydroxybiphenyl conjugation is very 
similar to that of 4-hydroxybiphenyl. Although the point at which the 
rates of both conjugating enzymes are equivalent are about the same 
(y 2.5 nmoles produced/45 minutes/2 x 10^  cells) the concentration of 
the 3-hydroxy-metabolite at which this occurs is very different, 10 yM 
compared with 20 y M with 4-hydroxybiphenyl. This is closer to the 
situation that prevails with 2-hydroxybiphenyl where the cross-over 
occurs at a concentration of 8 pM. Another similarity to 4-hydroJq>’- 
biphenyl is that the rate of glucuronic acid conjugation of 3-hydroxy-
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biphenyl is only 3 times that of sulphate conjugation. Sulphation 
of 3-hydroxybiphenyl is also not totally saturated over the concentration 
range studied (7-140 yM) (figure 3.22.(b)).
3.3.6. Investigation of the 'Lag' Phase in the Conjugation of 4-Hydroxy- 
biphenyl in Isolated Viable Rat Hepatocytes
Several approaches were used in atteimts to learn the nature and 
cause of this phenonenon. To investigate the possibility that the 
lag phase represents activation of the conjugating enzymes by the 
phEise I metabolite, hepatocytes were incubated with an alternative 
substrate, prior to the addition of 70 yM biphenyl. In an attempt 
to eliminate the lag phase 4-methylumbelliferone was used, as this 
particular substrate has been shown to be rapidly metabolised to the 
glucuronide and sulphate and then eliminated from the cells, 0.7 pM 
4-Methylumbelliferone was used as this level did not result in any 
significant drop in hepatocyte viability (less than 10% after 60 minutes 
at 37% compared to the appropriate controls). Fui"hhermore, removal 
of 4-methylumbelliferone from the cells as conjugates was complete 
after 60 minutes so that competition bebryeen this substrate and 
biphenyl is unlikely in these experiments. This preincubation of the 
hepatocytes with 0.7 yM 4-methylumbelliferone (Table 3.6.) increased 
the initial rate of the glucuronidation of 4-hydroxybiphenyl quite 
considerably over the appropriate control (175%) while the initial 
rate of sulphation of 4-hydroxybiphenyl was relatively unaffected 
by this treatment (25%). It is also worthy of note that even controls 
preincubated for 60 minutes at 37% without any addition of substrate 
for conjugation showed a significant increase in the initial rate of
4-hydroxybiphenyl glucuronide formed together with a significant
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decrease in the formation of 4-hydroxybiphenyl sulphate when 
biphenyl was subsequently added (Table 3.6.).
The results from incubations of rat liver slices in complete 
medium (L-15) v/ith biphenyl (70 yM) are shown in the time course 
in figure 3.23. The pattern and extent of 4-hydroxybiphenyl 
produced in the medium is similar to that produced by isolated 
rat hepatocytes incubated with biphenyl (figure 3.9.). Failure 
to detect significant amounts of 4-hydroxybiphenyl over the first 
10 minutes of incubation of the slices with biphenyl probably 
reflects the time required for the substrate to reach the active 
site of the enzymes involved and the 4-hydroxybiphenyl metabolites 
produced to be excreted in sufficient quantities to be detected. 
Changing the source of sugar from galactose (sole sugar in L-15 
medium) to glucose produced similar results. The time courses of 
biphenyl 4-hydroxylation and subsequent conjugation of 4-hydroxy­
biphenyl by rat hepatocyte suspensions in galactose and glucose 
containing medium (1 g/litre) were identical and very similar to 
that shown in figure 3.9.
3.3.7. Nature of Biphenyl 4-hydroxylation and Conjugation Reactions 
in Isolated Viable Rat Hepatocytes
A characteristic property of the hepatic mixed function oxidase
system is its inhibition by carbon monoxide and SICP 525A (final 
—4 —5concentration 10 - 10 M). That the biphenyl 4-hydroxylase in
isolated viable rat hepatocytes is a typical enzyme of this system
is danonstrated by the marked inhibition that occurs wben these cells 
are incubated with biphenyl (70 pM) in the presence of CO or 10’"^  M 
SKF 525A (76% and 71% inhibition respectively, Table 3.7.). Further-
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Figure 3.23. Time course of the appearance of free and conjugated 
4-hydroxybiphenyl in the medium of liver slices from 
untreated rats incubated with biphenyl CTO pM)
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Table 3.7. The Effects of Inhibitors, NADPH and Loss of Viability on 
Biphenyl 4-Hydroxylation and subsequent Conjugation in 
Suspensions of Rat Hepatocytes from Untreated animals.
7Rat hepatocytes (10 cells in 5 ml vol) were incubated with 70 uM 
biphenyl at 37^ C for 45 mins in the presence of various inhibitors or 
cofactors. Cells made non-viable by hypotonic lysis were similarly 
studied. Free and conjugated 4-hydroxybiphenyl metabolites were 
extracted and measured as outlined in Figure 3.1.
Treatment
4-hydroxybiphenyl produced (nmoles/loT cells/45 minutes)
Free Conjugated Total
Total as % of untreated control
Conjugated4-hydroxybiphenyl
Free4-hy droxyb ipheny1
None 0.07 12.2 12.3 100 188
+00 0 2.9 2.9 24 NA
+SKF525A(10“ /^I) 0.13 3.4 3.6 29 27
+NADPH(10“^) 0 14.3 14.3 117 NA
Non-viable cells 0.89 0 0.9 7 NA
Non-viable cells + NADPH(10 m) 6.0 2.2 8.2 66 0
NA - not applicable
Values are means of two separate determinations differing by less than 10% 
from each other.
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more, CO does not appear to inhibit conjugation (all the 4-hydroxy­
biphenyl is present as conjugate, Table 3.7.) whereas 8KF 525A does 
inliibit this reaction (conjugated: free ration is much lower in the 
SKF 525A-treated suspensions. Table 3.7.). Cells made non-viable by 
osmotic shock retain less than 10% of the hydroxyl at ing activity and 
no conjugating ability, almost certainly due to release and remval 
of necessary soluble cofactors. This is confirmed for the hydroxylation 
by the stimulating effect (800%) of added exogenous NADPH (10 ^ ,1) to 
the non-viable cells (Table 3.7.). In contrast the small (17%) 
stimulatory effect of adding NADPH to the viable cell suspension is 
probsibly due to its effect on the few non viable cells present in the 
suspension.
The low level of biphenyl 2-hydroxylase activity present in non 
induced isolated rat hepatocytes precluded studies on this enzyme 
simi_lar to those described for biphenyl 4-hydroxylase,
3.3.8. Effect of Metabolic Inliibitors on Biphenyl 4-hydroxylation
and Conjugation Reactions in Isolated Viable Rat Hepatocytes
Tlie effect of three metabolic inhibitors, rotenone, menadione 
and 2,4-dinitrophenol (the structures of which are shown in figure
3.24) on the production of free and conjugated 4-hydroxybiphenyl by 
isolated viable rat hepatocytes from untreated rats incubated with 
70 yM biphenyl for 25 minutes at 37^ C is summarised in Table 3.8. 
Rotenone (final concentration 2 x 10 M^) resulted in a 25% reduction 
in the initial hydroxylation step, the conjugation reaction was 
however much more severely affected, both 4-hydroxybiphenyl sulphate 
and glucuronide formation were inhibited by 89% and 64% respectively, 
resulting in much higher levels of free 4-hydroxybiphenyl being
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Figure 3.24. Structure of the metabolic inhibitors investigated
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detected (740% of control) in such incubations. Menadione (final
concentration 1.25 x 10 '^M) was a veiy potent inhibitor of enzyme
activity reducing the total 4-hydroxA’-bipheny 1 produced to less than
10% of the activity present in the uniniiibited hepatocytes. 2,4-
-4Dinitrophenol (final concentration 2 x 10 M) treatment resulted in 
marked inhibition of sulphate and glucuronide conjugation of the 
newly produced free 4-hydroxybiphenyl produced by these cells (88% 
and 50% re^ectively). However such treatment also results in a 
significant increase in the initial hydroxylation rate to 262% of the 
rate in control hepatocytes. A similar profile of inhibition was 
observed in biphenyl nfâtabolism when hepatocytes from phenobarbitone- 
treated rats were treated with the same iniiibitors (Table 3.9.). 
Menadione was again the most potent inhibitor, reducing biphenyl
4-hydroxylase activity and subsequent conjugating ability in these 
cells to very low levels (11% of control value). Rotenone also 
produced similar results in the phenobarbitone-treated hepatocytes, 
sulphate conjugation of the newly produced 4-hydroxybiphenyl was 
markedly inliibited, by 82%, as was glucuronide foimation, by 88%, the 
initial hydroxylation rate was also reduced by 52%. The stimulation 
of the hydroxylation of biphenyl in untreated hepatocytes after 
preincubation with .2,4-dinitrophenol (2 x 10 4^) (Table 3.8.) is not 
seen in the phenobarbitone-treated cells (Table 3.9.). Although both 
routes of conjugation of 4-hydroxybiphenyl are markedly inhibited 
(sulphate, by 82%; glucuronide, by 76%), the hydroxylation rate of 
biphenyl is unaffected in these cells. The effects of 2,4-dinitro- 
phenol (2 X 10~\l) on 7-ethoxycoumarin 0-deethylation and benzo(a)pyrene
3-hydroxylation and subsequent conjugation of the phase I metabolites 
produced by isolated hepatocytes from untreated rats are summarised
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in Table 3.10. The metabolic profile produced by this treatment is 
very similar to that seen with phenobarbitone-treated cells incubated 
with biphenyl, 2,4-dinitrophenol preincubation leads to a marked 
reduction in the foimation of conjugates of the phase I metabolites 
produced by the hepatocytes following incubation with either substrate, 
with little or no effect on the initial de-ethylating step of 7-ethoxy­
coumarin (81% of control rate) or hydroacylation of benzo(a)pyrene 
(97% of control).
To investigate the effect of these inhibitors directly upon 
conjugation, studies were carried out using 4-hydroxybiphenyl and 
7-hydroxycoumarin (both at a final concentration of 70 pM) as 
substrate and hepatocytes isolated from untreated rats at 37°C. Rotenone 
inhibited the sulphate and glucuronic acid conjugation of 4-hydroxy­
biphenyl markedly, the total conjugation rate being only 6% that of 
the control. 2,4-Dinitrophenol was just as potent as rotenone, 
inliibiting the overall conjugation rate of 4-hydroxybiphenyl by 95%, 
though not quite so effective with respect to 7-hydroxycoumarin conjugation 
which was inhibited by 84% (Table 3.11.). The inhibitor menadione was 
not included in these studies due to the fact that since 4-hydroxy­
biphenyl production from biphenyl in isolated hepatocytes from both 
untreated and phenobarbitone treated rats is so low after treatment 
with menadione (Tables 3,8 and 3.9) its direct effect on the conjugation 
of the phenol is not so Important as its effect on the initial hydroxy­
lation step. However it can be seen that menadione does inhibit the 
conjugation (both sulphate and glucuronic acid) of the 4-hydroxy­
biphenyl produced on incubation of rat hepatocytes with biphenyl (70 y M). 
The total conjugate : free ratio is much lower in hepatocytes which 
have been preincubated with menadione (1.25 x 10'~'^M) when compared to
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the control cells, 11.2 (control), 3.0 (menadione) in cells fron 
untreated rats (Table 3.8.), 5.3 (control, 0.7 (menadione) in cells 
fron phenobarbitone-treated rats (Table 3.9.).
In an attempt to further investigate the effect of 2,4-dinitro­
phenol (2 X 10 '^M) on biphenyl 4-hydroxylase activity and subsequent 
conjugation of 4-hydroxybiphenyl produced by isolated hepatocytes 
fron untreated rats^  the effect of a 10 minute preincubat ion of
2.4-dinitrophenol (2 x 10~'^ M) on the time course of free and 
conjugated 4-hydroxybiphenyl formed by isolated rat hepatocytes on 
incubation with 70 yM biphenyl at 37% was carried out; the same 
time hepatocytes were preincubated at 37% in the absence
of 2,4-dinitrophenol for 10 minutes before the biphenyl was added.
It was found to be very similar to that shown in figure 3.9. The 
time course of the 2,4-dinitrophenol preincubated hepatocytes is 
very different from the control cells, the free 4-hydroxybiphenyl 
being by far the major metabolite produced by these cells (figure
3.25) throu^out the 45 minute incubation with biphenyl^  4-hydroxy­
biphenyl sulphate the major metabolite in control cells has been 
dramatically reduced by this inhibitor.4-hydroxybiphenyl glucuronide 
production has not been so severely affected by tliis treatment, indeed 
after 45 minutes incubation, it is the major conjugate produced by 
these cells (figure 3,25.) being formed to a significantly greater 
extent than in control cells (figure 3.9). The total 4-hydroxybiphenyl 
produced by these 2,4-dinitrophenol preincubated cells is stimulated 
by over 5C% of that produced by control cells (figure 3.9).
The effects of altering the preincubation time and level of
2.4-dinitrophenol on the production of free and conjugated 4-hydroxy-
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Figure 3.25. Time course of the appearance of free and conjugated 
4-hydroxybiphenyl in suspensions of hepatocytes from 
untreated rats preincubated with 2,4-dinitrophenol (2 x 10 ^ M) 
followed by incubation with biphenyl (70 yM).
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biphenyl in isolated hepatocytes from untreated rats with 70 yM 
biphenyl at 37^C for 25 minutes is summarised in figure 3.26. At 
a final concentration of 2.x 10'"^ î, 2,4-dinitrophenol, while causing 
no increase in total 4-hydroxybiphenyl production in isolated hepato­
cytes (figure 3.26(a)), it enhanced the amount of free 4-hydroxy- 
biphenyl generated quite considerably (figure 3.26(b)). At this level 
there is a marked decrease in the 4-hydroxybiphenyl sulphate produced 
(figure 3.26(c)), with no apparent effect on the formation of 4-hydroxy­
biphenyl glucuronide (figure 3.26(d)). 1 x lO”*^ M 2,4-dinitrophenol
however, reduces the conjugation (both sulphate and glucuronic acid) 
of 4-hydroxybiphenyl to an almost undetectable level (figure 3.26(c) 
and (d)). All the 4-hydroxybiphenyl produced by the cells preincubated 
with 1 X 10 ^  2,4-dinitrophenol was in the free form and the increase 
in production of this metabolite (figure 3.26(a) and (b)) was much 
greater than that produced at the 2 x 10“ level. 2,4-Dinitrophenol 
at a concentration of 2.x 10“'^M produces the most dramatic effects on 
the metabolic profile of free and conjugated 4-hydroxybiphenyl production. 
Total and free 4-hydroxybiphenyl generation by the cells after preincubation 
at this level is again vastly increased to an even greater extent than 
at the 1 X 10 level. It is at the 2 x 10 level that preincubation 
time has its greatest effects on the resulting metabolic profile. Both 
total and free 4-hydroxybiphenyl production decreases with increase 
in preincubation time at this level; the same effect is observed with 
1 X 10 and 2 x 10“ ,^1, though far less dramatic at the lower level.
(figure 3.26(a) and (b)). As the preincubation time with 2,4-dinitro­
phenol is increased the concentration related inhibition of 4-hydroxy­
biphenyl sulphate production in the cells decreases (figure 3.26(c)).
At 2 X 10 2.4-dinitrophenol, 4-hydroxj^ biphenyl glucuronide is
completely inhibited after 5 minutes preincubation, but after 20 
minutes preincubation it is restored to control values (figure 3.26(d)).
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Figure 3.26. Effect of preincubation time and 2,4-dinitrophenol
concentration on the appearance of free and conjugated
4-hydroxybiphenyl in suspensions of hepatocytes from 
untreated rats incubated with biphenyl (70 yM)
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When the hepatocytes were preincubated with 1 x 10 2,4-dinitro­
phenol a slight cytotoxic response was detected, in the cells'(as 
judged by dye exclusion) and is almost certainly reflected in the 
reduced stimulation in the total and free 4-hydroxybiphenyl production 
by the cells on incubation with biphenyl, when compared to the 2 x 10  ^M 
level. No cytotoxic response was observed in the hepatocytes when they 
were preincubated with 2 x 10 %  or 2 x 10""^  M 2,4-dinitrophenol at 
37°C.
3.3.8.1. Effect of Metabolic Inhibitors on Biphenyl 4-hydroxylase 
activity in Rat Liver Microsones.
The effect of the inhibitors rotenone, menadione and 2,4-dinitro­
phenol on biphenyl 4-hydroxylase activity at 37°C in rat liver 
microsames isolated from untreated animals is shown in Table 3.12. 
Rotenone (2 x 10  ^M) results in a significant decrease in enzyme 
activity (38% inhibition), while menadione (1.25 x 10"^ M) is a much 
more potent inhibitor reducing the 4-hydroxylation of biphenyl to 
less than 1% of the control activity. 2,4-Dinitrophenol, (2 x 10 *Si) 
does not effect the enzyme activity at all.
3.3.8.2. Effect of Metabolic Inhibitors on the ATP content of Isolated 
Viable Rat Hepatocytes
The ATP content of the hepatocytes from untreated rats after
preincubation with rotenone, menadione and 2,4-dinitrophenol followed
by incubation with biphenyl (70 yM) at 37^C for 30 minutes is shown
in Table 3.13. All three inhibitors resulted in a reduction in the
ATP level within the cells, rotenone (2 x 10 ^ 1) caused a drop to
-460% of the control level, vÆiile menadione (1.25 x 10 M) and 2,4-dinitro­
phenol (2 x 10"'^ M) resulted in the level being reduced to 40% of the
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Table 3.12. Effect of Metabolic Inhibitors on Biphenyl 4-hydroxylase 
activity in Suspensions of Rat Liver Microsomes from 
Untreated animals
Rat liver microsomes (1 mg protein/ml) v;ere preincubated with certain 
metabolic inhibitors for 10 minutes at 37°C in the presence of an NADPH 
regenerating system then incubated for a futher 15 minutes with biphenyl 
(70 4-hydroxybiphenyl was extracted and measured as previously
described.
Treatment Activity*
None 5.05 ± 0.24 (100)
Rotenone ^(2 X 10 %) 3.11 ± 0.09 (62)
Menadione . (1.25 X 10 0.02 ± 0.01 (0.4)
2,4-Dinitrophenol(2 X 10-%) 5.03 ± 0.18 (100)
* Activities (± S.E.M) expressed as nnoles 4-hydroxybiphenyl produced/ 
15 minutes/mg microsomal protein.
Numbers in parentheses are values expressed as percentage of control.
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Table 3.13. Effect of Metabolic Inhibitors on the ATP content of 
Isolated Rat Hepatocytes from Untreated animals
7Rat hepatocytes (10 cells in 5 ml vol) were preincubated with 
inhibitors for 10 minutes at 37°C, then incubated for a further 
30 minutes with biphenyl (70 yM). The ATP content of the cells 
was estimated as described in Methods Section.
Treatment ATP content*
None 9.77 (100)
Rotenone _(2 X  10 %) 5.86 (60)
Menadione  ^(1.25 X  10 %) 3.91 (40)
2,4-Dinitrophenol (2 X  10-%) 3.91 (40)
* Values expressed as nmoles ATP/10^ cells, after 30 minutes incubation 
with biphenyl, and are the means of duplicate estimations differing 
by less than 10% from each other.
Numbers in parentheses are values expressed as percentage of the control
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control value.
3.3.8.3, Effect of Metabolic Inliibitors on the NADPH content of 
Isolated Viable Rat Hepatocytes
NADPH levels were also measured in hepatocytes from untreated 
rats preincubated with inhibitor followed by biphenyl incubation 
for 30 minutes at 37°C (Table 3.14.). Rotenone (2 x 10 ^) and 2,4-dinitro­
phenol (2 X lO'^ '^ M) caused the NADPH level to drop to 57% and 41% respectivel 
of the control value, while menadione (1.25 x 10 '^) preincubation 
resulted in an increase in the NADPH level mthin the hepatocytes 
to 136% of the control level.
3.3.8.4. Effect of Metabolic Inhibitors on Oxygen Uptalce in Isolated 
Viable Rat Hepatocytes
Incubation of rotenone (2 x 10 1^) with isolated hepatocytes 
from untreated rats at 37°C results in a decrease in the rate of 
endogenous oxygen uptalæ to 63% of the control rate, while menadione
_4(1.25 X 10 M) results in a dramatic stiimlation of oxygen uptal^ e 
to 310% of the control rate. 2,4-Dinitrophenol exhibits a concentration 
dependent enhancenent of the endogenous oxygen uptake of the
hepatocytes to 213% (2 x 10 ^ ) and 150% (2 x 10"%I) of the control
value (Table 3.15.). Biphenyl at the concentration used for these 
studies (70 y M) produced no measureable effect on the oxygen uptalce
of these cells, irrespective of whether any of the inhibitors hsid
been added prior to the biphenyl addition.
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Table 3.14. Effect of Metabolic Inhibitors on the NADPH Content of 
of Isolated Rat Hepatocytes. from Untreated animals
7Rat hepatocytes (10 cells in 5 ml toI) were preincubated with 
inhibitors for 10 minutes at 37°C, then incubated for a further 30 
minutes with biphenyl (70 yM). The MDPH content of the cells was 
estimated as described in Methods section.
Treatment NADPH content*
None 5.81 (100)
Rotenone _(2 X 10 %) 3.29 (57)
Menadione . (1.25 X 10^ "%) 7.82 (136)
2,4-Dinitrophenol
(2 X 10-%) 2.38 (41)
* Values expressed as nmoles NADPH/10^  cells after 30 minutes incubation 
with biphenyl, and are the means of duplicate estimations differing by 
less than 10% from each other.
Nlimbers in parentheses are values expressed as percentage of the control.
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Table 3.15 Effect of Metabolic Inhibitors on the Oxygen Uptake of 
Isolated Rat Hepatocytes frcxn Untreated animals
Rat hepatocytes (5 x 10® cells in 2.5 ml vol) were incubated at
.Or37 C in a Clark electrode to obtain the control rate of oxygen uptake, 
then further incubated with metabolic inhibitors to monitor the change 
in rate.
Inhibitor Og Uptake in rat hepatocytes (% of control rate)
Rotenone ^(2 X 10 % ) 63.0 ± 8.1
Menadione
(1.25 X 10~%) 309.5 ± 66.6
2,4-Dinitrophenol 
(2 X 10-%) 213.1 ± 18.4
(2 X 10"%) 150.2 ± 2.0
Values (± SEM) are expressed as the ^ .xar cent age of the control uninhibited rat^
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3.3.9. Metabolism of 2,4-Dinitrophenol and p-Nltrophenol in Isolated
Viable Rat Hepatocytes
The metabolism of 2,4-dinitrophenol (final concentration 200 y M) 
v/as studied in isolated rat hepatocytes from untreated animals and 
compared with p-nitrophenol (200 y M). After 10 minutes incubation 
with 2,4-dinitrophenol, biphenyl (70yM) was added to certain of the 
hepatocyte suspensions and incubated for a further 25 minutes at 
37°C. Biphenyl was omitted in other incubations. The results of 
these studies are -shown in Table 3.16. There is very low metabolism 
of 2,4-dinitrophenol and p^nitrophenol under these conditions. Some 
conjugates are formed but these do not account for all the free substrate 
lost, indicating metabolism by imites other than via conjugation. The 
presence of biphenyl (70 y M) decreases the sulphate conjugation of
2,4-dinitrophenol and increases the 2,4-dinitrophenol conjugation 
with glucuronic acid, together with an increase in the non-conjugative 
route of 2,4-dinitrophenol metabolism.
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3.4. DISCUSSION
Although many biochemical investigations have been carried out 
using viable hepatocytes isolated by collagenase/hyaluronidase 
dissociation over the past 10 years it is only recently that these 
studies have been extended to the phase I metabolism of xenobiotic 
compounds (Chapter 2). The importance of the subsequent conjugation 
of the phase I metabolites by isolated hepatocytes has been largely 
neglected^  although this must be regarded as an integral part of the 
mechanism by which the intact cell eliminates potentially toxic 
metabolites. To examine the conjugating ability of isolated rat 
hepatocytes 2-, 3-, and 4-hydroxybiphenyl have been used as model 
substrates and the nature and control of conjugation studied. The 
ability of viable hepatocytes to carry out the complete range of 
xenobiotic transformations and to reflect simultaneously the influence 
of xenobiotics on cellular integrity can be considered two of the 
major advantages to the use of viable hepatocyte suspensions for 
drug metabolism studies (Bridges and Fry, 1976; Fry and Bridges,
1977a).
An important early observation in this study was that biphenyl 
at the concentration normally employed in microsomal assay systems 
(1.4 mM) was toxic to viable rat hepatocytes (figure 3.3.) and it 
is probable that this cytotoxicity is due to biphenyl per se and 
not to the formation of primary metabolites. Approximately 10% of
7the biphenyl is metabolised by 10 viable hepatocytes over a 45 minute 
incubation period. No toxicity due to 2-, 3-, or 4-hydroxybiphenyl 
up to 140y M (figure 3.4.) could be detected in isolated hepatocytes, 
the level of metabolites that would be produced at the toxic concentration
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of biphenyl (1.4 mM), although possible toxicity due to an epoxide 
intermediate cannot be ruled out.
3.4,1. Establishment of the Drug Metabolising Capabilities of 
Isolated Viable Rat Hepatocytes
A number of different approaches (t.I.e. radioactive labelling, 
fluorimetry and high pressure liquid chromatography) have allowed 
the proposal of a tentative overall scheme of biphenyl metabolism 
by hepatocytes from young adult male rats (figure 3.27.). The major 
metabolites are 4-hydroxybiphenyl and its sulphate and glucuronide 
conjugates, minor metabolites include 2- and 3-hydroxybiphenyl, their 
sulphate and glucuronide conjugates and 4,4'-dihydroxybiphenyl and 
its conjugate, together with an an unidentified metabolite of
2-hydroxybiphenyl. Quantitatively, the 4,4' -dihydroxybiphenyl is 
of more importance than the 2- and 3-hydroxybiphenyls.
This pattern of metabolites broadly agrees with that deduced from 
previous investigations of the urinary excretion pattern of metabolites 
in various species and from microsomal studies in vitro (see section 
Sole). In the rabbit and rat biphenyl 2-hydroxylase activity is 
present in hepatic microsomes derived from yourg animals, but in 
microsomes derived from adult animals is barely detectable (Creaven 
et 1965). In the rat, 4-hydroxylation is maximal at 24 days after 
birth, 2-hydroxylation is maximal 3 days earlier but disappears 
almost totally by 70 days (Basu ^  1971). This fact explains why
2-hydroxy lat ion of biphenyl is detected in hepatocytes only from young 
adult male rats. In œntrast studies with viable hamster hepatocytes
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suggest that the extent of 2-hydroxylation in this species is 
much greater than in the rat and is not markedly age-dependent 
(Creaven et 1965). Further metabolism of 2- and 4-hydroxy­
biphenyl, not due to conjugation, has been detected when these 
compounds are incubated with adult hamster microsomes (Burke, 1972; 
Burke and Bridges^  1975). 2,2’-And 4,4'-dihydroxybiphenyl \rere,
after 2-hydro>>ylo\pVNev^ \^ the most important of the minor metabolites 
formed after incubation of biphenyl with hamster microsoiæs, the 
major metabolite being i-hydroxj^ biphenyl.
Gerayesh-Nejad ^  ^  (1975) have studied the 4-hydroxylation 
of biphenyl in isolated rat hepatocytes. The authors claim ths.t 
the very rapid loss of activity of this enzyme (as measiured by the 
presence of free metabolite) which occurred during 20-30 minutes' 
incubation may be due to loss of cofactors into the incubation 
media or to enzyme degradation. Under the ei^ eriiiBntal conditions 
used in this study no evidence can be found to substantiate this, 
for in the system reported here the total amount of 4-hydroxybiphenyl 
produced increased almost linearly up to 45 minutes incubation 
(figure 3.9.). The apparent decrease in 4-hydroxylation observed 
by Gerayesh-Nejad et ^  (1975) could be more satisfactorily explained 
by the extremely toxic level of biphenyl used (approx. 2.5 mM) or 
by the fact that since they only measured free 4-hydroxybiphenyl 
the rapid conjugation of the free metabolite as it was formed by the 
hepatocytes was responsible for the apparent loss of enzyme activity.
The viability of the hepatocyte suspensions used in the present 
study was confirmed by the only small stimulatory effect of NADPH 
on biphenyl 4-hydroxylation (Table 3.7.) due to the presence in the 
cell su^ension of a small number of non-viable cells, Tlie possibility
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of using the extent of stimulation of MFO-mediated metabolism in 
isolated hepatocytes by NADPH as a test of cellular integrity has 
been proposed by Fry et ^  (1976) using the rapid initial phase 
of the MneticO-dééthylation of 7-ethoxycoumai'in assay.
The intrinsic rate of 4-hydroxylation of biphenyl in isolated 
rat liver microsomes is of the order of 20-30 nmoles/min/g liver 
(Creaven ^  1965). This value contrasts with that obtained
in the present study using isolated rat hepatocytes from untreated 
animals (8-9 nmoles product/min/g liver). This difference probably 
reflects the involvement of various rate-limiting phenomena, such 
as entry of substrate into the cell, compartment at ion and levels of 
essential cofactors and the possibility of further metabolism in 
the intact-cell situation. The cellular results probably conform more 
closely to the state appertaining in vivo.
3.4.2. Means of Modifying the Drug Metabolism Profile
3,4.2.1. Inducing Agents
Biphenyl 4-hydroxylation in rat hepatocytes isolated from 
phenobarbitone (PB), 3-methylcholanthrene (S-^ C) and 3,4-benzo(a)~ 
pyrene (BP) pretreated animals is greatly enhanced (Table 3.5.), 
phenobarbitone being the most potent inducer. The 85G% increase of 
the initial rate of total 4-hydroxylation detected correlates well 
with the liver microsomal studies of Kato and Takanaka (1968) who 
reported that certain enzyme parameters were increased by 710% with 
phenobarbitone induction in 40 day old V/istar rats, the approximate 
age of the animals used in these studies«. When biphenyl (100 mg/kg) 
is dosed i^ vivo the correlation with rat hepatocytes is not so good 
since phenobarbitone has been shown to produce only a moderate (50%)
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increase of K^ lphenyl 4-hydroxylation activity in vreajiling rats 
(Creaven and Parke, 1966). The polycyclic hydrocarbons, 3-methyl­
cholanthrene and 3,4-behzo ( a)pyrene have a far less draraa.tic effect 
when compared to phenobarbitone, producing increases of 230% and 
100% respectively in the inital rate of total 4-hydi’oxylatioa in 
isolated rat hepatocytes. This broadly agrees with the studies 
of Creaven and Parke (1966) v/ho showed that both compounds produce 
a relatively smaller response in biphenyl 4-hydroxylation when 
compared to phenobarbitone both vivo and iu vitro.
Pretreatment of animals with all three inducers affects not 
only the rate of hydroxylation but the nature and extent of 
the conjugates produced by the isolated hepatocytes. The increased 
rate of hydroxylation in the induced cells causes the sulpho- 
transferase activity to become almost saturated and any further free 
metabolite produced is conjugated with glucuronic acid (figures 3*15- 
3.17).
Further metabolism studies in which the phase I metabolites 2-,
3- and 4-hydroxybiphenyl were added to untreated hepatocytes largely 
support these findings (figures 3.20-3.22), although sulphotransferase 
activity does not appear to be entirely saturated even b^r 140 uM, the 
highest concentration of the metabolites used which did not cause 
damage to the hepatocytes.
An interesting observation arising from these studies is the 
fact that the 'cross-over’ of glucuronide and sulphate conjugation 
of 4-hydroxybiphenyl in isolated rat hepatocytes when incubated with 
biphenyl (figure 3.19) and 4-hydroxybiphenyl (figure 3.20) occurs 
at approximately the same point i.e^  'when the rate of formation of
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both conjugates reaches a value of between 2,5-3.0 nmoles produced 
/45 minutes/2 x 10^  cells. In similar studies with 2- and 3-hydroxy­
biphenyl the 'cross-over' point occurs at a rate of 0.5 and 2.4 nmoles
6produced 45 minutes/2 x 10 cells respectively (figures 3.21 and 3.22).
The concentration at which the ’ cross-over ' point occurs in these chemically 
very similar metabolites varies quite considerably, 8 uM v/ith 2-hydroxy­
biphenyl, 10 ]aM with 3-hydroxybiphenyl and 20 yM mth 4-hydroxy­
biphenyl, illustrating that the position of the hydroxy-group 
insertion on the biphenyl nucleus has a very significant influence 
on its subsequent phase II metabolism.
It is notable that despite the fact that hydroxylation of 
biphenyl and glucuronidation are both located on the endoplasmic 
reticulum, it is sulphation, a cytoplasmic reaction, rather than 
glucuronidation that is the dominant conjugation mechanism for the 
hydroxybiphenyls at low biphenyl concentrations. This observation 
suggests that there may be close association of the sulphation 
enzymes with the surface of the endoplasmic reticulum where the 
phase I metabolites are generated.
Pretreatment with 3-methylcholantlirene and 3,4-benzo ( a)pyrene 
in vivo has been shown to preferentially stimulate the 2-hydroxyl at ion 
of biphenyl (Creaven and Parke, 1966). This selective induction by 
aromatic hydrocarbons of biphenyl metabolism is also operative in 
isolated rat hepatocyte suspensions. However, using higii pressure 
liquid chromatography it can be shown that the rate of 3-hydroxylation 
of biphenyl is also increased by pre treatment with 3-methylcholanthrene 
(Table 3.3.). Fluorimetric studies have revealedj^he inital rate of 
total 2- and 3-hydroxylation is increased by 600% in cells from
3-methylcholanthrene-induced animals (figure 3.18(a)) and by 670% in 
cells from 3,4-benzo(a)pyrene-induced animals (figure 3.18(b)) with
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no increase detectable in biphenyl 2- and 3-hydroxylation in 
hepatocytes from phenobarbitone-induced rats.
The reason for the lag phase between the 4-hydroxylation of 
biphenyl and its subsequent conjugation is uncertain. It is 
possible that the cell isolation procedure in some way inactivates 
conjugation, but the ready conjugation of higher concentrations 
of 4-hydroxybiphenyl (figure 3.14) tend to negate this possibility 
and also rules out the lack of adequate cofactors essential for 
conjugation as an explanation. The most likely explanation is that 
the presence of small amounts of 4-hydroxybiphenyl (as obtained on 
incubation with biphenyl) in sane way ’activates’ the conjugation 
reaction. The lag phase is not due to failure to excrete the 
conjugates, since none of those formed are accumulated by the 
hepatocytes (Table 3.17.). This lag phenomenon also exists in 
the 2- and 3-hydroxy lat ion of biphenyl and is especially seen in 
hepatocytes from: 3-methylcholantlirene and 3,4-benzo(a)pyrene-induced 
animals.
Although the imtabolic profile varied slightly between separate 
experiments, this lag was found to be only associated with the 
glucuronide conjugation of 4-hydroxybiphenyl, no such lag existing 
with sulphate conjugation (figure 3.9.). Induction by phenobarbitone,
3-msthylcholantlirene and 3,4-benzo(a)pyrene serves only to exaggerate 
this lag by increasing the rate of formation of free 4-hydroxybiphenyl 
di_iring the first 15 minutes of biphenyl incubation (figures 3.15.-3.17.)
The lag in glucuronidation occurs not only in isolated rat 
hepatocytes but also in the of rat liver slices incuî)ated with
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Table 3.17. Distribution of Biphenyl and its Metabolites between 
Isolated Rat Hepatocytes and the Extracellular Medium
Rat hepatocytes (2 x 10® cells in 1 ml vol) were incubated with 
biphenyl (specific activity, 0.6 vCi/’^-'iiole)(final concentration 
70 ]iM) at 37°C for various periods of Lime. The cells were then 
separated from the medium and both samples analysed for biphenyl and its 
metabolites. Free 2-, 3- and 4-hydroxybipheny1 were extracted, separated 
and analysed by high pressure liquid chromatography. Each sanple was 
collected and the fractions counted for radioactivity.
Metabolites detected in the medium*
Incubation 
Time (mins) 2-hydroxybiphenyl -hydroxybiphenyl 4-hydroxybiphenyl
5 Free 47 48 73
Sulphate 45 65 59
Glucuronide 45 48 38
30 Free 52 36 60
Sulphate 33 57
Glucuronide oo 79 74
* Values are expressed as the amount detected in the medium as a percentage 
of tliat found in the cells. They are the mean of duplicate determinations 
differing by less than 10% from each other.
** Denotes the absence of metabolite found wdthin the cells.
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biphenyl (figure 3.23.) and is therefore believed to be a true effect
and not an artificial one arising from sane peculiarity of the
isolated hepatocyte system. It is of interest to note that activation
of UDP-glucuronyltransferase in liver microscmal studies by detergents
is well Imown and has been reported by several workers (Winsnes,.,
1969; Graham and Wood, 1972; Graham et al, 1974). The possibility
that the galactose present as the sole sugar source in the Ir-15 medium
was being metabolised by the hepatocytes to UDP-galactose, a known
iniiibitor of glucuronyltransferase (Mamiemi et 1973) and that
this was responsible for the lag in 4-hydroxybiphenyl glucuronidation
(k a.was investigated by incubating hepatocytesj^ culture medium containing 
glucose instead of galactose. The extent and pattern of biphenyl 
metabolism was the same irrespective of the sugar source used (cf 
figure 3.9.).
The results of preincubation of isolated rat hepatocytes with 
and without 4-methylumbelliferone before the addition of biphenyl 
indicate that glucuronidation of 4-hydroxybiphenyl can be activated 
to a significant degree by a 60 minute preincubation at 37^C with 
an alternative substrate. Even in the absence of adAQci %
substrate some activation of glucuronidation is observed (Table 3.6.). 
The effect of preincubation on sulphate conjugation of 4-hydroxy­
biphenyl is not so straightforward; it is not activated to any 
appreciable extent by the alternative substrate and is depressed by 
incubation at 37*^ C in the absence of <\cld*d . substrate. It
may be, as inferred befc^ o' that the cell isolation procedure affects 
to a certain extent the onset of glucuronidation of 4-hydroxybiphenyl 
in isolated hepatocytes. It has been reported (Wagle, 1974) that 
hyaluronidase, the enzyme used with collagenase for the isolation of
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intact hepatocytes, results in the depletion of the cellular 
glycogen stores. It is conceivable though not supported by the 
liver slice studies, that such a reduction in the cellular glycogen 
levels could reduce the pools of the necessary cofactors UDPG 
and UDPGA thus affecting a reduction of glucuronic acid conjugation. 
The preincubation carried out in the absence of an alternative 
substrate in a support medium would presumably allow the cells time 
to replenish the levels of these cofactors. It must be emphasised 
that the activation of glucuronyltransf erase in isolated rat hepato- 
cytes produced by 4-methylumbelliferone does not however eliminate 
this lag effect. This could be due to the fact that a different 
enzyme is involved in the glucuronidation of 4-methylumbelliferone 
to the one employed for the glucuronidation of 4-hydroxybiphenyl, or 
that once the substrate disappears the activated glucuronyl trans­
ferase may return to the inactive state, or that UDPGA availability 
is limited due to its requirement elsewhere within the cell, or that 
the cofactor pools are still depleted even after preincubation at 
37°C. The results obtained with respect to the sulphation of
4-hydroxybiphenyl are more difficult to interpret; possibly the lack 
of any significant activation with 4-methylumbelliferone in the 
hepatocytes is due to depletion of cellular levels of 3'-phospho- 
adenine-5’-phosphosulphate (PAPS) or the fact that the sulpho- 
transferase activity of the cells has been saturated by the 4-methyl- 
umbelliferone sulphate produced and inhibits subsequent 4-hydroxy­
biphenyl formation on incubation with biphenyl. The decrease in the 
initial rate of sulphation of 4-hydroxybiphenyl that is produced after 
a 60 minute preincubation at 37^C in the absence of alternative 
substrate, however, is not understood and must be studied further.
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3.4.2.2. Inhibitors of Drug Metabolism
The typical mixed-function oxidase character of biphenyl
4-hydroxylase in isolated rat hepatocytes has been confirned by 
inhibition studies with CO and 8KF 525A (Table 3.7.). In accordance 
with Graham et ^  (1970) who reported that biphenyl 4-hydroxylation 
in rat liver microsomes is inhibited 68% by 10~^ M SKF 525A, compared 
to 71% inhibition of the biphenyl 4-hydroxylase activity by 10“^
SKF 525A in isolated rat hepatocytes^  Moldeus et ad (1974) have 
reported a 61% reduction in alprenolol metabolism by 5 x 10~® M 
8IŒ 525 A in isolated rat hepatocytes from starved animals. 8KF 525A 
also inhibited subsequent conjugation of the 4-hydroxybiphenyl in 
hepatocytes, as has been shown previously using microscmal assay 
systems (Ikeda et al, 1968; Hanninen et al, 1974).
Intense research during the last few years has increased our 
knowledge about the hepatic MFO system linked to cytochrome P-450, 
including its substrate specificity, læchanism of action and induction 
properties. Such studies have mainly utilised isolated liver 
microsomes (Chapter 2) or more recently a solubilised, partly 
purified enzyme system (Du et 1969; Coon et al, 1975; Lu, 1976; 
Thcraas et 1976). Substrate and NADPH and other cofactors have 
usually been added in excess and molecular* oxygen has been freely 
accessible. This may not, however, always be the case in the hepato­
cyte where the rate of substrate penetration.to, or product exit 
from the enzyme site within the endoplasmic reticulum, cellular 
energy levels, the redox state of the cyroplasmic and mitochondrial 
pyridine nucleotides (Cinti and Schenkman, 1972; Cinti et 1972a, 
b; Moldeus et al, 1973a) and the presence of competing endogenous
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substrates are some of the factors which m y  affect the efficiency 
by which an added substrate is handled by the cytochrome P-450 and 
the rate of conjugation of the oxidised mtsbolites produced by 
this system within the cell.. For these two riBtabolic sequences, 
oxidation and subsequent conjugation have been suggested to be 
tightly coupled in vivo so that the rate of the primary oxidation 
step should be dependent on the rate of zhe secondary conjugative 
step (von Bahr and Bertilsson, 1971).
With this in mind, the effect of a mitochondrial respiratory 
chain inhibitor, rotenone, an oxidant, menogiione and an uncoupler,
2,4-dinitrophenol on the phase I and phase II metabolism of xeno­
biotics in rat hepatocyte suspensions •
Rotenone, an inhibitor of mitochondrial NADH oxidation (Ragan 
and Racker, 1973) has been shown to decrease (at a final concentration 
of 2,5 X 10 ^) the level of NADPH in isolated rat hepatocytes from 
starved untreated and phenobarbitone prerreated animals to 59% and 
41% of the control levels (Moldeus et 1974). This compares 
well with the decrease observed in untreated hepatocytes caused by 
2 X 10 ®M rotenone in this study (57% of control) (Table 3.14.) 
though the animals were not starved. These reductions of NADPH 
levels were reflected in similar reductions of biphenyl 4-hydroxylase 
activity in isolated hepatocytes from unrreated and phenobarbitone- 
pretreated rats (75% and 48% respectively of control values)
(Table 3.8. and 3.9.). Moldeus al (1974) reported a similar 
reduction in alprenolol metabolism in isolated rat hepatocyte suspensions 
by 1 X 10~®M rotenone, though in a more recent report these authors
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claimed that 2 x 10  ^M rotenone does not significantly alter 
the metabolism of p-nitroanisole (Moldeus ^  1976) in rat
hepatocytes. Rotenone may act partly by directly competing with 
the substrate for cytochrome P-450 (Table 3.12.), for it has 
been reported (Pulcami et 1967; Yamamoto, 1969) that rotenone 
is hydroxylated to form rotenolones and that these reactions are 
brought about by the P-450 ]\1F0 system of the liver microsomes 
(Fukami et 1969). That rotenones inhibitory effects are 
probably not directly due to its mitochondrial interaction is 
indicated by the fact that it inhibits more effectively in 
microsomes (Table 3.12.) than in whole cells (Table 3.8.). Further­
more it is quite possible that rotenone plays an analogous role 
in the endoplasmic reticulum to that which it fills in the mito- 
diondria, i.e. it may interfere with the passage of reducing 
equivalents from NADPH^ to cytochrome P-450 reductase.
The reduction of oxygen uptalce in isolated rat hepatocytes 
preincubated with 2 x 10 rotenone to 63% of the uptake in 
control cells observed (Table 3.15.) agrees very well with studies 
in the perfused liver (Thiuraan and Scholz, 1969) and liver mitochondria 
(Ernster et 1963). Tie reduction in oxygen uptalce is presumably 
the result of rotenone reducing the electron flow down the mito­
chondrial electron transport chain. By inhibiting the electron 
transfer step between the NAD nucleotide and the flavin in the 
mitochondrial electron transport chain, rotenone would also reduce 
the energy available for the phosphorylation of 'ADP. This is indeed 
the case for the ATP content of isolated hepatocytes.is reduced quite 
significantly by such treatment (Table 3.13.) and hence affecting the
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rate of conjugation of the phase I metabolites produced by these 
cells (Tables 3.8,, 3.9. and 3.11.) probably by reducing the 
levels of essential conjugating cofactors. It has been shown that 
the rotenone effect in hepatocytes is not directly on conjugation 
(no effect in liver microsomes; Moldeus ec 1976) but is very 
likely due to decreased synthesis of the essential conjugating 
cofactors, 3'-phosphoadenonsine 5'phosphosulphate (PAPS) and 
uridinediphosphoglucuronic acid (UDPGA) caused by the decrease 
in ATP levels within the cells ^ though possible competitive 
inhibition by any phase II metabolites of ' rotenone hydroxylation 
products' that may have been formed by these cells cannot be 
entirely ruled out.
Menadione is an electron acceptor, interacting with NADH 
dehydrogenase in the., mitochondrial electron transport chain 
(Green et 1974) feeding electrons back into the chain at the 
level of cytochrome b (Conover and Emster, 1962). It stimulates 
mitochondrial respiration (Green et 1974) but markedly 
inhibits microsomal respiration (Wills, 1972). Since the maximal 
activities of the mitochondrial respiratory chain are more than 
3 times greater than the stimulated rates of the induced MFO 
system (Thurman and Scholz, 1969), any decrease in this system 
would be overwhelmed by an increase in the mitochondrial system, 
and is reflected by the significant increase in oxygen uptake 
detected in this study (Table 3.15.) in isolated rat hepatocyte 
suspensions.
Menadione (1-50 pM) has been reported (Wills, 1972) to cause 
a marked stimulation in the oxidation of NADPH and a marked decrease 
in the déméthylation of aminopyrine and p-chloro-N-methylaniline in
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rat liver niicrosomes. The rapid oxidation of NADPH in microsomal 
preparations not only renders it unavailable for the initiation of 
the microsomal electron transport chain but also decreases the 
NADPH : NADP ratio (NADp’*' being a potent competitive inhibitor of 
NADPH-cytoclirane P-450 reductase)(Ernster and Orrenius, 1965) and 
so may become rate-limiting for cytochrome P-450 dependent processes. 
In the present studies MK) activity was found to be reduced to very 
low levels both in isolated hepatocytes (untreated and phenobarbitone 
induced) and rat liver microsomes (Tables 3.8., 3.9. and 3.12.) but 
the reduction in the concentration of NADPH observed in microsomal 
suspensions (Wills, 1972) is not seen in isolated hepatocytes,
NADPH content is in fact increased by preincubation with 1,25 x lO^ Ssi 
menadione at 37^C (Table 3.14). As well as increasing the rate of 
NADPH oxidation, it is very likely that menadione also results in an 
increase in the rate of NADPH generation via the hexose monophosphate 
shunt (HÎÆP) in the cells, since Junge and Brand (1975) have shown 
that phenazine methosulphate (PMS), an electron acceptor results in 
a stimulation of reduced pyridine nucleotide generation via the 
HMP shunt in both untreated and phenobarbitone pretreated hepatocytes. 
li'eatment of hepatocytes with menadione therefore has a competing 
effect, on the one hand increasing the amount of oxidised cofactor 
through an ’uncoupling effect’ but on the other channeling oxidised 
cofactor equivalents into the HMP shunt pathway to increase NADPH 
generation. This increased NADPH/NADP flux caused by menadione in 
the hepatocytes could have the effect of loosening the close 
association that exists between NADPH reducing equivalents passii^ 
into cytochrcme P-450 reductase and P-450 itself through the electrons 
passing to the electron scavenger menadione. This would be anaJ.ogous 
with the role menadione plays in mitochondria. Such an uncoupling of
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this reaction would be compatible with the decrease in the 
P-450 mediated hydroxylation seen in this study and would also 
account for the enhanced level of the reduced cofactor found 
within the hepatocytes after treatment with rrenadione.
The reduction in the AlP content in the hepatocytes seen ; 
in this study (Table 3.13. ) can be possibly explained by the 
fact that menadione causes the electrons in the mitochondrial 
transport chain to by-pass at least one of the phosphorylation 
sites present within the chain (Conover and Ernster, 1962) resulting 
in the reduction of the conjugating ability of the hepatocytes by 
mechanisns already described (Table 3.8. and 3.9.).
These studies suggest that rotenone and menadione act by 
very similar mechanisms, except that rotenone does not possess the 
ability to direct oxidised cofactor back into the HMP shunt within 
the hepatocytes to regenerate NADPH.
The effects of the nitrophenols on the overall lœtabolism of 
animals have been known for nearly 100 years for Cazeneuve and 
Lepine (1885) found that injection of dinitro-u -naphthol by the 
dog caused a high fever. Many of the effects of the uncoupler
2,4-dinitrophenol were known, long before its relationship to 
mitochondrial oxidative phosphorylation had been recognised (Lardy 
and Elvehjera, 1945; Loomis and Lipmann, 1948), Uncouplers have 
the ability to abolish the coupling of substrate oxidation to ATP 
synthesis. As a consequence the formation of ATP comes to a halt, 
because it is deprived of the necessary energy input, whereas
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electron transport from the substrate to oxygen, uninhibited by 
respiratory control proceeds at the maximal velocity permitted by 
the enzymes of the transport system (Hanstein, 1976) and produces 
heat instead of ATP (Poe et 1967).
The stimulation of mitochondrial respiration caused by
2.4-dinitrophenol as measured by increases in oxygen uptalce in 
mitochondrial preparations (Loanis and Lipnann, 1948; Slater, 1966; 
Hanstein, 1976) is well documented and agrees with results obtained 
in isolated rat hepatocyte suspensions (Table 3.15.).
The primary effect of 2,4-dinitrophenol and possibly the most 
significant is the inhibition of ATP synthesis in isolated hepato­
cytes, reflected by the reduction of ATP levels seen within the cells 
(Table 3.13.). This results in a marked decrease in the synthesis 
of essential conjugating cofactors PAPS and UDPGA and hence the sulpho- 
transferase and glucuronidation activity within the cells (Tables 
3.8.-3.11.). 2,4-Dinitrophenol is also metabolised to its sulphate
and glucuronic acid conjugate in the presence of other substrates 
(Table 3.16.) and would therefore contribute to the marked decrease 
in the sulphate and glucuronic acid conjugates of the phase I 
metabolites of the xenobiotics studied.
In contrast cytochrome P-450-linked mixed function oxidase 
activity in isolated rat hepatocyte suspensions (Table 3.9. and 3.10.) 
and rat liver microsŒoes (Table 3.12. ) is relatively unaffected by
2.4-dinitrophenol preincubation. An interesting finding of these 
studies was the increase in biphenyl 4-hydroxylase activity in rat
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hepatocytes from untreated animals on preincubation with 2,4-dinitro­
phenol (2 X 10 \l) (Table 3.8., figure 3.25). Although there is a 
decrease in NADPH concentration in the hepatocytes (Table 3.14) due 
probably to the stimulation in the rate of mitochondrial respiration 
(as measured by increased oxygen uptalie) detected within the cells.
Vt is not however reflected by any decrease in MDO activity. This 
might be explained by the fact that in hepatocytes isolated fron fed 
rats the generation of cytoplasmic NADPH is mainly via the HIVIP shunt 
(Moldeus et al, 1974) and not via the malic enzyme systen. Since 
any reduction in mitochondrial reducing equivalents only affects 
this minor source of cytoplasmic NADPH generation in the fed state 
it would have little or no effect on the cytochrome P-450 linked 
MED activity in the hepatocytes isolated from fed rats used in this 
study.
The stimulatory effect of 2,4-dinitrophenol on biphenyl
4-hydroxylase activity in hepatocytes from untreated rats is more 
difficult to explain. 2,4-Dinitrophenol has been shown in these 
studies to be metabolised by isolated rat hepatocyte suspensions 
by route(s) other than conjugation, possibly by reduction of one 
or other of the nitro groups on the molecule, to the appropriate 
aminonitrophenol or, to the diaminophenol as has been shown both in 
vivo (Parker, 1952; Parke, 1961) and vitro (Parker, 1952;
Eiæman et al, 1972, 1974). It is conceivable therefore that a 
reduction product(s) of 2,4-dinitrophenol may 'activate’ in sane way, 
a particular form of cytochroiTe P-450 that is involved in biphenyl 
metabolism, and not in 7-ethoxycoumarin and 3,4-benzo ( a)pyrene 
metabolism. The increase in biphenyl metabolism is not seen in 
phenobarbitone-treated cells as this P-450 species has presumably
172
been maximally induced by this treatment. It is noteworthy that 
whereas biphenyl 4~hydroxylation is a P-450-mediated reaction, 
7-ethoxycoumarin 0-deethylation and benzo(a)pyrene hydroxylase 
activity is mediated primarily by another P-450 species, P-448.
The lack of any stimulation of biphenyl 4-hydroxylase activity in 
rat liver microsomes isolated from untreated animals is due to the 
fact that the incubation conditions required for the P-450 mediated 
oxidation reaction are not comparable with those necessary for the 
formation of reduction products of 2,4-dinitrophenol(Eiseman et al, 
1972, 1974). Although NADPH is utilised by both reactions, oxygen s 
an absolute requirement for P-450 MFO activity, j^ nitro-reductase 
activity requires relatively anaerobic conditions. Also the endo­
plasmic reticulum may not possess the appropriate nitro-reductase 
for this reduction, since it is known that much of the cells nitro­
reductase activity resides in the cytosol. Therefore under the 
artificial conditions used in the microsomal studies, reduced products 
of 2,4-dinitrophenol metabolism would not have been formed and could 
not have affected the 4-hydroxylation of biphenyl in the same way as 
occurs in the hepatocjdes where the conditions are closer to 
appertaining vivo.
The studies with these metabolic inhibitors have shown that 
in isolated hepatocyte suspensions, any interference with the 
mitochondrial electron transport chain by either altering or blocking 
the flow of reducing equivalents results in a far more dramatic 
effect in phase II than phase I metabolism of xenobiotics. î/îito- 
chondrial ATP synthesis is very sensitive to such perturbations 
and is reflected in a marked decrease in the conjugating ability
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(both sulphate and glucuronic acid) of the hepatocytes. In our 
cells which are from fed animals it is only when the cytochrome P-450 or 
the P-450-reductase complex is directly disturbed that any effect on 
the P-450-MF0 activity within the cells is detected. Changes in the 
redox state of the pyridine nucleotide within the mitochondria have 
little effect on P-450 linked oxidation, and therefore lervds weight 
to the findings of Moldeus et ^  (1974) who claimed that cytoplasmic 
NADPH is generated mainly via the HMP shunt in the fed state. It is 
only druing starvation, with a glycogen depleted liver, when the 
generation of reducing equivalents is completely mitochondrial ,|^ NADPH 
generation involving the malic enzyme system becomes more important.
The large amounts of free 2,~ 3- and 4-hydroxybiphenyl which 
escape from the cells in the early phase of biphenyl metabolism in 
isolated hepatocytes (Table 3.17.) and these studies with the 
metabolic inhibitors indicate that there is no tight coupling of 
phase I and phase II reactions initially, rather the two phases may 
be largely independent of one another, unlike the situation that has 
been proposed to exist in vivo (von Bahr and Bertilsson, 1971). 
Interactions between hydroxylation and glucuronidation however, may 
occur later due to the activation of the glucuronidat ion reaction by 
the phase I metabolites.
The present study has spotlighted some of the aspects of the 
metabolism of xenobiotic compounds which cannot be readily studied 
using conventional microsomal assay systems, including toxicity of 
the substrate, further metabolism of the primary metabolites and 
the interrelationship betv/een them. It has also been demenstrated 
that the various metabolic pathv/ays and the metaloolism pattern can
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be changed by inducing and inhibiting agents without any untoward damage 
to the cells arising. It is apparent these inducers and inhibitors 
used in these studies could be used to check ’active metabolite’ 
production by the hepatocytes, by selectively altering the metabolite 
pattern.
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aiAPIER 4
Use of Hepatocytes as a 'Metabolising' 
Component for in vitro Toxicity Assessment
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CHAPTER 4
4.1. nqraooucTioN
Tne literature is replete with references to the use of 
in vitro test systems for the evaluation of xenobiotic-induced 
toxicity. Such methods have involved the maintenance of cells 
in culture and the subsequent addition of the agents under 
examination, the toxicity of which have been evaluated by measuring 
effects upon some parameter of cellular vitality. These differ 
largely in the criterion of toxicity being measured (Table 4.1.). 
Tti^ re is no ideal method for determining xenobiotic-induced cell 
lethality (Bhuyan et al, 1976; Roper and Drewenko, 1976) for 
each criterion refers to only one of the many areas of cellular 
vitality which could be used as a parameter of cell death. It 
is therefore Important to define the purpose for which the cell 
viability is being measured, and to choose the most appropriate 
parameters to measure in the light of this. If one is interested 
in the metabolic activity of the cells then respiration or glucose 
utilisation can be used as the end-point, the reproductive potential
of the cells may be assessed by cell growrh or cloning efficiency;
51trepan blue exclusion, leal^ age of enzymes or Cr leakage could be 
used as a measure of the integrity of the cell membrane.
Such studies have been extensively reviewed by several authors 
(Rofe, 1971; Dawson, 1972; Worden, 1974; Styles, 1977). However 
a short review of the more recent studies v/ill be included here in 
order to illustrate the advantages and limitations these systems
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Table 4.1. Criteria that have been used for Xenobiotic-induced 
Toxicity in Cellular Test Systems
Inhibition of Cell Grov/th
Decrease in Cloning Efficiency
Inhibition of DNA, RNA and Protein Synthesis
Decrease in DNA, RNA and Protein Content
Impainænt of Respiration
Enzyme leaiiage
Lealiage of Cr
Dye Exclusion
Lysoscmal Fragility
Morphological Considerations
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possess. The most widely used systans are cell lines (usually 
fibroblastic or cancer-cell derived). Gablil^ s and Friedman (1969) 
determined the (the dose inhibiting the growth of 50% of the
cells) for 11 poisons, employing cell lines derived from human and 
mouse tissues. Litterst and Lichtenstein (1971) investigated the 
influences of certain pesticides, drugs and some other metabolites 
on 2 established cell lines (human skin fibroblasts and HeLa cells). 
Cell growth, DNA, RNA and protein synthesis were the parameters of cell 
vitality measured in this study. In studies on the effects of 
chlorophenamidine. and its metabolites on HeLa cells (ifurakami and 
Fukami, 1974) and butylated hydroxytoluene on Rhesus monkey kidney 
(MEv) epithelial cells (Metcalfe, 1971) the same parameters have been 
employed. Measurements of cell growth and DNA synthesis in rapidly 
proliferating lines are very popular for assessing cellular vitality 
and have been used by most of the workers in the field. Papaverine- 
induced changes in cultured human cells (Kelson ^  1974) were
monitored primarily by a reduction in cell growth, but vsere supported 
by changes in morphology. Changes in cell proliferation have also been 
observed after treatment TCDD several mammalian cell lines 
(Beatty et 1975), phthalate esters on Wl-38 human cell cultures 
(Jones et 1975), tobacco and tobacco smoke constituents on 
Ascites sarcoma EPS cells (Pilotti et al, 1975), asbestos on P388DI 
macrophages (Wade et al, 1976) and T^FC and aflatoxin B^ on human 
skin fibroblasts (Cooper and Goldstein, 1976a).
Ferguson and Prottey (1974) describe a simple assay procedure 
for cytotoxicity using guinea-pig kidney fibroblasts in vitro based 
on measuring the incorporation of tr it fated thymidine into DNA. They 
used hydroxyurea, a loiown inhibitor of DNA synthesis, sodium lauryl
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sulphate, a cytolytic agent and Rose Bengal, a phototoxic agent 
as examples of known toxic conpounds. Similar studies with a 
series of highly pure surfactants were carried out (Ferguson and 
Prottey, 1976) again using guinea-pig kidney fibroblasts^monitoring 
their capacity to inhibit DNA synthesis and to release histamine 
from isolated rat peritcneal mast cells. Incorporation of labelled 
thymidine was one of the parameters investigated, along with 
cellular proliferation when Nakazawa et ^  (1975) studied the cellular 
responses of cultured mouse leulcenic L5178Y cells to mercuric compounds,
3Freund and Forbes (1976) also used H thymidine uptake to look into 
alcohol toxicity in mouse spleen cell suspensions.
Cloning efficiency (the ability of a small number of cells 
to form colonies) has also been employed by some workers in in vitro 
toxicity studies. As well as cell growth, Landolph et ^  (1976) have
studied the effect of benzo(a)pyrene on the cloning efficiency of a 
mouse epithelial cell strain (MduLi), Styles (1974) also used this 
parameter of cellular vitality to study the responses of rat peritoneal 
and alveolar macrophages and mouse fibroblasts to paraquat and diquat.
He also used the ability of these cells to exclude the dye, trypan 
blue after similar treatment. Cell membrane integrity of a monlcey 
cell line was ironitored by Desi et ^  (1977) after exposure of cells 
to several pesticides, their growth and morphological changes were 
also investigated.
Sheinman and Yannai (1974) investigated the responses of cultured 
rat foetal liver cells and a human kidney cell line to the organo- 
chlorine insecticide dieldrin, monitoring changes in DNA, RNA and 
protein content of these cells, as well as dye exclusion.. Dieldrin
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was also investigated together with carbaryl, a carbamate insecticide, 
using HeLa cells (Blevins and Dunn, 1975), monitoring the effect of 
these compounds on cell proliferation, protein and phospholipid content. 
Walker et ad (1974) assessed the cytotoxic effects of alcohol on liver 
cells (Chang and 3T6 fibroblasts) using trypan blue exclusion as the 
criterion of viability, Tlie impairment of cellular respiration in 
several mammalian cell lines is another parameter of cellular vitality 
that has been used to assess the cytotoxicity of a number of synthetic 
and natural compounds, including actinomycin D, methotrexate (Pacsa,, 1974) 
as indicated by the decolorisation of the indicator 2,6-dichlorophenol- 
indophenol(DPl).
Reed and Wenzel (19753^ Acosta and Anuforo, (l976) using cultured 
rat heart muscle and endothelial cells have employed lysosomal fragility 
as a criterion of cell vitality in toxicity testing studies. The 
permeability (fragility) of the lysosomal membranes of the cells to the 
substrate g-glycerophosphate was measured by assessing the degree 
of particulate lysosomal staining seen after exposing the cells to the 
Qomori acid phosphatase staining reaction under carefully controlled 
conditions.
Unfortunately all of the cell lines used in these tests do not 
possess a significant capability for metabolising xenobiotics and the 
tests described above are therefore only suitable for detecting 
direct-acting toxins, for it is well Imown that many xenobiotics 
require metabolism for their toxic potential to be reedised. (Parke,
1974; Mitchell and Jollow, 1975). Sane attanpts have been made to 
overcome this problem by the incorporation into the culture system 
of liver microsomal fraction as the metabolising component (Dolfini 
et al, 1973; Williams, 1974; Phillips, 1974; Cooper and Goldstein,
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1976b; Martini et 1976). However, it is highly probable for a 
number of reasons that this use of microsomes leads to a very 
abnoimal production of toxic metabolites (Fry and Bridges, 1977a).
These reasons include the following: (a) the very high levels of 
reduced cofactors used which do not represent those existing within 
the intact cells: (b) the lack of active detoxicating enzymes, such 
as many of those for conjugation; (c) the possibility that non- 
microsomal pathways may bring about the production of the toxic 
metabolite(s); and (d) the probable loss in integrity of the sequence 
of the various metabolic reactions.
The use of viable, functional adult mammalian hepatocytes, 
with their full complement of drug metabolising enzymes, as the 
metabolising component is not open to such criticians and therefore 
the incorporation of these cells into a suitable culture system would 
be expected to be of much greater predictive value in such tests. 
Dividing cell-lines derived initially frcm hepatocytes cannot be 
used in this context because of considerable evidence e.g. Owens 
and Nebert (1975,1976) that they have undergone dedifferentiation/ 
reversion with regard to xenobiotic metabolism; as a consequence 
seme pathways of xenobiotic metabolism in such cells may be either 
completely absent or present in a very abnormal state. Tlierefore it 
appears that freshly isolated hepatoc^des or a short-term non-dividing 
hepatocyte culture may in many instances be the most appropriate 
adjunct in metabolism mediated cytotoxicity test systems. Certain 
polycyclic aromatic hydrocarbons are an exception to this generalisation 
in that seme rapidly proliferating cell lines (Diamond, 1971; Gelboin 
and Wiebel, 1971; Huberraan and Sachs,1973; Lubet et 1975; Gentil 
et al, 1977) still show aryl hydroxylation and it has been possible
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to link their metabolism to their cytotoxicity.
In the course of studies into the short-term culture of 
viable rat hepatocytes, it became apparent that wiiilst it was 
relatively straightforward to isolate appreciable numbers of 
viable hepatocytes, cultures of these cells for more than 3-4 
days was hampered by the rapid overgrowth of fibroblasts. The 
utilisation of this mixed-cell culture system in studies of the 
metabolism-mediated cytotoxicity of the anti-tumour agent cyclo­
phosphamide (CPA), using the freshly isolated hepatocytes as the 
’metabolising component’ has been described (Fry and Bridges, 1977b),
CPA is metabolised in the liver to alkylating agents (Torkelson 
et al, 1974) but exerts its toxic action on a number of non-hepatic 
cancers including leukaemia, breast, ovarian cancers and sarcoma.
Tlie initial step in the hepatic metabolism of CPA (figure 4.1.) is 
hydroxylation, catalysed by the microsomal MBD system to 4-hydroxy 
CPA, followed by 2 possible routes, both of which go via the tautomeric 
aldehydealdophosphamide by aldehyde dehydrogenase, a cytoplasmic 
enzyme, to either the non-toxic propionic acid, or through a chemical
3-elimination to phosphoramide mustard and acrolein both of which 
are extremely cytotoxic (Connors, 1975; Cox et ad, 1975). Nornitrogen 
mustard, a further brealcdown product of pho^hor ami de mustard (Mohn
and Ellenberger, 1976) has also been detected and probably contributes,
(Isalong with the other toxic metabolites of CPA toj^ biological effects.
This pattern of
metabolism whereby conversion of CPA to its cytotoxic metabolites 
is dependent on a balance of activating and inactivating enzymes clearly 
illustrates the relevance of using intact cell systems rather than 
isolated cell organelles in studies of metabolism-mediated cytotoxicity.
H^p— NH pH^CHo-ClI \ / ^HoC 0~P““ N\ / \H2C — 0 CH 2 CH 2 CI
Cyc lophosphaiTude
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Figure 4.1. Metabolism of Cyclophosphamide in the Liver
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This therefore prompted Fry and Bridges (1977b) to study the usefulness 
of the mixed hepatocyte/fibroblast culture system in cytotoxicity tests, 
using CPA as the model compound.
This unique cellular system was used in the present studies again 
using CPA as the model compound. Further studies reported here with 
a number of carefully selected compounds, most requiring metabolic 
activation to express their cytotoxic effects, have extended the work 
of Fry and Bridges (1977b).
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4.2. MATERIALS AND METEDDS
4.2.1. Animals
Male Wistar/albino rats (60-80 g body weight) bred in the 
University Animal Hopise and allowed free access to standard 
laboratory diet and water were used throughout this study.
4.2.2. Chemicals
Tissue cultui'e medium, serum and reagents were obtained frcm 
Gibco-Biocult, Scotland. Cyclophosphamide (CPA), 6-aminochryseme 
(6-AC ), 2-aminochrysene (2-AC), 2-acetylaminofluorene (2-AAP) and 4-acetyl- 
aminofluorene (4-AAF) were all purchased from Koch-Light Laboratories, 
Colnbrook, Bucks. 2-Methyl-4-dimethylaminoaàabenzene (2MeDAB), and 
3 ' -methyl-4-dimethylaminoazobenzene (3’MeDAB) were both obtained 
from Aldrich Chemical Co., London. Dimethylnitrosamine (DM) was 
purchased from Phase Separation Ltd., Flintshire, Mitonycin-C (Mito-C) 
from Sigma, London and 4-nitroquinoline-l-oxide(4-KQD) was a generous gift 
from Miss S. Hubbard, Cell Mutation Unit, University of Sussex,
Brighton. Pronase (type CB) was supplied by Calibiochen, Hereford.
9Tissue cLiltwe plasticware (Corning Disposables, 25 cm ' flasks)
was purchased from James A. Jobling and Co., Ltd, Stone, Staffordsliire.
All other reagents and solvents were of the highest purity obtainable.
All solutions, where necessary were sterilised either by autoclaving 
at 15 lb pressure for 15 minutes in the case of salt solutions or by 
filtration through a Millipore filter, pore size 0.22a.
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4.2.3. Incubation Procedure
Hepatocytes were isolated from rat liver by collagenase/ 
hyaluronidase digestion (Fry et 1976) as described in the 
previous chapter using sterile techniques througout and, after 
assesanent of viability by the dye exclusion test (Cummings, 1970) 
diluted to 2 X 10^  viable hepatocytes/ml in culture medium which 
comprised 10% (v/v)foetal calf serum, 10% (v/v) tryptose phosphate 
broth, and 1% (v/v) penicillin/streptanycin (100 units) in Leibovitz 
Lr-15 medium. 1 Ml samples of this cell suspension were pipetted 
into 10 ml conical flasks and incubated with various concentrations 
of the test compound at 37^ 0 in a shaking water bath (approx. 100 
oscillations/minute). Water soluble compounds, cyclophosphamide, 
dimethylnitrosamine, mitomycin-C, 4-nitroquinoline-l-oxide and 
SKF 525A were all dissolved in PBS’A' at 10 times the desired 
concentration and sterilised by menbrane filtration prior to use. The 
lipid soluble ones which included the aminoclirysenes, aminoazobenzenes and 
acetylaminofluorenes were first dissolved in dimethylformamide (DMF) 
followed by the addition of complete medj.um to 10 times the final 
concentration. The final DDÆF concentration in the cell incubation 
mixture did not exceed 0.2% (v/v) in all cases.
At the end of the incubation period the cell suspension was 
diluted 1 in 10 in complete medium and 1 ml samples of this diluted 
cell suspension were introduced into flasks already containing 2 ml 
of medium and these were cultured at 37°C. Medium was changed 
24 hours after initiation of the culture and thereafter at every 
third day. After 6-8 days culture, nuclei counts were performed 
(see Chapter 5 for method).
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4.2.4. Preparation of Rat Liver Fibroblasts
Rat liver fibroblasts essentially free of hepatocytes were 
obtained as follov/s. Vialok c£.\lsCZ.x lo^  ) freshly isolated from 
liver were introduced into 8 oz glass bottles and incubated at 
37°C until the fibroblasts formed a confluent monolayer. Cells 
were then stripped off the glass by means of pronase treatment 
(0.05% in 0,5 mM EGTA in PBS'A' for 10 mins at 37°C) and these 
isolated fibroblasts were counted then incubated with the test 
compounds and subsequently cultured as described above.
4.2.5. Photomicrography of Cultures
Cultures at various stages of growth were fixed and 
stained v/ith haematoxy^ lin/eosin (see Chapter 5 for method) and 
the stained preparations were photographed using an Olympus CK 
inverted microscope with a PM6 camera system.
4.2.6. Analysis and Presentation of Results
Results are presented as the mean of at least four samples 
+ S.E.M. Statistical analysis was carried out using the Students 
t-test. Some of the data presented in the subsequent tables and 
figures describe experiments.
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4.3. RESULTS
4.3.1. Nature of Mixed Liver Cell CulUire System
Preliminary experiments confirmed that \diilst the freshly 
isolated cell suspension contained more than 90% hepatocytes, this 
figure had dropped to less than 1% by day 8 and at this stage of 
the culture the fibroblasts overgrew the other cells (figure 4.2.). 
Also, incubation of the cultures with colcemid (0.05 n g/ml for 2 hr) 
indicated that the hepatocytes in culture were not dividing (mitotic 
index <0.1%) (Fry and Bridges, 1977b). The growth curve (figure 4.2.) 
demonstrates that very little increase in cell number occurs in the 
first 4 days of culture but after this time a very rapid increase in 
cell number takes place which starts to plateau by the eighth day of 
cultLU’e due to the onset of confluency. This finding is confirræd 
by light microscopy (figure 4.3.) in that the cells predominant after 
24 hrs in culture were hepatocytes (figure 4.3,(a)); by 4 days in 
culture the fibroblasts start to grow up (figure 4.3(b)) such, that 
by the eighth day the fibroblast monolayer is nearly confluent 
(figure 4.3.(c)).
4.3.2. Xenobiotic Metabolite - mediated Growth Inhibition of 
Culttued Rat Liver Fibroblasts
Incubation of CPA at 91 p g/ml with freshly isolated liver cells 
for varying periods of time followed by their culture, produces a 
decrease in the number of cells present after 6-8 days in culture 
(figure 4.4.). The extent of this change increased in a linear manner 
with increasing incubation times and was not observed when CPA was 
omitted from the incubation.
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Figure 4.2. Growth Characteristics of Rat Liver Cells in Cultur,
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Figure 4.3.(a) Light microscopic appearance of rat liver cell culture 
after 1 day in culture (x 200 ).
Stained with Haematoxylin and Eosin.
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Figure 4.3.(b) Light microscopic appearance of rat liver cell culture 
after 4 days in culture (x 200)
Stained with Haematox\'lin and Eosin.
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Figure 4.3.(c) Light microscopic appearance of rat liver cell culture 
after 8 days in culture (x 200)
Stained with Haematoxylin and Eosin
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(b) % Growth inhibition of fibroblasts as a function of 
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Hie effect of varying the CPA concentration on fibroblast 
growth inliibition in the presence and absence of hepatocytes was 
also studied and the results are shov.n in figiure 4.5. In the presence 
of hepatocytes there was a sharp drop in the number of fibroblasts 
present after 6-8 days in culture as the concentration of CPA was 
increased such that at a concentration of 455 p; g/ml only 2% of the 
cell number present in the control cultures was recovered. When the 
hepatocytes were omitted from the incubation stage no toxicity could 
be detected even at the highest CPA concentration used.
The results from figures 4.4. and 4.5. indicate that CPA is 
non-toxic per se at the levels used in this study but is converted 
to extremely toxic entities when incubated in the presence of 
hepatocytes. This contention is supported by the finding that 
co-incubation of the freshly isolated hepatocytes with CPA (91 y g/ml) 
and SKF 525A (final concentration 10 I^), a known inhibitor of 
microsomal drug metabolism in intact hepatocytes (Fry and Bridges, 
1977a) results in a reduction of cytotoxicity (57%) shown in figure
4.6. The level of SKF 525A used was not toxic to the cells as judged 
by its lack of growth inhibition properties when incubated in the 
absence of CPA (figure 4.6.) From these results it is possible to 
construct a dose-response curve of activated CPA (figure 4.7.) from 
which an ID^  ^value (defined as that dose of CPA which inhibits 
cell growth by 50%) and this value is compared with literature 
values (Table 4.2.) for CPA toxicity in other cell and tissue 
preparations.
A number of other selected xenobiotics have been studied using
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Figure 4.5. Influence of CPA concentration on fibroblast growth in 
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Figure 4.7. Dose-response curve for CPA with hepatocytes plus fibroblasts
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Table 4.2. Comparison of 10^ ^^ Values of CPA obtained in this study 
with those reported in the literature.
Cell System IDj^  Value Reference
''kb
KB + monse liver raicrosomes
> 1000
~ 56 (computed) Dolfini et al ) (1973)
Ascites
Ascites + rat liver microsomes
6000
10
)X Phillips (1974)
Rat liver fibroblasts > 500 )
Rat liver fibroblasts + Rat hepatocytes 20 . Pry and Bridges  ^ (1977b)
)Rat liver fibroblasts > 500
Rat liver fibroblasts + Rat hepatocytes 21 X This study.
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this system (Table 4.3.). Metabolitennaediated cellular toxicity 
appears to occur with dimethylnitrosarnine, aminoazobenzenes, 
acetylaminofluoreues, aminochrysenes and mitomycin-C for as with 
CPA the presence of hepatocytes is required before their cytotoxicit5?- 
to the rat liver fibroblasts is fully expressed. The 10^^ values 
of these particular xenobiotics to the rat liver fibroblasts alone 
are, except in the case of mitomycin-C, limited by their solubility 
in complete medium, 4-tlitroquinoline-l-oxide shows evidence for 
the opposite effect, namely, protection against fibroblast toxicity 
in the presence of hepatocytes, Carbon tetrachloride (CCl^ ), however 
is equally cytotoxic to rat liver fibroblasts, whether or not 
hepatocytes are present (Table 4.3.). Tliis finding is supported by 
the dose-response curve of CCl^ in the presence and absence of 
hepatocytes (figure 4.8.).
The effect of incubating 3000 ppn CCl  ^for 1 hour at 37°C with 
freshly isolated liver cells on the subsequent growth of fibroblasts 
in culture is shown in figure 4,9. There is a significant decrease 
in the number of the CCl^ -incubated cells present on the first day 
of culture, followed by a small increase in cell number by day 9 when 
compai’ed to the untreated cells. This profile is in marked contrast 
to the one produced on Incubation of the freshly isolated liver cells 
with CPA (91 y g/ml) (figure 4,6.), No cytotoxicity is observed in 
the treated cells on the first day in culture; however cytotoxicity 
is apparent at day 3 which becomes very marked by the ninth day of 
culture. No growth of the CPA-treated liver cells over the culture 
period is observed unlike that detected in the CCl^-treated cells 
(figure 4.9,).
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Legends to Table 4.3.
* Value expressed as parts per million 
** 2i\î€DAB not entirely inactive, possesses borderline carcinogenicity which 
is potentiated by feeding at 0.06% level, combined with partial 
hepatectomy (Warwick, 1967) or combined with 2-Methoxy DAB (Neish et ai, 
1967) producing a significant incidence of hepatic tumours.
Abbreviations used:- DMN - Dimethyfüiitrosamine;
3 ’ -MeDAB - 3 ' -Methyl~4-dimethylaminoazobenzene ; 
2-MeDAB - 2-Methyl-4-dimethylaminoazobenzene;
2-AAF - 2-Acetylaminofluorene;
4-AAF - 4-Acetylaminofluorene;
6-AC - 6-Aminochrysene;
2-AC - 2-Aminochrysene;
Mto-C - Mitomycin-C;
4-NQP - 4-Nitroquinoline-l-oxide ;
CCl.^  - Carbon tetrachloride.
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FigLire 4.8. Dose-response curve for CCl^ with hepatocytes plus 
fibroblasts ( O ) and fibroblasts alone ( © ).
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4.4. DISCUSSION
It has been clearly denonstrated (Chapters 2 and 3) that 
rat hepatocytes isolated by collagenase/hyaluronidase digestion 
retain a capability for metabolising a wide range of xenobiotics 
in a similar manner to that found in the in vivo situation» The 
studies described here have further confirmed this conclusion, 
in that CPA is of low toxicity when incubated with rat liver 
fibroblasts but that this toxicity is considerably enhanced when 
these fibroblasts are co-incubated with rat hepatocytes as the 
metabolising component. The ID^ values of CPA cytotoxicity to 
rat liver fibroblasts alone and in the presence of rat hepato­
cytes are almost identical to those obtained by Fry and Bridges 
(1977b) (Table 4.2.). The inhibition by SKB’ 525A of the cyto­
toxicity of CPA (figure 4,6) also agrees well with the findings 
of these authors who aso found a significant reduction in the 
production of total alkylating activity from CPA. This further 
strengthens the argument that metabolism of CPA is required for 
its full cytotoxicity to be expressed.
Previous work (Dolfini et 1973; Phillips, 1974; Cox et al , 
1975) has indicated that activation of CPA by liver microscraes is 
required for its full cytotoxicity to be expressed. Fran the study 
described here it is possible to derive a number of conclusions 
concerning the mechanism of CPA toxicity, including:- (a) CPA 
activation occurs in the hepatocytes, although other cells present 
in the liver e.g. Kupffer cells could be equally or more active;
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(b) microsomal metabolism is the major cellular pathway for CPA 
activation, based on the fact that the ID^ value for CPA in the 
presence of cells and rat liver microsoræs (10y g/ml, Phillips,
1974; see Table 4.2.). is of the same order as that for CPA in the 
presence of rat liver fibroblasts and rat hepatocytes 20y g/ml; 
see Table 4.2.) and that this cytotoxicity can be inhibited by 
SKF 525A (figure 4.6.); (c) the reactive metabolite(s) of CPA once 
formed in the hepatocytes can pass out of these cells and (d) these 
reactive metabolites are toxic only to dividing cells.
Several other xenobiotics put through this novel mixed-cell 
system produced similar results to that of CPA (Table 4.3.).
It is well loaown that the various biological effects of these 
chemicals, which includes cytotoxicity, are not elicited by the 
parent compound itself, but by active metabolites, rather than the 
parent compound and that these active metabolites are produced 
predominantly in the liver,|^ dimethylnitrosamine (Magee and Barnes,
1967; Gravela et al, 1974; Montesano and Bartsch, 1976), the 
aminoazobenzenes (Terayama, 1967; Kriek, 1974; Decloitre et al,
1975), the acetylaminofluorenes (Weisburger and Weisburger, 1958;
Cramer et 1960; Irving, 1972), the aminochrysenes (Rudali 
et al, 1953; Grantham et al, 1976) and mitanycin-C (Iyer and Szybaliski, 
1964; Szybaliski and Iyer, 1964). Of this group, the antibiotic 
mitomycin-C was by far the most cytotoxic xenobiotic to the rat 
liver fibroblasts alone (Table 4.3.). However the presence of rat 
hepatocytes served to increase the cytotoxicity to the fibroblasts 
still further, indicating that the hepatocytes possess the NADPH- 
dependent reductase reported to be involved in its activation 
(Szybaliski and Iyer, 1964). The results obtained with 4-nitroquinoline-
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1-oxide (4-N(p) on the other hand suggest that it is the parent 
compound which is mainly responsible for the cytotoxicity 
expressed in the rat liver fibroblasts (Table 4.3.) and the rat 
hepatocytes are converting the 4-NQOto less biologically active 
species, although the possibility that the reduction to active 
metabolites is more effective in the fibroblasts cannot be 
entirely ruled out. The former would seem more likely for it has 
been shown that 4-%) is carcinogenic both in vivo and in vitro, ' 
whilst most of its reduction products are not (Arcos and Argus, 1974) 
In vitro studies (Sugiraura et al, 1966) have shown the presence in 
the liver of at least two distinct reductases responsible for the 
sequential reduction of 4-NQ3, one of which is distributed equally 
between the microsanal and mitochondrial subfractions whilst the 
other is of cytoplasmic origin. This contention is also supported 
by the work of Weinstein et ^  (1977) who reported that exposure 
to 4-NQp (0.25 vM for 1 hour) induced chromosomal damage in human 
diploid fibroblast cultures GVl~38)^ was eliminated by incorporation 
of a 9000 g supernatant (8-9) mixture. They postulated that either 
the 8-9 mix had some effect on the cell cycle (e.g.mitotic delay) 
thus exposing a different population of cells to 4-NQp, or that 
8-9 metabolised the 4-NQP, since in their hands a decrease in 
mutagenicity by 4-NQP plus 8-9 as compared to 4-NQP alone was 
observed in the Ames test with 8. typhimurium TA 100. However as 
pointed out previously (section 3.4.2.2.) it is questionable whether 
the incubation conditions erployed in such an ih vitro system, that 
are more compatible to oxidative reactions would favour the reductive 
pathways that are essential to 4-NQP metabolism. It may well be that 
the artificial conditions of the Ames test incubation, the close 
association of the seni-solid agar, bacteria, xenobiotic and the
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heterogenous 8-9 mixture could produce in some way, small 
anaerobic areas sufficient to allow a certain amount of metabolism 
of 4-KQP, or that reduction of 4-NQ3 may be carried out by the 
bacteria. jCn vitro cellular systems using freshly isolated 
hepatocytes as the 'metabolising canponent' do not suffer from 
such limitations being much closer to the situation appertaining 
in vivo.
The results obtained in this system with the hepatotoxin, 
carbon tetrachloride (OCl^ ) (Table 4.3., figure 4.8.) suggests 
that its effect on the rat liver fibroblasts is not via metabolic 
activation as it is both vivo (Recknagel, 1987 ; Castro et al,
1974; Diaz Gonez et 1975; de Toranzo et 1975) and vitro
(Archakov and Karuzina, 1973; Villarruel et ad, 1975) but due to
non-specific damage of the plasma membranes of both the rat liver 
fibroblasts and rat hepatocytes. However it must be borne in mind
that high levels of CCl^ were required to cause these effects and
that if the CCl^ * radical (activated species) were formed, it would 
probably have very little chance of getting out of the hepatocyte, 
due to its very short half-life.
Originally it was proposed to extend these studies to investigate 
the possibility of using this mixed-cell culture system as the basis 
of an in vitro carcinogenicity screen. With selected pairs of compounds, 
one a liver carcinogen and the other a non-carcinogen, cytotoxicity 
was first assessed (Table 4.3.) and then the surviving fibroblasts 
were maintained in culture for much longer periods of time. At 
suitable intervals these treated cells and the appropriate controls
209
were to have been tested for in vitro trarsfonration, using 
criteria such as irregular growth, piling up of colonies, growth 
in soft agar and chromosomal aberrations (Heidelberger, 1973, 1975). 
However it proved impossible to maintain these fibroblasts in 
culture for the time periods required for such studies to be carried 
out. No contamination of these fibroblasts, bacterial or fungal 
was observed. The 'premature* death of the rat liver fibroblasts 
could be due either to changes in nutritional requirements brought 
about by the chenical treatment or longevity in culture, or more likely 
it is an example of in vitro senescence in the cells. Hayflick 
(1974); Choe and Rose (1976) amongst others have reported that 
normal human fibroblasts when cultured in vitro reproducibly display 
a finite number of doublings, cellular ageing and finally death, 
resulting from some subtle inadequacy of the in vitro environment. 
However these metabolism-mediated cytotoxicity studies in the 
cultured rat liver fibroblasts indicate that there is no direct 
relationship between the carcinogenic potential and the cytotoxicity 
of the xenobiotics studied (Table 4.3.). This is in broad agreement 
with Heidelberger (1973) and Dibert et ^  (1975) \dio found that 
although xenobiotic mtbaWiswv was to îw
Recently, Hooson and Grasso (1977) reported the effect of water 
soluble chemicals on growth and mitosis of newborn rat kidney fibro­
blasts in primary culture. Proximate carcinogens, and seme chanicals 
with a defined inliibitory action, depressed the growth and division 
of the cultures. Non-carcinogenic compounds and precarcinogens did 
not interfere with the subsequent growth rare and mitotic activity 
of the cultures. These authors therefore suggested that the possession
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of growth inhibitory properties could give an indication of the 
carcinogenic activity of the carcinogenic activity of a chanical 
on a short term basis. The omission of a 'metabolising component' 
in this systan, is probably the reason the precarcinogens did not 
iiiiibit growth and mitotic rate. Also Painter (1977) using HeLa 
cells has pointed out the differences that exist between agents 
that inliibit D M  synthesis (as measured by the incorporation of 
tritiated thymidine) but do not damage D M  - cycloheximide, 
hydroxyurea, dimethylsulphoxide and nickel chloride and those that 
do damage D M  - benzo(a)pyrene, methylmethanesulphonate (MS), 
ultraviolet light and 4-nitroquinoline-l-oxide (4-NQO), which may 
be considered to be potential mutagens and/or carcinogens. In the 
case of the non-DM damaging agents the rate of thymidine incorporation 
into D M  increased rapidly as did cell division immediately after 
their removal from the medium (although complete recovery invariably 
took several hours). In contrast, with the D M  damaging agents, the 
rate of D M  synthesis continues to decrease even after the agent has 
been removed from the medium.
Studies using the carcinogen, cyclophosphamide (Prejean et al ,
1972) (figure 4.6.) and the potent hepatotoxin, carbon tetrachloride 
(Reclmagel, 1967) (figure 4.9.) in our mixed liver cell culture 
system, would seem to support these findings. Treatment with CPA 
(91 Tjg/ml) results in an almost total abolition of growth in the fibro- 
blasts over the 9-day culture period whilstjysimilar treatment with 
CCl^ (3000 ppm), there is some recovery of cellular growth of the 
fibroblasts by the ninth day of culture, reaching 33% of the control 
level. However it is very likely, as mentioned before that the CCl^ 
effect is a reflection of the loss of membrane integrity rather than
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inhibition of DNA synthesis in the rat liver fibroblasts as occurs 
mth the carcinogen, CPA. It imy be that with further work this 
growth inhibitory effect could be used as a marker in a prescreening 
programne for chemical carcinogens using the mixed liver cell culture 
system.
These studies have demonstrated the feasibility of using mixed 
hepatocyte 'metabolising component'/fibroblast Response component* 
system for assessing metabolian-mediated cytotoxicity and that this 
approach for the testing of liver generated toxic metabolites which 
subsequently affect other cell types is probably of more predictive 
value (to the i^ vivo situation) than is the use of microsomes as 
the 'metabolising canponent* in the various microbial mutagenesis 
(McCann et 1975) and mammalian cell transformation system 
(Heidelberger et 1973) currently being errployed as tests for 
chemical carcinogens.
Mixed-cell systans allow not only the study of metabolite excretion 
from the hepatocytes but their effect on the 'res%oonse' cells. Many 
uses of a mixed-cell system approach in xenobiotic toxicity testing 
are apparent. Metabolism-mediated oxidant damage to red blood cells 
could be tested for by co-incubating red blood cells with hepatocytes 
in the presence of the xenobiotic. Using this approach, metabolism- 
mediated mutagenicity and/or carcinogenicity could also be studied. 
Indeed there is some evidence that the incorporation of hepatocytes 
into the Ames test system for detecting bacterial mutagens is a 
feasible proposition (Green et al, 1977). Cell selective and organ 
specific xenobiotic toxicity may be studied in such mixed-cell systems, 
by using different cell types and cells from different organs as the
212
'response' system. Cells from other species (including human material) 
could also be incorporated into such a system.
Finsilly, such a system described here is relatively siiTQ^)le and 
could be put into routine use as an in vitro screening test, detecting 
both direct-acting and metabolism-mediated toxic agents.
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Use of Hepatocytes as a 'Metabollsins
and ’Response’ Coiiponent for in vitro
Toxicity Assessment
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CHAPTER 5
5.1. INIRCDUGTION
It has been clearly shown (Chapter 4) that viable hepatocytes 
can be successfully used as a 'metabolising con^nent' in various 
cytotoxicity test systems and also that valuable insights can be 
gained into the mechanisms of metabolism-mediated cytotoxicity by 
such studies. However, can hepatocyte systems be used both as the 
'metabolising caTponent' and as the 'response corponent' in the 
study of xenobiotic-induced hepatotoxicity? Two approaches are 
available for such investigations, isolated viable hepatocyte 
suspensions and short-term adult maintenance cultures.
5.1.1. Hepatocyte Suspensions as a model for Xenobiotic-indiiced
Zimmerman and his group have amply demonstrated that isolated 
viable hepatocyte suspensions can be successfully used for ^  vitro 
hepatotoxicity assessment. Zimmerman ^  ^  (1974) studied the effects 
of tliree erythromycin derivatives and of chloropromazine on isolated 
rat hepatocytes. Hepatotoxicity was assessed by leakage of a cyto­
plasmic enzyme (glutamic oxaloacetate transaminase, GOT) into the 
extracellular medium. A correlation between the cytotoxicity of the 
xenobiotics studied and their ability to produce jaundice in humans 
was noted by these workers. Abernathy et ai (1975b)looked into the 
relative hepatotoxicity (as measured by GOT leakage) of a range of 
tricyclic antidepressant drugs (amitriptyline, nortriptyline, 
desipramine, protriptyline, imipramine and chlorlmpramine) and from 
this study they were able to sirrive at a number of conclusions relating
216
Chemical structure to ability to produce cytotoxicity. A similar 
study was carried out by Abernathy and Zimmerman (1975) who looked 
at the toxicity of some thioxanthene neuroleptics to isolated rat 
hepatocytes. These last two studies, in addition to illustrating 
the use of hepatocyte suspensions for assessing xenobiotic-induced 
hepatotoxicity, also demonstrate one of the major advantages of intact 
cell systems, the ability to study structure-activity relationships 
using hepatocytes. However, the relevance of the toxicity of these 
agents (both tricyclic antidepressants and thioxanthene neuroleptics) 
demonstrated in this simple in vitro model to hepatic injury in vivo 
remains to be established.
The early damage induced by the toadstool Amanita phalloides 
in the liver of several animals is due to phalloidin, which has 
been shown to disaggregate cell membranes, leading to cell swelling 
and to formation of large vacuoles in hepatocytes in vivo (Miller and 
Wieland, 1967). It has also been shown (Gravela et al, 1975) that 
phalloidin ^  vivo induces a strong dissociation of rat liver poly­
ribosomes. Although probably not a direct inhibitor of protein 
synthesis, studies with isolated viable rat hepatocytes (Gravela and 
Poli, 1977) showed that phalloidin addition in vitro resulted in a 
depression of protein synthesis, as measured by the incorporation of 
a labelled protein hydrolysate, in the range of 6-20 yg/ml. At a 
concentration of 12yg/ml, protein synthesis was reduced to 50% of the 
control value. Morphological changes in the hepatocytes were also 
observed in this study after treatment with phalloidin, almost all the 
hepatocytes showed cytoplasmic bulges outc’.ards frcm various regions 
of the cell surface. This feature of the in vitro phalloidin poisoned
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hepatocytes has been reported by Weiss et ^  (1973).
Freshly isolated hamster hepatocyte suspensions have been 
used to examine the mechanism of the enhancement of paracetamol 
hepatotoxicity by salicylamide, salicylic acid, aspirin and galacto- 
samine in hamsters (Smith and Jollow, 1977). Isolated hamster 
hepatocytes were shown to metabolise paracetamol linearly for at 
least 60 minutes by both non-toxic (glucuronidation and sulphation) 
and toxic (measured by glutathione conjugation) in vivo pathways.
At a paracetaird concentration of 2 cfi, glutatliione was depleted 
linearly with time and the drug was found to bind covalently to 
cellular proteins to an extent similar to that seen in vivo after
hepatotoxic doses. Since this m^odel allowed ' simultaneous
analysis of the effect of the treatment regimens on both non-toxic 
and toxic pathways of paracetamol metabolism, the authors were able 
to conclude that the observed enliancement of paracetamol hepato­
toxicity results from the partial inhibition of the non-toxic 
deactivating pathways causing a larger fraction of the dose of 
paracetamol to be metabolised to its hepatotoxic metabolite(s ).
In a similar study using isolated rat hepatocyte suspensions
Hogberg and Kristoferson (1977) have shown that the level of glutathione
in these cells was decreased by the in vitro addition of diethyl
maleate (0.6 - 18 moles), as occurs in vivo (Boyland and Chasseaud, 1970)by
presumably by direct conjugation (Cliasseaud, 1974) andj^ paracetamol (10 mf,M) 
which is known to be first oxidised by cytochrcme P-450 dependent step 
and then conjugated with glutathione in a second step (Mitchell et al,
1973). Hogberg and Kristoferson concluded that this consumption of 
glutathione could be taken as evidence for paracetamol metabolism, since
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it has been well established lUxhW /^ccWocVsYv. fcW
cy V^m z^M jc.va ttJv^ c^Ks.. No toxic effects were observed in the 
hepatocytes (as ineasured by enz^ rae leakage) when diethylmaleate 
and paracetamol were used separately. Toxicity was observed however 
when these treatments were condjined, or an excessive dose (18 a moles) 
of diethylmaleate was used. Malondialdehyde accumulation in these 
treated hepatocytes was also observed, suggesting that lipid 
peroxidation is a possible inport ant factor in the mechEinism of 
cellular toxicity of these agents.
Lipid peroxidation, determined by malondi aldehyde formation and 
alteration of membrane lipids in isolated rat hepatocyte suspensions 
exposed to the in vivo hepatotoxin, carbon tetrachloride (CCl^ ) has 
also been used to assess its hepatotoxic activity ir vitro (Weddle 
et 1976). Tlie results of this study showed that endogenous 
lipid peroxidation is enhanced in isolated hepatocytes by both vivo 
phenobarbitone and in vitro CCl^ (5000 ppm) treatment. The latter 
requinid the participation of cytochrome P-450, as it does in the 
in vivo situât ion (Plaa and Witschi, 1976).
These examples clearly illustrate that hepatocyte systems can 
be used for the study of xenobiotic-induced hepatotoxicity ^  vitro.
In fact Orrenius et ^  (1976) have used these cells in studies of a 
more fundamental nature, designed to obtain information that could 
contribute to a better understanding of the cellular responses to 
injury and possibly shed some light on the critical event(s) in 
the initiation of cell death. They found that a decrease in cellular 
ATP levels was an early event in cell injury, preceding changes in 
plasma membrane permeability. The initiation of cell death was
regarded by than as occurring when such permeability changes became
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irreversible.
5.1.2. Short-term Maintenance Primary Adult Hepatocyte Cultures as 
a model for Xenobiotic-induced Hepatotoxicity
Several laboratories have been successful in establishing long­
term epithelial cultures frcan foetal and newborn rat liver (Katsuta 
and Takaoka, 1963; Gerschenson and Casanello, 1968; Williams et al,
1971: Leffert and Paul, 1972; Chessebeuf et 1974; Bausher and 
Schaeffer, 1974), adult rat liver (Gerschenson et al, 1970; lype, 1971; 
Diamond ^  sd, 1973; Williams and Gunn, 1974) as well as mouse (Waymouth 
et al, 1971), chick (Grieninger and Granick, 1975) and human liver 
(Kaighn and Prince 1971 ; Congote et 1977 ). However these liver 
cell lines display few phenotypic properties of adult hepatocytes and 
so cannot be considered fully representative of the liver in vivo. 
Long-tem cultures initiated from isolated adult parenchymal cells 
appear to maintain some functions of the cells of origin. These 
include induction of tyrosine aminotransferase (Gerschenson et 1970), 
retention of specific cell surface antigens (lype et 1972), synthesis 
of albumin (Kaighn and Prince, 1971) and the retention of certain 
morphological characteristics (Williams and Gunn, 1974). However, 
since these cells are continuously dividing unlike adult liver parenchymal 
cells in vivo, they lack many of the differentiated biochemical functions 
of the jn vivo system (Lambiotte et 1972; Walker et 1972).
Recent advEinces in tissue culture techniques have resulted in the 
production by several groups, of short-term non-proliferating adult 
hepatocyte primary cultures from both fully regenerated adult rat liver 
(Bissell et al, 1973; Chapman et al, 1973; Bonney et al, 1974; Bonney,
1974) and normal resting rat liver (Michalopoulos and Pitot, 1975;
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Laislies and Williams 1976a,b). These and other workers have shown 
that primary adult maintenance cultures retain many of the morphological 
and biochemical characteristics of the normal resting adult liver in vivo 
including albumin synthesis and secretion, gluconeogenesis, responsiveness 
to insulin and glucagon, glycogen secretion (Bissell et al, 1973), 
tyrosine aminotransferase induction by cyclic nucleotides and steroids 
(Michalopoulos and Pitot, 1975), lipogenesis (Geelen and Gibson, 1975) 
hormonal stimulation of DNA synthesis (Richman et 1976) and inducible 
metabolism of xenobiotics (Bissell et 1973; Michalopoulos, at al,
1976a, b; Guzelian et 1977). Such systems would therefore seem
to be the most appropriate cell culture model to employ in the investigation
of xenobiotic-induced hepatotoxicity.
Present studies have been directed to the effects of short-term 
exposure of the hepatotoxins carbon tetrachloride, paracetamol, dieldrin 
and phenobarbitone on the viability and function of adult rat hepatocytes 
in short-term maintenance cultLire, and the effect of carbon tetrachloride 
and triethyltin on the viability of isolated rat hepatocytes in suspension 
in an attempt to further illustrate the value of hepatocjrtes in studying 
the mechanists of xenobiotic induced hepatotoxicity. The compounds 
used were selected on the basis that they all produced pronounced 
hepatic effects in vivo, though not always by the same mechanism.
Carbon tetrachloride hepatotoxicity is probably primarily due to 
increased lipoperoxidation, while the analgesic paracetamol may act 
via the depletion of cellular glutathione stores. Dieldrin and 
phenobarbitone,. though both inducers of hepatic cytoclxrane P-450 
1 iniced MPO activity, may differ in the t^ Tpe of induction produced. 
Triethyltin is probably toxic to the liver through mitochondrial 
uncoupling. Though metabolism is probably not required for the effects
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of dieldrin, phenobarbitone and triethyltin to become manifest in
the liver, it is though: to be an essential prerequisite for carbon
tetrachloride and paracetamol hepatotoxicity.
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5.2. MATERIALS AND METHODS
5.2.1. Animals
As described in the previous chapter.
5.2.2. Chemicals
Carbon tetrachloride and paracetamol were both obtained frcm 
BDH Ltd. Poole, Dorset. Recrystallised dieldrin, major constituent 
lliiDD (1,2,3,4,10,lO-hexachloro-6,7-epoxy-l,4,4a,5,6,7,8,Sa-octaliydro- 
exo, -1,4-endo-5,8-dimethanonaphthalene ) was a generous gift fron 
Dr. A. S. Wright, Tunstall Laboratory, Sliell Research Ltd., Sittingbourne 
Kent, Triethyitin sulphate (ShEtg)g80^  was donated by Dr. B. Elliot,
MRC Toxicology Unit, Carshalton, Surrey. Polypeptides (P-5115),
NADPH (type III tetrasodium salt), NADP (disodium salt) and D-glucose- 
6-phosphate (disodium salt) were all obtained from Sigma Ltd., London^  
néotétrazolium chloride fron Koch-Light Laboratories, Colnbrook 
Bucks and sodium succinate GH^O from HDH, Ltd., Poole, Dorset.
Collagen, (from bovine achiles tendon) was purchased from Aldrich 
Chemical Co. Ltd.; L-[1^ C^] leucine (specific activity 56 mCi/mmol) 
was obtained from the Radiochemical Centre, Amersham, Bucks. All 
tissue culture medium serum and solutions were supplied by Gibco-Biocult, 
Scotland. Leighton tubes were obtained from Bellco Ltd. (U.K. agents 
Arnold R. Horwell). All other reagents, stains and solvents were of 
the highest grade obtainable. Solutions were sterilised by methods 
described in the previous chapter.
5.2.3. Establishment of Adult Rat Hepatocytes in Primary Maintenance 
Culture
Hepatocytes were isolated from adult rat liver by the method
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of Fry et ^  (1976) except that all operations were performed
asceptically. PBS'A’ solutions were supplŒnented with the antibiotic
gentamycin (76 pg/ml) and the enzyme solution was filter sterilised
(0.22y Millipore filters) as before. Once isolated the hepatocytes
were dispersed in Leibovitz (L-15) medium supplemented with 10% (v/v)
foetal bovine serum, 10% (v/v) tryptose phosphate broth and 1% (v/v)
penicillin/streptomycin, counted and diluted to 1 x 10^  viable cells/
ralj 2 mis of this diluted suspension was innoculated into each flask 
2(25 cm ) and 1 ml into each Leighton tube, containing a collagen- 
coated cover si ip (10.5 mm x 22 mm). All flasks and tubes were then 
incubated at 37°C for 2 hours after which the medium containing 
unattached cells was carefully removed and replaced wdth fresh medium.
After a further 15 hours in culture the cells were thoroughly washed 
with PBS ' A '/gentamycin in an attempt to remove the non-viable loosely 
attached cells. Fresh complete medium was then added to the cultured 
cells wKAW^ inci±)ated for a further 24 hours at 37 C before they were 
exposed to the xenobiotics.
Paracetamol, dissolved in L-15 medium with the aid of 
sonication was filter sterilised prior to use. Carbon tetrachloride 
was also dispersed in L-15 medium with the aid of sonication.
Dieldrin was first dissolved in dimethyformamide (DMF) at 2000 times the 
desired concentration, then added to complete medium. Final DMF concentratio 
in complete medium did not exceed 0.05%, as higher levels found to 
interfere with cytochemical assays used. Triethyltin was dissolved in 
PBS'A' at 10 times the desired concentration. Studies that were carried 
out with paracetamol and carbon tetrachloride in the rat hepatocyte 
cultures used serum-free medium. However in the studies with dieldrin 
using the hepatocyte culture system,j^ carbon tetrachloride and triethyltin 
in isolated rat hepatocyte eu^ penaipns, serum was included in the 
medium.
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5.2.4. Nuclei Count Determination in Cultured Cells
The medium was first decanted from the cell monolayer and 
after washing with PBS'A’ , replaced with 2 mis of crystal 
violet (0.1%) in 0.1 M citric acid (Absher, 1973). Following 
incubation at 37°C for 1 hour, v/ith shaking every 20 minutes, the 
nuclei were counted in an Improved Neubaur Counting Chamber.
5.2.5. Enzyme Lealcage in Cultured Adult Rat Hepatocytes
Cytoplasmic enzymes measured were glutamic oxaloacetate trans­
aminase (GOT) and glutamic pyruvate tranasaminase (GPI') and methods 
adopted were based on the Boelxringer Test Combination Kits (Cat 
No's 124478 and 124621). After appropriate treatment of the cultured 
hepatocytes, the medium was removed, and the cells washed (x 2) with 
PBS'A' and the washings pooled with the medium. The hepatocytes were 
removed from the flask with a ' rubber policeman ' after the introduction 
of distilled water (1 ml). This procedure was repeated to ensure 
complete removal of the hepatocytes. The cell samples were then 
subjected to repeated quick freezing and slow thawing (3 times) in order 
to facilitate total cell disruption and enzyme release. Aliquots of 
cell and medium sanples were taken for estimation of enzyme activity. 
Both GOT and GPT activity was measured by absorbance changes at 
340 nm.
5.2.6. Protein Synthesis in Cultiured Adult Rat Hepatocytes
Protein synthesis was measured by the incorporation of labelled 
leucine into trichloroacetic acid (TCA) insoluble material. Cultured
5hepatocytes (approx. 4 x 10 cells) after suitable treatment were 
incubated with 1 y Ci of L-fl^ '^ Cj leucine (specific activity 56 mCi/ramol)
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for 30 minutes at 37°C^  after which the medium was removed and 
the hepatocytes were washed 3 times with PBS'A' , to remove all 
unincorporated label. 1 ml of distilled water was added to the 
hepatocytes which were then removed using a ' rubber policeman '.
The cells were transferred to a test tube to which was added 
1 ml of ice-cold 20% TCA. The resulting precipitate was then 
washed twice with 10% TCA and finally digested in IN NaOH for 
1 hour at 37^ 0. Samples were then taken for determination of 
protein (Lowry et 1951) and for radioactivity counting. The 
scintillant consisted of 0.4% w/v PPO (2,5-Diphenyloxazole), 10% 
v/v methanol, 6% w/v naphthalene in 1,4-dioxane.
All cell nuclei counts, GOT and GPT estimations and protein
synthesis studies in cultured adult rat hepatocytes were carried
2out using cells maintained in 25 cm 'falcon' flasks.
5.2.7. Enzyme Cytochenical Studies in Adult Rat Hepatocytes in Culture
Enzyme cytochanical analysis of cultured rat hepatocytes was 
carried out using methods essentially as described by Chayeri et ^  
(1973) with only slight modifications. Three enzymes were monitored:- 
(a) glucose-6-phosphate dehydrogenase, (b) succinate dehydrogenase and 
(c) NADPH diaphorase.
(a) GlucQse-6-phosphate dehydrogenase
Incubation mixture:- NADP (2.5 ng/ml of disodium salt)
G-6-P (1.5 mg/iTQl of disodium salt)
PMS (0.2 mg/ml)
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(b) Succinate dehydrogenase
Incubation mixture : - Sodium succinate (13.6 mg/ml)
P^ IS (0.2 ng/ml)
(c) NADPH diaphorase
Incubation mixture:- NADPH (5 mg/ml).
The buffer used for all three enzymes was 0.05 M glycylglycine 
buffer pH 7.9, containing 5% (w/v) polypeptide P-5115 and 0.3% (w/v) 
néotétrazolium chloride (NT), an hydrogen acceptor, which on reduction 
is converted from a soluble salt to its formazan, a red insoluble 
precipitate (figiure 5.1).
Although the first tétrazolium salt, triphenyl tétrazolium was 
prepared in 1894, the use of these compounds in histochemistry dates 
from the 1940's. Several hundred tétrazolium salts have been 
prepared, but only relatively few have found application in biological 
studies. The synthesis of new tetrazoles, with more suitable 
properties from the histochemical point of view, enabled more precise 
localisations to be obtained, and techniques for electron microscopy 
of formazan deposits are now available (Seligman 1971). The
use of high concentrations of colloid stabilisers, such as polyvinyl 
alcohol or commercial polypeptide preparations, overcame the problem 
of tissue disruption during incubations, and enabled even 'soluble' 
enzymes to be retained inside unfixed sections (Altman and Chayen,
1965; Altman, 1971a). The development of quantitative spectrophotonetric 
(Altman, 1969a,b) and microdensitcmetric (Chayen et al, 1970; Altman, 
1971b) procedures added a further degree of precision to the technique. 
Thus, quantitative measuraments of oxidative activity can be made in
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N%:Nt N=zN+
Néotétrazolium chloride (soluble)
\ _ y
N%:N N%:N
+2HCI
Néotétrazolium foiroazon (insoluble)
Substrate
OxidisedSubstrate
Cofactor
Reduced 
Cofactor
^ Néotétrazolium
formazan(red ppt)
—  Néotétrazolium Chloride
Figure 5.1. Structure of Néotétrazolium chloride and its formazan,
and its coupling with substrate and cofactor in reaction 
sequence. (-— ~) shows transport of hydrogen.
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unfixed, stabilised, tissue sections.
In the present study, a slight modification of these techniques 
was employed to assess oxidative enzyme activity in unfixed short­
term maintenance cultures of adult rat hepatocytes and the effect of 
certain xenobiotics on these enzymes, using néotétrazolium chloride 
(NT) as the hydrogen acceptor.
The enzymes succinate dehydrogenase and glucose-G-phosphate 
dehydrogenase were selected as marker enzymes for mitochondrial and 
cytoplasmic activity in the culture hepatocytes. Due to the 
considerable gap that exists between the electrode potential at which 
the cofactors involved are reduced and that at which the néotétrazolium 
chloride can accept hydrogen, it must be carried by a hydrogen-transport 
systan until it can react with the tetrazole. The rate of dehydrogenation 
detected is therefore dependent on the activity of the hydrogen-transport 
system and not on the dehydrogenase. The activity of the dehydrogenase 
is determined by the use of phenazine methosulphate (PMS), a powerful 
hydrogen acceptor which very rapidly and non-enzymically takes hydrogen 
from the reduced cofactor and transmits it to the néotétrazolium 
chloride. The choice of a microsomal marker for these studies was a 
little more difficult, primarily due to the paucity of a suitable 
enzyme whose activity could be readily measured by the techniques 
available. NADPH diaphorase, an enzyme syston possessing the ability 
to catalyse the oxidation of NADPH, which could be coupled to the 
reduction of neotetrazoliums was found to be the most appropriate 
microsomal marker in these studies. It is probably equivalent to one 
of the carrier enzymes of the hydrogen-transport pathway dealing with 
the oxidation of NADPH, i.e. the flavoprotein component of the micro­
somal cytoclircme P-450 system, possibly closely related to NADPH-
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cytochrome c reductase (Chayen et al, 1973). A simplified reaction sequence 
including the transport of hydrogen frcm the substrate to the insoluble 
formazan is shown in figure 5.1.
After bubbling the incubation mixture with nitrogen (oxygen 
inliibits the action of NT) approximately 0.5 ml was used for each 
hepatocyte cultiure. Adult rat hepatocytes cultured on collagen- 
coated coverslips in Leighton tubes were oiployed for all these 
studies. After 45-50 minutes incubation at 37°C, the reaction 
was terminated by v/ashing the hepatocytes in PBS’A' followed by 
mounting with glyc<if\<WL jelly on a microscoptL slide. The NT formazan 
localised within the hepatocytes as a result of enzyme activity 
(see figure 5.2.) was then quantitated with a Vickers M85 Scanning 
and Integrating Microdensitometer, which may be described as a 
spectrophotometer which works through a microscope. A monochrcmmting 
system allows the illumination of cells with light wiiich is absorbed 
maximally by the histochemical reaction product, NT fonm.zan in this 
case (see figure 5.3. for absorption spectrum of this formazan) 
and this image is projected on to a photomultiplier. To overcome 
the variation of stain, even in one cell, the image is transmitted 
point by point by means of an automatic scanning system. The 
instrument integrates all the readings over the whole of the selected 
field and registers the integrated absorption present in that field.
Great care was exercised in these studies to ensure objectivity in 
the selection of cell areas to be quantitated by this method. All 
enzyme activities were expressed in arbitrary machine units.
5.2.8. Staining Procedures for Cultured Cells
(a) Haenatoxylin and Eosin
(i) Rinse in PBS’A'
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Figure 5.2. Néotétrazolium formazan localised within adult rat
hepatocytes in primary maintenance culture as a result 
of NADPH diaphorase activity
(x 400)
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Figure 5.3. Absorption Spectrum of Néotétrazolium chloride
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(ii
(ill
(iv
(v
(vi
(vii
(viii
(ix
(X
(xi
(xii
AoclFix in Aceticy^ Alcohol Formalin (5 : 85 ; 10 v/v) 5 rnin 
Rinse in tap water
Stain with 50% (v/v) aq Haematoxylin (Harris) 2 min
'Blue’ in tap water
Differentiate in 0.5% HCl 15 sec
'Blue’ in 0.05% LigO^ 5 min
Rinse in 70% (v/v) Alcohol
Stain with Eosin 1 min
Rinse (x 2) in Absolute Alcohol 
Clear in Xylene 
Mount in D.P.X.
IHis is a general morphological stain in which nuclei are stained 
blue and cytoplasm red,
(b) Oil Red ’O'
(i) Rinse in PBS’A'
(ii) Fix in neutral formalin
(iii) Stain with Oil Red 'O’
10 min 
5 min 
30 min
Stock of Oil Red 'O' is a saturated solution (0.4 g) in iso­
propanol; for use 6 ml of stock stain is diluted with 4 ml of distilled 
water, allowed to stand for 10 minutes and then filtered. It must be 
used within 2 hours.
(iv) Differentiate with 60% (v/v) Alcohol 
(v) Wash with distilled water 
(vi) Stain with 50% (v/v) aq. Haematoxylin (Harris) 10 min 
(vii) 'Blue' in tap water 
(viii) Differentiate in 0.5% HCl 15 sec
233
( ix )  'B lu e ' in  0.05% LigO ^ 1 m in
(x) Mount in Glycerine Jelly
This is a specific stain for lipid, which is stained red and 
nuclei stained blue.
Both staining procedures described are for use with hepatocytes 
cultwed on collagen coated coverslips.
5.2.9. Photaiicrography of Cultures
Stained hepatocyte cultures were photographed using an Olympus 
CK inverted microscope with a PM6 camera system.
5.2.10. Analysis and Presentation of Results
Results are presented in most cases as the mean of at least 
four samples + S.E.M. Microdensitometric measurements however 
are the mean of between 10 and 50 separate determinations + S.E.M. 
Statistical analysis was carried cut using the Students b-test.
Some of the data presented in the subsequent tables and figures 
describe single experiments, in these instances each study was 
performed at least twice with similar results in each case.
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5.3. RESULTS
5.3.1. Culture of Freshly Isolated Adult Rat Hepatocytes
The culture of freshly isolated adult rat hepatocytes obtained 
by collagenase/hyaluronidase dissociation of liver slices has been 
described in detail elsewhere (Fry, 1974) and so only a brief 
description will be given here, lîie most abundant cell type seen 
24 hours after initiating the culture is an epitheliocyte, (figure
5.4.) present mostly in groups, showing marked polygonality strongly 
reminiscent of true hepatocytes, together with large numbers of dead 
cells which lay over the epithelial colonies. The cell nuclei are 
round, large and contain one or two centrally placed nucleoli. A 
nunber of these epitheliocytes are binucleate and the use of a 
metaphase-arresting agent (colcemid, 0.05yg/ml) reveals that
the epithelial cells have a mitotic index of < 0.1% (Fry 1974, Fry 
and Bridges, 1977b). The cell cytoplasm is highly granular and 
occasionally shows a small number of vacuoles which stain positively 
for glycogen (Fry, 1974) and on the basis of these observations 
and functional abilities, including production of urea and albumin, 
responsiveness to hormones and xenobiotic metabolian (Fry, 1974) 
these epitheliocytes are designated as hepatocytes in culture.
Other cell types were observed by Fry (1974) after 1 day in 
culture; the first bizarre 'foamy' cells, not observed to any
extent in this study; the second cell t^ pe, which was seen in the 
cultures used in the present study is of fibroblastic origin (figure
5.4.). These cells are small in size and number, spindle and stellate 
forms are apparent, their nuclei are elongated and the cytoplaan 
clear.
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Figure 5.4. Light microscopic appearance of adult rat hepatocytes 
in primary maintenance culture after 1 day in culture
( X  400)Stained with Haematoxylin and Eosin.
236
After 2 days in culture the areas of epitheliocyte formation 
increase in size, starting to assume a sheet-like appearance 
(figure 5.5.). However by day 4 the culture begins to take on a 
different appearance in that the fibroblasts start to dominate 
(figure 5.6.) (see also Chapter 4). This leads to the eventual 
encirclanent of the hepatocyte colonies by the fibroblasts which 
by day 7 Is complete. The culture at this stage is almost totally 
fibroblastic in nature, although small hepatocyte colonies are to 
be found. Similar patterns of growth were observed in these 
cultui’es when the freshly-isolated cells were maintained either 
on collagen-coated coverslips or tissue culture flasks.
Tlie study of xenobiotic-induced hepatotoxicity using this 
system is therefore limited to the first few days when the fibro­
blasts do not constitute a significant proportion of the total 
number of cells in culture. In practice, all studies reported 
here were routinely carried out on a 24 hour culture of adult 
rat hepatocytes (Day 2), and investigations did not exceed 
48 hours in length i.e. 72 hours from initiation. 24 hour cultures 
being used to allow recovery of the hepatocytes from the trauma 
of the cell isolation andaccliraatise to the new in vitro culture 
conditions,
5.3.2. Xenobiotic-induced Hepatotoxicity Studies in Short-term 
Maintenance Primary Cultures of Adult Rat Hepatocytes
Cultured adult rat hepatocytes were exposed to 2 levels of 
carbon tetrachloride (CCl^ ), (10^  ppm and lO'^ ppm) for 2 and 
6 hours. Viability of the hepatocytes was assessed by measuring 
cell number, leakage of cytoplasmic enzymes (GOT and GPT) and
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Figure 5.5. Light microscopic appearance of adult rat hepatocytes 
in primary maintenance culture after 2 days in culture
( X  200)
Stained with Haematoxylin and Eosin.
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r*
Figure 5.6. Light microscopic appearance of adult rat hepatoc^ùes 
in primary maintenance culture after 4 days in culture
(X 300)
Stained with Haematoxylin and Eosin.
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[^ C^] leucine uptake. The functional state of the hepatocytes WvS 
assessed by quantitative cytochemical analysis of three enzyme markers, 
glucose-6-phosphate dehydrogenase (cxrtoplasmic), succinate dehydrogenase 
(mitochondrial) and NADPH diaphorase (microsomal) measuring total 
enzyme activity within single cells which were still attached and 
considered to be viable. The results are presented in figures 5.7. 
and 5.8. IVhen hepatocytes were exposed to 10^  ppm CCl^ there was a 
very rapid toxic effect as judged by the various viability criteria 
(figure 5.7.), similar, but less marked effects, occurred with the
310 ppm dose. If, however the functional state of the hepatocytes 
was examined a slightly different pattern emerged (figure 5.8.). Once 
again the 10^  ppm dose caused a decrease in all tlrree enzymes studied 
the most rapid effect occurring with the cytoplasmic enzyme. Similar
3but less marked effects at the 10 ppm dose were observed with 
the mitochondrial and cjrtoplasmic enzyme markers. The microscrnal 
marker (NADPH diaphorase) on the other hand showed a steady increase in 
activity as the exposure time increased (154% of control value at 
6 hours). An increase in NADPH diaphorase was also detected in 
cultured adult rat hepatocytes exposed to much lower levels of CCl^ 
for 24 and 48 hours (figure 5.9. (a)). Tiiis increase, most marked after
48 hours continuous exposure at the lower levels studied (10 ^  ppm and
“210 ppm) decreases to almost control values at the 10 ppm dose. This 
is probably a reflection of CCl^ toxicity at the 10 ppm level, as it is 
accompanied by a significant decrease in the succinate dehydrogenase 
activity of the cultured rat hepatocytes (figure 5,9. (b)).
Changes in the viability of cultured rat adult hepatocytes after 
2 and 6 hoiucs exposure to 10 nM paracetamol were also detected (figure
5.10.). At this level paracetamol was found to be as toxic to rat
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Figure 5.9. Effect of Carbon Tetrachloride on (a) NADPH diaphorase activity 
and (b) Succinate dehydrogenase activity in Cultured Adult Rat 
Hepatocytes after 24 hours ( a ) and 48 hours ( © )
continuous exposure.
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3hépatocytes in culture as 10 ppa OCl,. Although decreases were 
noted in cell number and protein synthesis, leakage of cytoplasmic 
enzyeras (GOT and GPT) was relatively unaffected by paracetamol 
treatment. Changes in the functional state of the cultured hepatocytes 
after paracetamol treatment were again similar to those detected after
3exposure to 10 ppm CCl^ (figure 5.11.). Glucose-6-phosphate dehydrogenase 
and succinate dehydrogenase activity of treated hepatocytes was reduced, 
while JSIADPH diaphorase activity was increased (152% of control value).
owd cVcvvveyiS '
cAsc cN\4sLr Vovcvs
be (Table 5.1.). At the lowest level studied (0.1 pg/ml) NADPH
diaphorase activity was significantly increased (142% of control value), 
but was unchanged at the higher levels (1.0 and 10 ag/ml). Succinate 
dehydrogenase activity of these cultured hepatocytes was reduced by 
10 yg/ml dieldrin, whereas glucose-G-phosphate dehydrogenase activity 
was unaffected by all dose levels investigated. Viability changes were 
noted in the cultured hepatocytes after exposure to dieldrin at the 
1.0 and 10 yg/ml levels.
The morphological appearance of cultured adult rat hepatocytes 
after exposure to CCl^ (lo"^  ppm) and paracetamol (10 mM) for 6 hours 
compared to untreated cells is shown in figure 5.12. After staining 
v/ith haematoxylin and eosin, paracetamol-treated hepatocytes show no 
apparent morphological changes from the control cells, while the CCl^- 
treated hepatocytes exhibit a marked morphological response, manifested as 
an almost total loss in cytoplasmic staining properties. Plasma membranes 
of the 0C1^“treated hepatocytes are barely visible.
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Table 5.1. Effect of Dieldrin (48 hours Continuous Exposure) on 
Cultured Adult Rat Hepatocytes.
Rat hepatocytes were isolated and cultured as described in the 
Methods section. After 24 hours in culture at 37°C, the cells were 
subjected to continuous treatment with dieldrin, in the concentration 
range 0.1 - 10.0 yg/ml. for a further 48 hours at 37°C. Cell counts 
and the detection and quantitadion of enzyme activities within the 
hepatocytes were then carried out as already described.
Dieldi'in
Treatment(yg/ral)
Cell
Number
NADPH
diaphorase
Succinatedehydrogenase
Glucose-6-phosphate
dehydrogenase
None 15.7 ± 0.8 825 ± 80 1084 ± 111 3655 ± 221
0.1 13.0 ± 1.5 1174 ± 67** 1114 ± 70 3915 ± 392
1.0 12.2 ± 1.1* 989 ± 115 1032 ± 95 3891 4 232
10.0 11.0 ± 1.4* 798 ± 49 585 ± 98** 3614 ± 430
Cell numbers expressed as 10 cells/flask ± S.E.M.
Enzyme activities expressed in arbitrary machine units ± S.E.M. 
* Significantly different from control p < 0.05 
** Significantly different from controls p < 0.01
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Figure 5.12(a) Light microscopic appearance of untreated adult rat 
hepatocytes in primary maintenance culture
(x 400)
Stained with Haematoxylin and Eosin.
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Figure 5.12(b) Light microscopic appearance of adult rat hepatocytes 
in primary maintenance culture after exposure to 
10 rriM paracetamol for 6 hours.
(X 400)
Stained with Haematoxylin and Eosin.
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Figure 5.12(c) Light microscopic appearance of adult rat hepatocytes
4in primary maintenance culture after exposure to 10 ppm 
carbon tetrachloride for 6 hours
(X 400)
Stained wdth Haematoxylin and Eosin
250
Studies with the inducer phenobarbitone in cultured adult rat 
hepatocytes revealed that in vivo pretreatment of the animal with 
80 mg/kg phenobarbitone prior to isolation and culture of the 
liver results in an increase in MDPH diaphorase activity in 
the cultured hepatocytes, to 138% of the control value after 
24 hours, rising to over 200% after 48 hours of in vivo pretreatment 
with this inducer (figure 5.13.). This later increase agrees 
reasonably well with the increase detected after 48 hours treatment 
with (2 irM) phenobarbitone in vitro, (155% of control value).
5.3.3. Xenobiotic-induced Hepatotoxicilo/ Studies in Freshly Isolated 
Adult Rat Hepatocyte Si_ispensions
Freshly isolated rat hepatocyte suspensions were also used in 
the present studies. Toxicity in the hepatocytes was judged by the 
ability of the cells to exclude the dye rrypan blue after treatment 
with triethyltin and CCl^ . Triethyltin (lOyM-lmM) showed a dose- 
dependent cytotoxic response in the isolated rat hepatocytes (figure 
5.14) as did CCl^ (10^  ppm - 10^  ppm) (figure 5.15.).
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Figure 5.14 Toxicity of Triethyltin in Isolated Viable Adult Rat 
Hepatocyte Suspensions.
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Figure 5,15. Toxicity of Carbon Tetrachloride in Isolated Viable Adult 
Rat Hepatocyte Suspensions.
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5.4. DISCUSSION
5.4.1. Assessment of Xënobiotic-induced Hepatotoxicity in vitro in 
Adult Rat Hepatocytes
(i) Short-term Maintenance Primary Cultures
Studies have been directed toward the validity of this hepatocyte 
system for simulating vivo hepatotoxic potential using carbon 
tetrachloride, paracetamol and dieldrin as model compounds. The 
structural and biochemical changes that occur in the liver following 
carbon tetrachloride (Slater, 1972; Farber and El-Mofty, 1975; Judah, 1968), 
paracetamol (Mitchell et al, 1973; Dixon et 1975) and dieldrin 
(Alexander et 1968; Wright et 1972) intoxication have been 
well documented, as has the fact that metabolic activation is a pre­
requisite for the changes elicited by carbon tetrachloride (Slater,
1972) and paracetamol (Davis et 1976) to be manifested.
Inhibition of protein synthesis in the cultured rat hepatocytes 
observed in this study after treatment with CCl^ and paracetamol (figures 
5.7. and 5.10.) agrees well with observations in vivo (Smckler, 1968; 
Tliorgeirssonet al, 1976). Indeed this parameter was found to be the 
most sensitive criterion of normality employed. Toxicity in the 
cultured hepatocytes, as measured by a reduction in the incorporation 
of labelled leucine was detected after paracetamol treatment, before 
any other toxic manifestations, i.e. a reduction in cell number or 
lealcage of cytoplasmic enzymes were picked up (figure 5.10.). Enzyme 
leakage, a measure of severe damage to the plasma membrane was the most 
insensitive of the viability parameters used in these studies. This is 
an interesting finding, since this parameter is used clinically to indicate
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liver disease ^  vivo. It is conceivable therefore that enzyme 
leakage may not be the most sensitive diagnostic marker to use.
The most obvious signs of Œl. toxicity in this hepatocyte 
system was found to be in the cytoplasm, as indicated by the loss 
of glucose-6-phosphate dehydrogenase activity (figure 5.8.).
Paracetamol and dieldrin toxicity however was rrost apparent in 
the mitochondria and endoplasmic reticulum. For cytoplasmic activity 
as measured by glucose-6-phosphate dehydrogenase is relatively 
unaffected by these xenobiotics, the activities of the mitochondrial 
(succinate dehydrogenase) and endoplasmic reticulum (NADPH diaphorase) 
enzyme markers are significantly altered (figure 5.11., Table 5.1.).
Prom this study it was not possible to decide whether the increase 
in NADPH diaphorase activity (microsomal marker) after treatment with 
paracetamol, OCl^ or dieldrin, was due to activation of pre-existing 
enzyme or to ^  novo protein synthesis. Recent studies (J. Gwynn, 
unpublished work) showed that the increase in NADPH diaphorase activity 
reached a maximum after 8 hours continuous exposure to 10 ppm OCl^ 
but fell to control values after 24 hours exposure, indicating that 
activation is perhaps the more lilæly explanation. The increase in 
NADPH diaphorase activity of the cultured rat hepatocytes observed 
after pretreatment both in vivo and in vitro with the known inducer 
phenobarbitone (Figure 5.13. ), indicates that ^  novo protein 
synthesis cannot be entirely ruled out, especially as a similar effect 
was noted with-dieldrin which is also an inducer of cytochrome P-450 
MFO activity in vivo in rats, dogs and mice (Wright et 1972).
Activation of NADPH diaphorase acti\i.ty in cultured adult rat
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hepatocytes occurs only at low dose levels of the xenobiotics studied.
At higher levels, inhibition of enzyme activity results. This 
phenomenon has also been noted in cultured hepatocytes after treatment 
with a number of carcinogens and non-carcinogens (Lowing, 1977). %ether 
drug metabolising enzymes are also activated at these levels is not 
certain, for most in vivo studies with CCl  ^and paracetamol have used 
extremely high dose levels (Archakov and Karuzina, 1973; Thor^irsson 
et al, 1976) and have consequently detected only inhibition of the microscmal 
drug metabolising enzyme markers studied. It is conceivable that this 
phenomenon may represent a normal physiological response of the cell to 
stiess.
Changes that occur in liver cell morphology after in vivo administration 
of CCl^ and paracetamol are well known (Slater, 1972; Dixon et 1975) 
notably centrilobular necrosis and an increase in intracellular lipid. 
Although paracetamol (10 m&Q did not significantly affect the morphological 
appearance of cultured adult rat hepatocytes, lo"^ ppm CCl^  treatment was 
found to elicit a similar response to that which occurs ^  vivo (figure 
5.12.) i.e. an almost complete loss of c^ dioplasmic staining properties.
The absence of visible plasma membranes in the hepatocytes after such 
treatment, lend weight to the hypothesis that the mechanism of CCl^ 
toxicity in cultured adult rat hepatocytes is associated with a loss of 
membrane integrity.
(ii) Freshly-isolated Cell Suspensions
\V>iL oV Ct\v|, kx> isolated adult rat hepatocyte suspensions further
supports this contention (figure 5.15) as results obtained using this 
hepatocyte system are very similar to those obtained in the short-term 
hepatocyte cultures (figure 5.7.). Triethyltin is extremely toxic
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in vivo to rat liver and rat brain mitochondrial function (Aldridge, 1976) 
and the present studies show that it is toxic to isolated adult rat 
hepatocytes in suspension, though whether this effect is mediated by 
the impairment of mitochondrial function of these hepatocytes remains 
to be established.
With such studies it is important to know whether the best, i.e. 
the most sensitive parameters are being measured, and if another 
set of parameters were chosen would a different recense pattern emerge? 
Ihis is particularly important in the case of the cytochomical enzymes 
used in the present studies. The cytoplasmic enzyme marker, glucose- 
6-phosphate dehydrogenase is an important rate-limiting enzyme in 
cellular intermediary metabolism, and the microsomal enzyme marker 
NADPH diaphorase almost certainly reflects the rate-limiting step in 
the microsomal respiratory chain linked to cytochrome P-450 and so 
should be sensitive to xenobiotic-induced changes within the cell. The 
data presented here would suggest that microsomal NADPH diaphorase 
activity is particularly sensitive to such disturbances. Succinate 
dehydrogenase, the membrane-bound mitochondrial enzyme marker, is an 
essential part of the Krebs tricarboxjdic acid cycle, but how sensitive 
the enzyme is to xenobiotic-induced cell injury is unknown.
These studies demonstrate the potential of using viable rat 
hepatocytes both as short-term non-proliferating primary cultures and 
in suspension for the investigation of xenobiotic-induced hepatotoxicity 
in vitro, especially if adaptations of existing cell isolation and culture 
techniques can be made suitable for use with other species, in particular 
adult human liver. Adult human hepatocytes derived from human biopsy 
samples or freshly obtained hiojmn post-mortem spechmens, retaining most, 
if not all, of the in vivo adult liver specific functions in vitro
258
including xenobiotic metabolism would be the most appropriate in vitro 
model for the assessment of xenobiotic-induced hepatotoxicity and the 
carcinogenic and mutagenic potential of xenobiotics, providing problems 
of storage of such samples and sophistication of the appropriate 
measurement techniques can be overcome. Indeed there are reports already 
to be found in the literature concerned with the use of non-proliferating 
adult rat hepatocyte primary cultures for the assessment of carcinogenic 
potential, by the ability of the xenobiouic to induce unscheduled DNA 
synthesis in the cells (Williams, 1976; 1977; Lowing, 1977) and by the 
secretion of embryonic liver specific proteins, such as %-foetoprotein 
(Lowing, 1977). Preliminary studies in our laboratory using isolated 
rat hepatocytes in suspension have been able to detect early membrane 
changes (as measured by Concanavalin A-msdiated cellular agglutinability) 
after treatment in vitro with certain chemical carcinogens. They have 
highlighted the potential this system possesses as a possible In vitro 
screening technique for both direct-acting carcinogens, and those v/hich 
require activation. Validation of such in vitro systems however must 
be the priority of these investigations so that their relevance to the 
in vivo situation can be satisfactorily assessed.
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CHAPTER 6
Discussion
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CHAFIER 6
6.1. Final Discussion
Every extrapolation involves a conjectured knowledge of an 
unlmown area by inferences based on an assumed parallelism between 
it and what is known. In the present case we are interested in 
knowing viiat the hazard might be of xenobiotics bo humans. If the 
effects have been observed in humans, they can be described. If 
not, methods of predicting the effects of chemicals in man without 
deliberately exposing humans to substances of unknown toxic potential 
must be used. We can, for example, expose suitable non-human species, 
or even cell and tissues from humans to test substances and observe 
the effects. Then on the basis of these observations, we can 
conjecture about effects in humans. This is extrapolation. It is 
never perfect, but is is the best available approach so far devised.
Our under St anding of the toxic potential of xenobiotics newly 
introduced or already in the environment is at present based largely 
on pathological considerations. Conney et al (1974) have pointed 
out that because marked species differences exist in the rates and 
pathways of drug metabolism, they must be considered during the 
extrapolation of both pharmacological and toxic effects of a xenobiotic 
from one animal species to another and from animals to man. Since 
the liver is largely responsible for the metabolic fate of xenobiotics 
in both animals and man (Conney et 1977), the use of viable 
hepatocytes systems in vitro to investigate a wide range of toxicological 
problems would seem a desirable approach to the evaluation of species 
differences in metabolism and toxicity in man and other animal species.
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With the development of techniques for the isolation of 
large numbers of viable adult hepatocytes that retain a wide 
range of metabolic characteristics of the intact adult liver 
in vivo including xenobiotic metabolism (Chapter 2) such studies 
are feasible. Using viable adult rat hepatocytes in suspension 
or in short-term maintenance primary culture, the work described 
in this thesis has illustrated that the metabolic fate of a 
xenobiotic and the factors influencing it, the relationship between 
metabolism and toxicity and the mechanisms of xenobiotic-induced 
hepatotoxicity can be investigated.
Much information has been gained concerning xenobiotic metabolism 
that would not be possible using homogenate/fraction systems (Chapter 3). 
These include, toxicity of the substrate, further metabolism of the 
primary/ metabolite and the interrelationship between the various 
metabolic pathways. Since the hepatocyte systems bear a far closer 
resemblance to the state iu vivo than do tissue homogenates or cell 
fractions, they produce a much greater range of metabolites, particularly 
conjugates of the newly-formed phase I metabolites. The. use of inducers 
and certain metabolic inhibitors have shown how the total metabolic 
profile may be altered, both in extent and pattern,as would occur in 
vivo, as well as elucidating the role of cofactor levels and other 
organelles (i.e. mitochondria) in the regulation of drug metabolism.
Other possible rate-limiting phenomena operating in the intact cell 
such as control of of xenobiotics and/or tWvr metabolites has
also been assessed.
Armed with this information the hepatocytes have then been used For 
the production and detection of active metabolites.
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The mixed-cell approach used in the present -work (Chapter 4) 
has demonstrated that a number of xenobiotics that are known to 
require activation in vivo before their biological effects are 
manifested, also require activation by the hepatocytes in vitro 
before their fibroblast cytotoxicity is fully realised.
This approach potentially is a very versatile one, allowing the 
study of tissue, strain and species (including man) specific 
toxicity, as well as in vitro assessment of the mutagenic and/or 
carcinogenic potential of a xenobiotic. With this system not only 
can the rate at which the xenobiotic and/or its metabolites leave 
the cell be assessed, but also with the use of metabolic inhibitors 
and inducers (Chapter 3) the ' active metabolite ' contribution to the 
total metabolic profile and its relation to the cytotoxicity of the 
xenobiotic can be followed.
Studies with short-term maintenance primary adult rat primary 
cultures (Chapter 5) have shown that this preparation has a gi-eat 
deal to offer in the study of the mechanisms involved in xenobiotic- 
induced hepatotoxicity. Compounds that are knovzn to be injurious to 
the liver by very different mechanisms in vivo have been shown to be 
hepatotoxic in vitro. However such work has highlighted the paucity 
of suitably sensitive parameters available and the correct selection 
of such methods to assess toxicity in the hepatocytes.
Considerable further research is required in order to validate 
the use of such cells in vitro for general toxicological assessment 
of xenobiotics.
The use of isolated viable adult human hepatoc^ rtes would make
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the extrapolation of results obtained to the adult human in vivo 
much easier, providing problems concerning human liver cell 
isolation, culture, storage and the availability of sufficiently 
sensitive tecimiques can be overcome. However, extreme care must 
be exercised with extrapolation to the in vivo situation of any effects 
observed at the cellular level, \ttiile the lesion induced in a 
single cell or molecule is very significant and much can be learned 
from its pathogenesis, in vitro cellular systems to a degree lack 
complexity and the opportunity for interplay that is present in the 
whole intact animal.
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